PKN1
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A0A2R8Y4L2 | S95 | Sugiyama | HNRNPA1L3 HNRNPA1P48 | RPHKVDGRVVEPKRAVSREDsQRPDAHLTVKKIFVGGIKED |
| A5A3E0 | S1068 | Sugiyama | POTEF A26C1B | SLSTFQQMWISKQEyDEsGPsIVHRKCL_____________ |
| O00116 | T68 | Sugiyama | AGPS AAG5 | RPREALSTNECKARRAAsAAtAAPtAtPAAQEsGtIPKKRQ |
| O00273 | S28 | Sugiyama | DFFA DFF1 DFF45 H13 | GVPESGEIRTLKPCLLRRNysREQHGVAAsCLEDLRSKACD |
| O14617 | S658 | Sugiyama | AP3D1 PRO0039 | DERPRAVFHEEEQRRPKHRPsEADEEELARRREARKQEQAN |
| O14965 | S342 | EPSD | AURKA AIK AIRK1 ARK1 AURA AYK1 BTAK IAK1 STK15 STK6 | FLVGKPPFEANTYQETYKRIsRVEFTFPDFVTEGARDLISR |
| O14965 | T288 | EPSD | AURKA AIK AIRK1 ARK1 AURA AYK1 BTAK IAK1 STK15 STK6 | GELKIADFGWsVHAPssRRttLCGTLDYLPPEMIEGRMHDE |
| O14974 | S910 | Sugiyama | PPP1R12A MBS MYPT1 | yETssTsAGDRyDsLLGRsGsysYLEERKPYSSRLEKDDST |
| O15067 | S215 | Sugiyama | PFAS KIAA0361 | LDSWDLDFYTKRFQELQRNPstVEAFDLAQsNsEHSRHWFF |
| O15067 | T216 | Sugiyama | PFAS KIAA0361 | DSWDLDFYTKRFQELQRNPstVEAFDLAQsNsEHSRHWFFK |
| O15143 | T21 | EPSD | ARPC1B ARC41 | MAYHSFLVEPISCHAWNKDRtQIAICPNNHEVHIyEKSGAK |
| O15553 | S208 | SIGNOR|EPSD|PSP | MEFV MEF TRIM20 | PGPCRALEGGQAEVRLRRNAssAGRLQGLAGGAPGQKECRP |
| O15553 | S242 | SIGNOR|EPSD|PSP | MEFV MEF TRIM20 | GQKECRPFEVYLPSGKMRPRsLEVTISTGEKAPANPEILLT |
| O43615 | S193 | Sugiyama | TIMM44 MIMT44 TIM44 | TAAFRALsQGVEsVKKEIDDsVLGQtGPyRRPQRLRKRTEF |
| O43623 | S251 | EPSD | SNAI2 SLUG SLUGH | HLQTHsDVKKYQCKNCsKTFsRMsLLHKHEESGCCVAH___ |
| O43823 | S125 | Sugiyama | AKAP8 AKAP95 | KEGGRGGsGGGGEGIQDREssFRFQPFESYDSRPCLPEHNP |
| O60814 | S37 | Sugiyama | H2BC12 H2BFT HIRIP1 HIST1H2BK | KAVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| O60814 | S39 | Sugiyama | H2BC12 H2BFT HIRIP1 HIST1H2BK | VTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| O60841 | S222 | Sugiyama | EIF5B IF2 KIAA0741 | KNQKNKPGPNIEsGNEDDDAsFKIKTVAQKKAEKKERERKK |
| O95678 | S162 | Sugiyama | KRT75 K6HF KB18 | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWA |
| O95863 | S246 | SIGNOR|EPSD | SNAI1 SNAH | HLQTHsDVKKYQCQACARTFsRMsLLHKHQESGCSGCPR__ |
| P00533 | T678 | SIGNOR|EPSD|PSP | EGFR ERBB ERBB1 HER1 | LVVALGIGLFMRRRHIVRKRtLRRLLQERELVEPLtPsGEA |
| P00558 | Y161 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | KAEPAKIEAFRAsLSKLGDVyVNDAFGtAHRAHssMVGVNL |
| P02538 | S176 | Sugiyama | KRT6A K6A KRT6D | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWT |
| P03372 | S305 | EPSD | ESR1 ESR NR3A1 | DMRAANLWPsPLMIKRSKKNsLALSLtADQMVSALLDAEPP |
| P04049 | S338 | SIGNOR|EPSD | RAF1 RAF | RAPVsGtQEKNKIRPRGQRDssyyWEIEASEVMLSTRIGsG |
| P04049 | S339 | SIGNOR|EPSD | RAF1 RAF | APVsGtQEKNKIRPRGQRDssyyWEIEASEVMLSTRIGsGs |
| P04075 | S336 | Sugiyama | ALDOA ALDA | GKKENLKAAQEEYVKRALANsLACQGKytPsGQAGAAAsEs |
| P04075 | S39 | Sugiyama | ALDOA ALDA | IAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRRFy |
| P04075 | S46 | Sugiyama | ALDOA ALDA | PGKGILAADEstGsIAKRLQsIGtENtEENRRFyRQLLLtA |
| P04259 | S176 | Sugiyama | KRT6B K6B KRTL1 | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLDTKWT |
| P04406 | S241 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | IPELNGKLtGMAFRVPtANVsVVDLtCRLEKPAKyDDIKKV |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P04792 | S83 | Sugiyama | HSPB1 HSP27 HSP28 | IEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVNH |
| P05455 | S94 | Sugiyama | SSB | KSKAELMEIsEDKTKIRRsPsKPLPEVTDEyKNDVKNRsVY |
| P05783 | S93 | Sugiyama | KRT18 CYK18 PIG46 | GMGGIQNEKETMQsLNDRLAsyLDRVRSLETENRRLESKIR |
| P05787 | S104 | Sugiyama | KRT8 CYK8 | IQAVRTQEKEQIKTLNNKFAsFIDKVRFLEQQNKMLETKWS |
| P05787 | S410 | Sugiyama | KRT8 CYK8 | TYRKLLEGEESRLEsGMQNMsIHtKTTSGYAGGLSSAYGGL |
| P06899 | S37 | Sugiyama | H2BC11 H2BFR HIST1H2BJ | KAVTKAQKKDGKKRKRSRKEsysIyVyKVLKQVHPDTGISS |
| P06899 | S39 | Sugiyama | H2BC11 H2BFR HIST1H2BJ | VTKAQKKDGKKRKRSRKEsysIyVyKVLKQVHPDTGISSKA |
| P07195 | S303 | Sugiyama | LDHB | GIENEVFLSLPCILNARGLtsVINQKLKDDEVAQLKKsADt |
| P07205 | Y161 | Sugiyama | PGK2 PGKB | KAEPDKIEAFRAsLSKLGDVyVNDAFGtAHRAHSSMVGVNL |
| P07737 | S57 | Sugiyama | PFN1 | GKtFVNITPAEVGVLVGKDRssFyVNGLtLGGQKCsVIRDs |
| P07737 | S58 | Sugiyama | PFN1 | KtFVNITPAEVGVLVGKDRssFyVNGLtLGGQKCsVIRDsL |
| P07814 | S335 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | PIEKNLQMWEEMKKGsQFGQsCCLRAKIDMSSNNGCMRDPt |
| P07900 | S53 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | IINtFySNKEIFLRELIsNssDALDKIRyEsLtDPsKLDsG |
| P07900 | Y284 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | DEEEEKKDGDKKKKKKIKEKyIDQEELNKtKPIWtRNPDDI |
| P08238 | S45 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | MSLIINTFYSNKEIFLRELIsNAsDALDKIRyEsLtDPsKL |
| P08238 | S462 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | HEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKs |
| P08238 | Y276 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | DEEDDsGKDKKKKTKKIKEKyIDQEELNKtKPIWtRNPDDI |
| P08670 | S51 | EPSD | VIM | VttsTRtYsLGsALRPstsRsLyAssPGGVyAtRssAVRLR |
| P08670 | S56 | EPSD | VIM | RtYsLGsALRPstsRsLyAssPGGVyAtRssAVRLRssVPG |
| P08670 | S73 | EPSD | VIM | yAssPGGVyAtRssAVRLRssVPGVRLLQDsVDFsLADAIN |
| P08729 | S104 | Sugiyama | KRT7 SCL | LQRVRQEESEQIKTLNNKFAsFIDKVRFLEQQNKLLETKWT |
| P09651 | S95 | Sugiyama | HNRNPA1 HNRPA1 | RPHKVDGRVVEPKRAVsREDsQRPGAHLtVKKIFVGGIKED |
| P0C0L4 | S1294 | Sugiyama | C4A CO4 CPAMD2 | LHEGKAEMADQASAWLTRQGsFQGGFRSTQDTVIALDALSA |
| P0C0L5 | S1294 | Sugiyama | C4B CO4 CPAMD3; C4B_2 | LHEGKAEMADQAAAWLTRQGsFQGGFRSTQDTVIALDALSA |
| P0CG38 | S1068 | Sugiyama | POTEI | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P0CG39 | S1031 | Sugiyama | POTEJ | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P10636 | S214 | EPSD | MAPT MAPTL MTBT1 TAU | GDLHQEGPPLKGAGGKERPGsKEEVDEDRDVDESsPQDsPP |
| P10636 | S531 | EPSD | MAPT MAPTL MTBT1 TAU | RsGyssPGsPGtPGsRsRtPsLPtPPTREPKKVAVVRtPPK |
| P10636 | S575 | EPSD | MAPT MAPTL MTBT1 TAU | sAKSRLQTAPVPMPDLKNVKsKIGstENLKHQPGGGKVQII |
| P10636 | S637 | SIGNOR|EPSD | MAPT MAPTL MTBT1 TAU | VPGGGsVQIVyKPVDLSKVTsKCGsLGNIHHKPGGGQVEVK |
| P10636 | S669 | EPSD | MAPT MAPTL MTBT1 TAU | PGGGQVEVKSEKLDFKDRVQsKIGsLDNITHVPGGGNKKIE |
| P11142 | S340 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | ALRDAKLDKsQIHDIVLVGGstRIPKIQKLLQDFFNGKELN |
| P11532 | S3623 | Sugiyama | DMD | EAKVNGttVssPstsLQRsDssQPMLLRVVGSQTSDSMGEE |
| P12035 | S211 | Sugiyama | KRT3 | IGQVKAQEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWN |
| P13639 | S23 | Sugiyama | EEF2 EF2 | NFtVDQIRAIMDKKANIRNMsVIAHVDHGKStLtDsLVCKA |
| P13639 | S38 | Sugiyama | EEF2 EF2 | NIRNMsVIAHVDHGKStLtDsLVCKAGIIAsARAGEtRFtD |
| P13647 | S181 | Sugiyama | KRT5 | IQRVRTEEREQIKTLNNKFAsFIDKVRFLEQQNKVLDTKWT |
| P13667 | S126 | Sugiyama | PDIA4 ERP70 ERP72 | NILKDKDPPIPVAKIDAtsAsVLAsRFDVsGyPtIKILKKG |
| P13797 | S339 | Sugiyama | PLS3 | PRIDINMsGFNETDDLKRAEsMLQQADKLGCRQFVTPADVV |
| P13861 | S99 | Sugiyama | PRKAR2A PKR2 PRKAR2 | EsEEDEDLEVPVPsRFNRRVsVCAEtyNPDEEEEDTDPRVI |
| P14314 | S126 | Sugiyama | PRKCSH G19P1 | yNsGVICENtCKEKGRKEREsLQQMAEVtREGFRLKKILIE |
| P14625 | S106 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | MKLIINSLYKNKEIFLRELIsNAsDALDKIRLISLTDENAL |
| P14625 | S514 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | LGVIEDHsNRtRLAKLLRFQssHHPtDItsLDQyVERMKEK |
| P14625 | T519 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | DHsNRtRLAKLLRFQssHHPtDItsLDQyVERMKEKQDKIy |
| P15056 | S446 | EPSD | BRAF BRAF1 RAFB1 | RKsssssEDRNRMKtLGRRDssDDWEIPDGQITVGQRIGsG |
| P15880 | S190 | Sugiyama | RPS2 RPS4 | WGNKIGKPHTVPCKVTGRCGsVLVRLIPAPRGtGIVsAPVP |
| P16949 | S16 | EPSD | STMN1 C1orf215 LAP18 OP18 | _____MAssDIQVKELEKRAsGQAFELILsPRsKEsVPEFP |
| P16949 | S38 | EPSD | STMN1 C1orf215 LAP18 OP18 | QAFELILsPRsKEsVPEFPLsPPKKKDLsLEEIQKKLEAAE |
| P17600 | S605 | EPSD | SYN1 | QQRQGPPQKPPGPAGPTRQAsQAGPVPRTGPPTTQQPRPSG |
| P17812 | S575 | Sugiyama | CTPS1 CTPS | LQKGCRLsPRDtysDRsGsssPDsEItELKFPsINHD____ |
| P17987 | S374 | Sugiyama | TCP1 CCT1 CCTA | ERICDDELILIKNTKARTsAsIILRGANDFMCDEMERSLHD |
| P18615 | S135 | Sugiyama | NELFE RD RDBP | sADDDLQEsSRRPQRKsLyEsFVsssDRLRELGPDGEEAEG |
| P18669 | S118 | SIGNOR|EPSD | PGAM1 PGAMA CDABP0006 | LNKAETAAKHGEAQVKIWRRsyDVPPPPMEPDHPFysNIsK |
| P18669 | S23 | SIGNOR|EPSD | PGAM1 PGAMA CDABP0006 | AYKLVLIRHGEsAWNLENRFsGWyDADLsPAGHEEAKRGGQ |
| P19086 | S16 | EPSD | GNAZ | _____MGCRQSSEEKEAARRsRRIDRHLRSEsQRQRREIKL |
| P19338 | S328 | Sugiyama | NCL | NLFVGNLNFNKSAPELKtGIsDVFAKNDLAVVDVRIGMTRK |
| P19338 | S460 | Sugiyama | NCL | ADAEKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKNST |
| P20618 | S162 | Sugiyama | PSMB1 PSC5 | DEEGKGAVysFDPVGsyQRDsFKAGGSASAMLQPLLDNQVG |
| P21333 | S2152 | EPSD | FLNA FLN FLN1 | VKVTGEGRVKEsITRRRRAPsVANVGsHCDLsLKIPEIsIQ |
| P21333 | S2292 | EPSD | FLNA FLN FLN1 | AIAVEGPsKAEIsFEDRKDGsCGVAyVVQEPGDyEVsVKFN |
| P21333 | S2370 | EPSD | FLNA FLN FLN1 | PASFAVSLNGAKGAIDAKVHsPsGALEECyVtEIDQDKYAV |
| P22626 | S189 | Sugiyama | HNRNPA2B1 HNRPA2B1 | IVLQKyHtINGHNAEVRKALsRQEMQEVQssRsGRGGNFGF |
| P22626 | S212 | Sugiyama | HNRNPA2B1 HNRPA2B1 | EMQEVQssRsGRGGNFGFGDsRGGGGNFGPGPGsNFRGGsD |
| P23246 | S283 | Sugiyama | SFPQ PSF | GPGGRsEEKIsDsEGFKANLsLLRRPGEKTyTQRCRLFVGN |
| P23527 | S37 | Sugiyama | H2BC17 H2BFH H2BFN HIST1H2BO | KAVTKAQKKDGKKRKRSRKEsysIyVyKVLKQVHPDTGISS |
| P23527 | S39 | Sugiyama | H2BC17 H2BFH H2BFN HIST1H2BO | VTKAQKKDGKKRKRSRKEsysIyVyKVLKQVHPDTGISSKA |
| P24534 | S141 | Sugiyama | EEF1B2 EEF1B EF1B | ERLAQYESKKAKKPALVAKssILLDVKPWDDEtDMAKLEEC |
| P24844 | S20 | EPSD | MYL9 MLC2 MRLC1 MYRL2 | _MssKRAKAKtTKKRPQRAtsNVFAMFDQSQIQEFKEAFNM |
| P25789 | S7 | Sugiyama | PSMA4 HC9 PSC9 | ______________MSRRyDsRttIFsPEGRLYQVEYAMEA |
| P25789 | T9 | Sugiyama | PSMA4 HC9 PSC9 | ____________MSRRyDsRttIFsPEGRLYQVEYAMEAIG |
| P26373 | S181 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | YKKEKARVItEEEKNFKAFAsLRMARANARLFGIRAKRAKE |
| P26373 | S77 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PIVRCPTVRYHTKVRAGRGFsLEELRVAGIHKKVARTIGIs |
| P26641 | T287 | Sugiyama | EEF1G EF1G PRO1608 | EQALAAEPKAKDPFAHLPKstFVLDEFKRKysNEDtLsVAL |
| P27348 | S45 | Sugiyama | YWHAQ | CMKAVtEQGAELsNEERNLLsVAyKNVVGGRRSAWRVIsSI |
| P27816 | S827 | Sugiyama | MAP4 | VAKtttAAAVAstGPssRsPstLLPKKPTAIKTEGKPAEVK |
| P29466 | S376 | EPSD | CASP1 IL1BC IL1BCE | HMQEYACSCDVEEIFRKVRFsFEQPDGRAQMPTTERVTLTR |
| P29692 | S44 | Sugiyama | EEF1D EF1D | RFyEQMNGPVAGAsRQENGAsVILRDIARARENIQKsLAGs |
| P29966 | S159 | SIGNOR|iPTMNet|EPSD | MARCKS MACS PRKCSL | EDGAtPsPsNEtPKKKKKRFsFKKsFKLsGFsFKKNKKEAG |
| P29966 | S163 | SIGNOR|iPTMNet|EPSD | MARCKS MACS PRKCSL | tPsPsNEtPKKKKKRFsFKKsFKLsGFsFKKNKKEAGEGGE |
| P29966 | S170 | SIGNOR|iPTMNet|EPSD | MARCKS MACS PRKCSL | tPKKKKKRFsFKKsFKLsGFsFKKNKKEAGEGGEAEAPAAE |
| P30086 | S52 | Sugiyama | PEBP1 PBP PEBP | AAVDELGKVLtPtQVKNRPtsIsWDGLDsGKLytLVLtDPD |
| P30101 | T485 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | KKyEGGRELsDFIsyLQREAtNPPVIQEEKPKKKKKAQEDL |
| P30307 | S216 | SIGNOR|iPTMNet|EPSD | CDC25C | EFsLKDQEAKVSRsGLYRsPsMPENLNRPRLKQVEKFKDNt |
| P30622 | S312 | EPSD|PSP | CLIP1 CYLN1 RSN | KANAVRRVMATtsAsLKRsPsAssLsSMSSVASSVSSRPSR |
| P31152 | S186 | EPSD | MAPK4 ERK4 PRKM4 | IGDFGLARIVDQHYSHKGYLsEGLVTKWYRsPRLLLSPNNY |
| P31946 | S47 | Sugiyama | YWHAB | AMKAVtEQGHELsNEERNLLsVAyKNVVGARRSsWRVIsSI |
| P31947 | S45 | Sugiyama | SFN HME1 | FMKGAVEKGEELsCEERNLLsVAyKNVVGGQRAAWRVLSsI |
| P32969 | Y180 | Sugiyama | RPL9 OK/SW-cl.103; RPL9P7; RPL9P8; RPL9P9 | LIQQATTVKNKDIRKFLDGIyVsEKGtVQQADE________ |
| P33778 | S37 | Sugiyama | H2BC3 H2BFF HIST1H2BB | KAITKAQKKDGKKRKRsRKEsysIyVyKVLKQVHPDTGISS |
| P33778 | S39 | Sugiyama | H2BC3 H2BFF HIST1H2BB | ITKAQKKDGKKRKRsRKEsysIyVyKVLKQVHPDTGISSKA |
| P35222 | S675 | EPSD | CTNNB1 CTNNB OK/SW-cl.35 PRO2286 | AAAVLFRMSEDKPQDyKKRLsVELtssLFRTEPMAWNETAD |
| P35240 | S518 | EPSD | NF2 SCH | FNLIGDSLSFDFKDTDMKRLsMEIEKEKVEYMEKSKHLQEQ |
| P35579 | S1915 | Sugiyama | MYH9 | KLQRELEDAtEtADAMNREVssLKNKLRRGDLPFVVPRRMA |
| P35908 | S191 | Sugiyama | KRT2 KRT2A KRT2E | IQNVKAQEREQIKTLNNKFAsFIDKVRFLEQQNQVLQTKWE |
| P36578 | S87 | Sugiyama | RPL4 RPL1 | WGtGRAVARIPRVRGGGtHRsGQGAFGNMCRGGRMFAPTKT |
| P36578 | T84 | Sugiyama | RPL4 RPL1 | AEsWGtGRAVARIPRVRGGGtHRsGQGAFGNMCRGGRMFAP |
| P36871 | T467 | SIGNOR|EPSD | PGM1 | ALMFDRSFVGKQFSANDKVYtVEKADNFEysDPVDGsIsRN |
| P37802 | S163 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | LFsGDPNWFPKKSKENPRNFsDNQLQEGKNVIGLQMGtNRG |
| P37802 | S185 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | NQLQEGKNVIGLQMGtNRGAsQAGMtGyGMPRQIL______ |
| P37837 | S13 | Sugiyama | TALDO1 TAL TALDO TALDOR | ________MsssPVKRQRMEsALDQLKQFTTVVADTGDFHA |
| P38606 | S384 | Sugiyama | ATP6V1A ATP6A1 ATP6V1A1 VPP2 | RLAEMPADSGYPAyLGARLAsFYERAGRVKCLGNPEREGSV |
| P38646 | T116 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | DGERLVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDPEVQKD |
| P38646 | Y118 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | ERLVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDPEVQKDIK |
| P39023 | S13 | Sugiyama | RPL3 OK/SW-cl.32 | ________MSHRKFSAPRHGsLGFLPRKRSSRHRGKVKSFP |
| P42677 | S78 | Sugiyama | RPS27 MPS1 | GCSTVLCQPTGGKARLtEGCsFRRKQH______________ |
| P43034 | S152 | Sugiyama | PAFAH1B1 LIS1 MDCR MDS PAFAHA | IKVWDyEtGDFERtLKGHtDsVQDIsFDHsGKLLASCSADM |
| P43243 | S188 | Sugiyama | MATR3 KIAA0723 | EPPyRVPRDDWEEKRHFRRDsFDDRGPsLNPVLDyDHGsRs |
| P43487 | S60 | Sugiyama | RANBP1 | TLEEDEEELFKMRAKLFRFAsENDLPEWKERGTGDVKLLKH |
| P43490 | S472 | Sugiyama | NAMPT PBEF PBEF1 | EYGQDLLHTVFKNGKVTKsysFDEIRKNAQLNIELEAAHH_ |
| P46108 | S41 | EPSD | CRK | QEAVALLQGQRHGVFLVRDsstsPGDyVLSVSENSRVSHYI |
| P46776 | S68 | Sugiyama | RPL27A | yHPGyFGKVGMKHYHLKRNQsFCPtVNLDKLWtLVsEQtRV |
| P46777 | S176 | Sugiyama | RPL5 MSTP030 | GNKVFGALKGAVDGGLsIPHstKRFPGyDsEsKEFNAEVHR |
| P46777 | S224 | Sugiyama | RPL5 MSTP030 | VADyMRyLMEEDEDAyKKQFsQyIKNsVtPDMMEEMyKKAH |
| P47914 | Y98 | Sugiyama | RPL29 | PKEVKPKIPKGVSRKLDRLAyIAHPKLGKRARARIAKGLRL |
| P48668 | S176 | Sugiyama | KRT6C KRT6E | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLDTKWT |
| P49023 | S258 | EPSD | PXN | NQGEMssPQRVTsTQQQtRIsAssAtRELDELMAsLsDFKI |
| P49023 | S272 | EPSD | PXN | QQQtRIsAssAtRELDELMAsLsDFKIQGLEQRADGERCWA |
| P49588 | S775 | Sugiyama | AARS1 AARS | VTGAEAQKALRKAESLKKCLsVMEAKVKAQTAPNKDVQREI |
| P50395 | T425 | Sugiyama | GDI2 RABGDIB | DAttHFEttCDDIKNIYKRMtGsEFDFEEMKRKKNDIYGED |
| P51114 | S420 | EPSD | FXR1 | GtNsELsNPsEtEsERKDELsDWsLAGEDDRDsRHQRDSRR |
| P51116 | S601 | Sugiyama | FXR2 FMR1L2 | RPQRRNRSRRRRNRGNRtDGsIsGDRQPVtVADyIsRAEsQ |
| P51532 | S1382 | Sugiyama | SMARCA4 BAF190A BRG1 SNF2B SNF2L4 | EEEKMFGRGSRHRKEVDYsDsLTEKQWLKAIEEGtLEEIEE |
| P51991 | S375 | Sugiyama | HNRNPA3 HNRPA3 | ssGsPyGGGyGsGGGsGGyGsRRF_________________ |
| P52298 | S13 | Sugiyama | NCBP2 CBP20 PIG55 | ________MSGGLLKALRsDsyVELSQYRDQHFRGDNEEQE |
| P52565 | S101 | EPSD | ARHGDIA GDIA1 | SAPGPLELDLtGDLEsFKKQsFVLKEGVEYRIKISFRVNRE |
| P52565 | S174 | EPSD | ARHGDIA GDIA1 | EEyEFLtPVEEAPKGMLARGsYsIKSRFTDDDKTDHLSWEW |
| P53350 | S49 | EPSD | PLK1 PLK | GAPAAAPPAKEIPEVLVDPRsRRRYVRGRFLGKGGFAKCFE |
| P53396 | S455 | Sugiyama | ACLY | ANFLLNAsGststPAPsRtAsFsEsRADEVAPAKKAKPAMP |
| P53667 | T508 | EPSD | LIMK1 LIMK | EKTQPEGLRSLKKPDRKKRYtVVGNPyWMAPEMINGRSYDE |
| P55010 | S10 | Sugiyama | EIF5 | ___________MSVNVNRsVsDQFyRyKMPRLIAKVEGKGN |
| P57053 | S37 | Sugiyama | H2BC12L H2BFS H2BS1 | KAVTKAQKKDGRKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| P57053 | S39 | Sugiyama | H2BC12L H2BFS H2BS1 | VTKAQKKDGRKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| P58012 | S263 | EPSD | FOXL2 | AVVKGLAGPAASYGPyTRVQsMALPPGVVNSYNGLGGPPAA |
| P58876 | S37 | Sugiyama | H2BC5 H2BFB HIRIP2 HIST1H2BD | KAVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| P58876 | S39 | Sugiyama | H2BC5 H2BFB HIRIP2 HIST1H2BD | VTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| P60709 | S199 | Sugiyama | ACTB | DLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyV |
| P60709 | S323 | Sugiyama | ACTB | ttMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGG |
| P60709 | S368 | Sugiyama | ACTB | sLstFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P60709 | S52 | Sugiyama | ACTB | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P60709 | T324 | Sugiyama | ACTB | tMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGGs |
| P60709 | Y53 | Sugiyama | ACTB | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEH |
| P60900 | S177 | Sugiyama | PSMA6 PROS27 | AGyyCGFKATAAGVKQtEstsFLEKKVKKKFDWTFEQTVET |
| P61254 | S31 | Sugiyama | RPL26 | RsKNRKRHFNAPsHIRRKIMssPLSKELRQKYNVRSMPIRK |
| P61313 | S100 | Sugiyama | RPL15 EC45 TCBAP0781 | tyGKPVHHGVNQLKFARsLQsVAEERAGRHCGALRVLNsyW |
| P61313 | Y6 | Sugiyama | RPL15 EC45 TCBAP0781 | _______________MGAYKyIQELWRKKQSDVMRFLLRVR |
| P61978 | S75 | Sugiyama | HNRNPK HNRPK | GAVIGKGGKNIKALRtDyNAsVsVPDssGPERILsISADIE |
| P61981 | S46 | Sugiyama | YWHAG | AMKNVtELNEPLsNEERNLLsVAyKNVVGARRSsWRVIsSI |
| P62258 | S46 | Sugiyama | YWHAE | SMKKVAGMDVELTVEERNLLsVAyKNVIGARRASWRIIssI |
| P62263 | S139 | Sugiyama | RPS14 PRO2640 | LARSGMKIGRIEDVtPIPsDstRRKGGRRGRRL________ |
| P62266 | S45 | Sugiyama | RPS23 | KQYKKAHLGtALKANPFGGAsHAKGIVLEKVGVEAKQPNSA |
| P62273 | Y7 | Sugiyama | RPS29 | ______________MGHQQLyWsHPRKFGQGSRSCRVCSNR |
| P62277 | S12 | Sugiyama | RPS13 | _________MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDD |
| P62277 | S14 | Sugiyama | RPS13 | _______MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDDVK |
| P62280 | T15 | Sugiyama | RPS11 | ______MADIQTERAyQKQPtIFQNKKRVLLGEtGKEKLPR |
| P62701 | T247 | Sugiyama | RPS4X CCG2 RPS4 SCAR | VIGKGNKPWIsLPRGKGIRLtIAEERDKRLAAKQSSG____ |
| P62736 | S325 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P62736 | S54 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P62736 | T326 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P62736 | Y55 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P62807 | S37 | Sugiyama | H2BC4 H2BFL HIST1H2BC; H2BC6 H2BFH HIST1H2BE; H2BC7 H2BFG HIST1H2BF; H2BC8 H2BFA HIST1H2BG; H2BC10 H2BFK HIST1H2BI | KAVTKAQKKDGKKRKRsRKEsysVyVyKVLKQVHPDTGIss |
| P62807 | S39 | Sugiyama | H2BC4 H2BFL HIST1H2BC; H2BC6 H2BFH HIST1H2BE; H2BC7 H2BFG HIST1H2BF; H2BC8 H2BFA HIST1H2BG; H2BC10 H2BFK HIST1H2BI | VTKAQKKDGKKRKRsRKEsysVyVyKVLKQVHPDTGIssKA |
| P62899 | S15 | Sugiyama | RPL31 | ______MAPAKKGGEKKKGRsAINEVVtREytINIHKRIHG |
| P62899 | T26 | Sugiyama | RPL31 | KGGEKKKGRsAINEVVtREytINIHKRIHGVGFKKRAPRAL |
| P62906 | S64 | Sugiyama | RPL10A NEDD6 | QKDKRFsGTVRLKSTPRPKFsVCVLGDQQHCDEAKAVDIPH |
| P62917 | S130 | Sugiyama | RPL8 | GTIVCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKL |
| P62917 | S14 | Sugiyama | RPL8 | _______MGRVIRGQRKGAGsVFRAHVKHRKGAARLRAVDF |
| P62917 | T135 | Sugiyama | RPL8 | CLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSGSK |
| P62917 | Y133 | Sugiyama | RPL8 | VCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSG |
| P62942 | T22 | Sugiyama | FKBP1A FKBP1 FKBP12 | GVQVEtIsPGDGRtFPKRGQtCVVHytGMLEDGKKFDSSRD |
| P63104 | S45 | Sugiyama | YWHAZ | CMKsVtEQGAELsNEERNLLsVAyKNVVGARRssWRVVssI |
| P63167 | S88 | EPSD | DYNLL1 DLC1 DNCL1 DNCLC1 HDLC1 | HETKHFIYFYLGQVAILLFKsG___________________ |
| P63261 | S199 | Sugiyama | ACTG1 ACTG | DLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyV |
| P63261 | S323 | Sugiyama | ACTG1 ACTG | ttMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGG |
| P63261 | S368 | Sugiyama | ACTG1 ACTG | sLstFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P63261 | S52 | Sugiyama | ACTG1 ACTG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P63261 | T324 | Sugiyama | ACTG1 ACTG | tMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGGs |
| P63261 | Y53 | Sugiyama | ACTG1 ACTG | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEH |
| P63267 | S324 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P63267 | S53 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P63267 | T325 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P63267 | Y54 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P67809 | S136 | Sugiyama | YBX1 NSEP1 YB1 | GEKGAEAANVtGPGGVPVQGsKYAADRNHYRRYPRRRGPPR |
| P67809 | Y196 | Sugiyama | YBX1 NSEP1 YB1 | sAPEGQAQQRRPyRRRRFPPyyMRRPYGRRPQysNPPVQGE |
| P68032 | S325 | Sugiyama | ACTC1 ACTC | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P68032 | S54 | Sugiyama | ACTC1 ACTC | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68032 | T326 | Sugiyama | ACTC1 ACTC | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P68032 | Y55 | Sugiyama | ACTC1 ACTC | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P68104 | T432 | Sugiyama | EEF1A1 EEF1A EF1A LENG7 | VEsFSDyPPLGRFAVRDMRQtVAVGVIKAVDKKAAGAGKVT |
| P68133 | S325 | Sugiyama | ACTA1 ACTA | TTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P68133 | S54 | Sugiyama | ACTA1 ACTA | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68133 | T326 | Sugiyama | ACTA1 ACTA | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P68133 | Y55 | Sugiyama | ACTA1 ACTA | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P68431 | S11 | EPSD | H3C1 H3FA HIST1H3A; H3C2 H3FL HIST1H3B; H3C3 H3FC HIST1H3C; H3C4 H3FB HIST1H3D; H3C6 H3FD HIST1H3E; H3C7 H3FI HIST1H3F; H3C8 H3FH HIST1H3G; H3C10 H3FK HIST1H3H; H3C11 H3FF HIST1H3I; H3C12 H3FJ HIST1H3J | __________MARtKQtARKstGGKAPRKQLATKAARKsAP |
| P68431 | T12 | EPSD | H3C1 H3FA HIST1H3A; H3C2 H3FL HIST1H3B; H3C3 H3FC HIST1H3C; H3C4 H3FB HIST1H3D; H3C6 H3FD HIST1H3E; H3C7 H3FI HIST1H3F; H3C8 H3FH HIST1H3G; H3C10 H3FK HIST1H3H; H3C11 H3FF HIST1H3I; H3C12 H3FJ HIST1H3J | _________MARtKQtARKstGGKAPRKQLATKAARKsAPA |
| P78545 | S207 | EPSD | ELF3 ERT ESX JEN | GAPSPGSSDVSTAGTGASRSsHSsDsGGsDVDLDPTDGKLF |
| P83731 | S38 | Sugiyama | RPL24 | GRRYARTDGKVFQFLNAKCEsAFLSKRNPRQINWtVLyRRK |
| P84098 | S12 | Sugiyama | RPL19 | _________MSMLRLQKRLAssVLRCGKKKVWLDPNEtNEI |
| P84098 | S122 | Sugiyama | RPL19 | LRRLLRRYRESKKIDRHMyHsLyLKVKGNVFKNKRILMEHI |
| P84098 | S13 | Sugiyama | RPL19 | ________MSMLRLQKRLAssVLRCGKKKVWLDPNEtNEIA |
| Q00341 | S904 | Sugiyama | HDLBP HBP VGL | FHRSVMGPKGSRIQQITRDFsVQIKFPDREENAVHSTEPVV |
| Q00587 | S192 | Sugiyama | CDC42EP1 BORG5 CEP1 MSE55 | PHDRDRDGsFPsEPGLRRsDsLLsFRLDLDLGPSLLSELLG |
| Q00839 | Y260 | Sugiyama | HNRNPU C1orf199 HNRPU SAFA U21.1 | GDKKRGVKRPREDHGRGyFEyIEENKysRAKsPQPPVEEED |
| Q01546 | S196 | Sugiyama | KRT76 KRT2B KRT2P | IGQVKAQEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWE |
| Q02750 | S298 | EPSD | MAP2K1 MEK1 PRKMK1 | QVEGDAAEtPPRPRtPGRPLssyGMDsRPPMAIFELLDYIV |
| Q02878 | T213 | Sugiyama | RPL6 TXREB1 | FVIAtsTKIDISNVKIPKHLtDAyFKKKKLRKPRHQEGEIF |
| Q04917 | S46 | Sugiyama | YWHAH YWHA1 | AMKAVtELNEPLsNEDRNLLsVAyKNVVGARRSsWRVIsSI |
| Q05639 | T432 | Sugiyama | EEF1A2 EEF1AL STN | VESFSQYPPLGRFAVRDMRQtVAVGVIKNVEKKSGGAGKVT |
| Q06210 | S261 | Sugiyama | GFPT1 GFAT GFPT | GsQGERGKDKKGSCNLsRVDsttCLFPVEEKAVEyyFASDA |
| Q12778 | S256 | SIGNOR|EPSD | FOXO1 FKHR FOXO1A | WWMLNPEGGKSGKsPRRRAAsMDNNSKFAKSRSRAAKKKAs |
| Q12965 | T936 | Sugiyama | MYO1E MYO1C | LQVSIGPGLPKNSRPTRRNttQNtGySsGtQNANyPVRAAP |
| Q13153 | S144 | EPSD | PAK1 | VLDVLEFYNsKKTSNSQKYMsFtDKsAEDyNssNALNVKAV |
| Q13153 | S149 | EPSD | PAK1 | EFYNsKKTSNSQKYMsFtDKsAEDyNssNALNVKAVsETPA |
| Q13153 | S165 | EPSD | PAK1 | FtDKsAEDyNssNALNVKAVsETPAVPPVsEDEDDDDDDAt |
| Q13153 | S199 | EPSD | PAK1 | DDDDDAtPPPVIAPRPEHTKsVytRsVIEPLPVtPtRDVAt |
| Q13153 | S204 | EPSD | PAK1 | AtPPPVIAPRPEHTKsVytRsVIEPLPVtPtRDVAtsPIsP |
| Q13153 | S21 | EPSD | PAK1 | MsNNGLDIQDKPPAPPMRNTsTMIGAGSKDAGTLNHGSKPL |
| Q13153 | S57 | EPSD | PAK1 | GSKPLPPNPEEKKKKDRFYRsILPGDKTNKKKEKERPEISL |
| Q13153 | T423 | EPSD | PAK1 | VKLTDFGFCAQITPEQSKRstMVGTPYWMAPEVVTRKAYGP |
| Q13233 | S67 | EPSD | MAP3K1 MAPKKK1 MEKK MEKK1 | AGSGGRERADWRRRQLRKVRsVELDQLPEQPLFLAASPPAS |
| Q13263 | S473 | Sugiyama | TRIM28 KAP1 RNF96 TIF1B | sGDDPyssAEPHVsGVKRsRsGEGEVsGLMRKVPRVsLERL |
| Q13352 | S28 | EPSD | ITGB3BP CENPR NRIF3 | KLDGLLEENsFDPSKITRKKsVItYsPttGtCQMsLFAsPT |
| Q13363 | S158 | EPSD | CTBP1 CTBP | NLYRRAtWLHQALREGTRVQsVEQIREVASGAARIRGETLG |
| Q13418 | S246 | EPSD | ILK ILK1 ILK2 | DWSTRKsRDFNEECPRLRIFsHPNVLPVLGACQSPPAPHPT |
| Q13418 | T173 | EPSD | ILK ILK1 ILK2 | EKMGQNLNRIPYKDTFWKGttRTRPRNGtLNKHsGIDFKQL |
| Q13761 | T209 | EPSD | RUNX3 AML2 CBFA3 PEBP2A3 | DQTKPFPDRFGDLERLRMRVtPstPsPRGsLsttsHFssQP |
| Q14152 | S584 | Sugiyama | EIF3A EIF3S10 KIAA0139 | EHQRILARRQtIEERKERLEsLNIQREKEELEQREAELQKV |
| Q14152 | S988 | Sugiyama | EIF3A EIF3S10 KIAA0139 | PRRGPEEDRFsRRGADDDRPsWRNTDDDRPPRRIADEDRGN |
| Q14247 | S405 | EPSD | CTTN EMS1 | EEARRKLEEQARAKtQtPPVsPAPQPtEERLPssPVyEDAA |
| Q14247 | S418 | EPSD | CTTN EMS1 | KtQtPPVsPAPQPtEERLPssPVyEDAAsFKAELsyRGPVs |
| Q14568 | S53 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | IINTFYSNKEIFLRELIsNssDALDKIWYESLTDPSKLDSG |
| Q14568 | Y283 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | sDEEEEKKDGDKKKKKTKEKyIDQEELNKTKPIWTRNPDDI |
| Q14CN4 | S138 | Sugiyama | KRT72 K6IRS2 KB35 KRT6 KRT6IRS2 | IQRVRAQEREQIKALNNKFAsFIDKVRFLEQQNQVLETKWN |
| Q15185 | S72 | Sugiyama | PTGES3 P23 TEBP | EIDLFHCIDPNDsKHKRtDRsILCCLRKGEsGQsWPRLTKE |
| Q15365 | T127 | EPSD | PCBP1 | TQCGsLIGKGGCKIKEIREstGAQVQVAGDMLPNstERAIT |
| Q15365 | T60 | EPSD | PCBP1 | REEsGARINIsEGNCPERIItLTGPTNAIFKAFAMIIDKLE |
| Q15746 | S1772 | EPSD | MYLK MLCK MLCK1 MYLK1 | VRAIGRLssMAMISGLSGRKsstGsPtsPLNAEKLEsEEDV |
| Q15746 | S18 | EPSD | MYLK MLCK MLCK1 MYLK1 | ___MGDVKLVASSHIsKTsLsVDPSRVDSMPLTEAPAFILP |
| Q16512 | S156 | Sugiyama | PKN1 PAK1 PKN PRK1 PRKCL1 | AIELKVKQGAENMIQTYSNGsTKDRKLLLTAQQMLQDSKTK |
| Q16512 | S205 | Sugiyama | PKN1 PAK1 PKN PRK1 PRKCL1 | RRALQAGQLENQAAPDDtQGsPDLGAVELRIEELRHHFRVE |
| Q16512 | S296 | Sugiyama | PKN1 PAK1 PKN PRK1 PRKCL1 | GELPADHPKGRLLREELAAAssAAFstRLAGPFPATHYSTL |
| Q16512 | S297 | Sugiyama | PKN1 PAK1 PKN PRK1 PRKCL1 | ELPADHPKGRLLREELAAAssAAFstRLAGPFPATHYSTLC |
| Q16512 | S301 | Sugiyama | PKN1 PAK1 PKN PRK1 PRKCL1 | DHPKGRLLREELAAAssAAFstRLAGPFPATHYSTLCKPAP |
| Q16512 | S372 | EPSD|Sugiyama | PKN1 PAK1 PKN PRK1 PRKCL1 | GtPDSRPPFLSRPARGLYSRsGsLsGRssLKAEAENTSEVS |
| Q16512 | S374 | SIGNOR|EPSD|Sugiyama | PKN1 PAK1 PKN PRK1 PRKCL1 | PDSRPPFLSRPARGLYSRsGsLsGRssLKAEAENTSEVSTV |
| Q16512 | S376 | Sugiyama | PKN1 PAK1 PKN PRK1 PRKCL1 | SRPPFLSRPARGLYSRsGsLsGRssLKAEAENTSEVSTVLK |
| Q16512 | S380 | EPSD | PKN1 PAK1 PKN PRK1 PRKCL1 | FLSRPARGLYSRsGsLsGRssLKAEAENTSEVSTVLKLDNT |
| Q16512 | S533 | Sugiyama | PKN1 PAK1 PKN PRK1 PRKCL1 | ATWVRLLRRLIPNAtGtGtFsPGAsPGsEARTTGDIsVEKL |
| Q16512 | S537 | Sugiyama | PKN1 PAK1 PKN PRK1 PRKCL1 | RLLRRLIPNAtGtGtFsPGAsPGsEARTTGDIsVEKLNLGt |
| Q16512 | S559 | Sugiyama | PKN1 PAK1 PKN PRK1 PRKCL1 | GsEARTTGDIsVEKLNLGtDsDssPQKssRDPPssPssLss |
| Q16512 | S561 | Sugiyama | PKN1 PAK1 PKN PRK1 PRKCL1 | EARTTGDIsVEKLNLGtDsDssPQKssRDPPssPssLssPI |
| Q16512 | S562 | Sugiyama | PKN1 PAK1 PKN PRK1 PRKCL1 | ARTTGDIsVEKLNLGtDsDssPQKssRDPPssPssLssPIQ |
| Q16512 | S576 | EPSD | PKN1 PAK1 PKN PRK1 PRKCL1 | GtDsDssPQKssRDPPssPssLssPIQEstAPELPsEtQEt |
| Q16512 | S608 | EPSD | PKN1 PAK1 PKN PRK1 PRKCL1 | ELPsEtQEtPGPALCsPLRKsPLtLEDFKFLAVLGRGHFGK |
| Q16512 | S69 | Sugiyama | PKN1 PAK1 PKN PRK1 PRKCL1 | ELKLKEGAENLRRAttDLGRsLGPVELLLRGSSRRLDLLHQ |
| Q16512 | T202 | Sugiyama | PKN1 PAK1 PKN PRK1 PRKCL1 | MQLRRALQAGQLENQAAPDDtQGsPDLGAVELRIEELRHHF |
| Q16512 | T531 | SIGNOR|EPSD | PKN1 PAK1 PKN PRK1 PRKCL1 | DVATWVRLLRRLIPNAtGtGtFsPGAsPGsEARTTGDIsVE |
| Q16512 | T63 | Sugiyama | PKN1 PAK1 PKN PRK1 PRKCL1 | RREIRKELKLKEGAENLRRAttDLGRsLGPVELLLRGSSRR |
| Q16512 | T64 | SIGNOR|EPSD|Sugiyama | PKN1 PAK1 PKN PRK1 PRKCL1 | REIRKELKLKEGAENLRRAttDLGRsLGPVELLLRGSSRRL |
| Q16512 | T774 | EPSD|PSP|Sugiyama | PKN1 PAK1 PKN PRK1 PRKCL1 | VKIADFGLCKEGMGyGDRtstFCGtPEFLAPEVLTDTSYTR |
| Q16512 | T778 | Sugiyama | PKN1 PAK1 PKN PRK1 PRKCL1 | DFGLCKEGMGyGDRtstFCGtPEFLAPEVLTDTSYTRAVDW |
| Q16659 | S189 | EPSD | MAPK6 ERK3 PRKM6 | IGDFGLARIMDPHYSHKGHLsEGLVTKWYRSPRLLLSPNNY |
| Q16778 | S37 | Sugiyama | H2BC21 H2BFQ HIST2H2BE | KAVTKAQKKDGKKRKRSRKEsysIyVyKVLKQVHPDTGIss |
| Q16778 | S39 | Sugiyama | H2BC21 H2BFQ HIST2H2BE | VTKAQKKDGKKRKRSRKEsysIyVyKVLKQVHPDTGIssKA |
| Q32P51 | S95 | Sugiyama | HNRNPA1L2 HNRNPA1L | TPHKVDGRVVEPKRAVsREDsQRPGAHLtVKKIFVGGIKED |
| Q3SY84 | S143 | Sugiyama | KRT71 K6IRS1 KB34 KRT6IRS1 | IQKVRAQEREQIKALNNKFAsFIDKVRFLEQQNQVLETKWE |
| Q58FF8 | Y198 | Sugiyama | HSP90AB2P HSP90BB | DEEDDsGKDKKKKTKKIKEKyIDQEELNKTKPIWTRNTEDI |
| Q5QNW6 | S37 | Sugiyama | H2BC18 HIST2H2BF | KAVTKVQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| Q5QNW6 | S39 | Sugiyama | H2BC18 HIST2H2BF | VTKVQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| Q5SSJ5 | S227 | Sugiyama | HP1BP3 | LKRELNRGVIKQVKGKGAsGsFVVVQKSRKTPQKSRNRKNR |
| Q5SYE7 | S1495 | Sugiyama | NHSL1 C6orf63 KIAA1357 | KNRRAQEEWAKNEGLMPRsLsFsGPRYGRSRTPPSAASSRY |
| Q5VTE0 | T432 | Sugiyama | EEF1A1P5 EEF1AL3 | VEsFSDyPPLGRFAVRDMRQtVAVGVIKAVDKKAAGAGKVT |
| Q5XKE5 | S155 | Sugiyama | KRT79 K6L KB38 KRT6L | IQRVRTQEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWA |
| Q6DN03 | S37 | Sugiyama | H2BC20P HIST2H2BC | KAVTKAQKKDGKKRKRSRKEsysIyVyKVLKRVHPDTGIWC |
| Q6DN03 | S39 | Sugiyama | H2BC20P HIST2H2BC | VTKAQKKDGKKRKRSRKEsysIyVyKVLKRVHPDTGIWCKA |
| Q6DRA6 | S37 | Sugiyama | H2BC19P HIST2H2BD | KAVTKAQKKDGKKRKRSRKEsysIyVyKVLKRVHPDTGIWC |
| Q6DRA6 | S39 | Sugiyama | H2BC19P HIST2H2BD | VTKAQKKDGKKRKRSRKEsysIyVyKVLKRVHPDTGIWCKA |
| Q6S8J3 | S1068 | Sugiyama | POTEE A26C1A POTE2 | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| Q70Z35 | S1107 | EPSD | PREX2 DEPDC2 | FNVAGDEQEDSGHDTISNRDsYSDCNSNRNSIASFTSICSS |
| Q71UM5 | S78 | Sugiyama | RPS27L | GCSTVLCQPTGGKARLtEGCsFRRKQH______________ |
| Q7RTS7 | S153 | Sugiyama | KRT74 K6IRS4 KB37 KRT5C KRT6IRS4 | IQKVRAQEREQIKVLNDKFAsFIDKVRFLEQQNQVLETKWE |
| Q7Z417 | S652 | Sugiyama | NUFIP2 KIAA1321 PIG1 | NtLLGsAKEQRYQRGLERNDsWGsFDLRAAIVYHTKEMEsI |
| Q7Z794 | S177 | Sugiyama | KRT77 KRT1B | IQRIKTQEREQIMVLNNKFAsFIDKVRFLEQQNQVLQTKWE |
| Q86V81 | S145 | Sugiyama | ALYREF ALY BEF THOC4 | LFAEFGtLKKAAVHYDRsGRsLGtADVHFERKADALKAMKQ |
| Q86VQ1 | S223 | Sugiyama | GLCCI1 | QTPsCWAEEGAEKRSHQRsAsWGsADQLKEQIAKLRQQLQR |
| Q86Y46 | S145 | Sugiyama | KRT73 K6IRS3 KB36 KRT6IRS3 | IQKVRAQEREQIKVLNNKFAsFIDKVRFLEQQNQVLETKWE |
| Q8IWX8 | S904 | Sugiyama | CHERP DAN26 SCAF6 | KGVGVALDDPyENyRRNKsysFIARMKARDECK________ |
| Q8IYU2 | S385 | EPSD | HACE1 KIAA1320 | HSLDEWLVLIATELMKNKRDstEITSILLKQKGQDQDAASI |
| Q8IZ21 | S590 | Sugiyama | PHACTR4 PRO2963 | SKEEWNEIRHQIGNTLIRRLsQRPtPEELEQRNILQPKNEA |
| Q8N201 | S495 | Sugiyama | INTS1 KIAA1440 UNQ1821/PRO3434 | KFLAMVFQDLLTNKDDYLRAsRALLREIIKQTKHEINFQAF |
| Q8N257 | S37 | Sugiyama | H2BC26 H2BU1 HIST3H2BB | KAVTKAQKKDGKKRKRGRKEsysIyVyKVLKQVHPDTGIss |
| Q8N257 | S39 | Sugiyama | H2BC26 H2BU1 HIST3H2BB | VTKAQKKDGKKRKRGRKEsysIyVyKVLKQVHPDTGIssKA |
| Q8N8S7 | S125 | Sugiyama | ENAH MENA | MHALEVLNSQETGPTLPRQNsQLPAQVQNGPSQEELEIQRR |
| Q8NBJ7 | S256 | Sugiyama | SUMF2 PSEC0171 UNQ1968/PRO4500 | EWTASPYQAAEQDMRVLRGAsWIDtADGsANHRARVttRMG |
| Q8TD47 | T247 | Sugiyama | RPS4Y2 RPS4Y2P | VIGNGNKPWISLPRGKGIRLtIAEERDKRLAAKQSSG____ |
| Q8TEW0 | S837 | Sugiyama | PARD3 PAR3 PAR3A | AFQREGFGRQsMsEKRtKQFsDAsQLDFVKTRKsKsMDLGI |
| Q92890 | S299 | Sugiyama | UFD1 UFD1L | KKVEEDEAGGRFVAFsGEGQsLRKKGRKP____________ |
| Q92934 | S118 | EPSD | BAD BBC6 BCL2L8 | RsAPPNLWAAQRYGRELRRMsDEFVDsFKKGLPRPKsAGtA |
| Q92934 | S134 | EPSD | BAD BBC6 BCL2L8 | LRRMsDEFVDsFKKGLPRPKsAGtATQMRQSSSWTRVFQsW |
| Q92934 | S74 | EPSD | BAD BBC6 BCL2L8 | QPTSSSHHGGAGAVEIRsRHssyPAGtEDDEGMGEEPsPFR |
| Q92934 | S75 | EPSD | BAD BBC6 BCL2L8 | PTSSSHHGGAGAVEIRsRHssyPAGtEDDEGMGEEPsPFRG |
| Q92934 | S99 | EPSD | BAD BBC6 BCL2L8 | GtEDDEGMGEEPsPFRGRsRsAPPNLWAAQRYGRELRRMsD |
| Q92974 | S886 | SIGNOR|EPSD | ARHGEF2 KIAA0651 LFP40 | TEPLPAEAPWARRPVDPRRRsLPAGDALyLsFNPPQPSRGT |
| Q93079 | S37 | Sugiyama | H2BC9 H2BFJ HIST1H2BH | KAVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| Q93079 | S39 | Sugiyama | H2BC9 H2BFJ HIST1H2BH | VTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| Q96FS4 | S55 | Sugiyama | SIPA1 SPA1 | PLTPHTFEPRPVRGPLLRsGsDAGEARPPtPAsPRARAHsH |
| Q96T58 | S3486 | EPSD | SPEN KIAA0929 MINT SHARP | stPPGLVLPHTEFQPAPKQDssPHLTSQRPVDMVQLLKKYP |
| Q96T58 | T3568 | EPSD | SPEN KIAA0929 MINT SHARP | RIAQRMRLEATQLEGVARRMtVETDYCLLLALPCGRDQEDV |
| Q99426 | S128 | EPSD | TBCB CG22 CKAP1 | tIsQEAyDQRQDtVRSFLKRsKLGRyNEEERAQQEAEAAQR |
| Q99426 | S65 | EPSD | TBCB CG22 CKAP1 | VGSPASCMELELYGVDDKFYsKLDQEDALLGsYPVDDGCRI |
| Q99661 | S111 | EPSD | KIF2C KNSL6 | QKRRsVNSKIPAPKEsLRsRsTRMstVSELRITAQENDMEV |
| Q99661 | S192 | EPSD | KIF2C KNSL6 | QVHsIRGsssANPVNsVRRKsCLVKEVEKMKNKREEKKAQN |
| Q99848 | S269 | Sugiyama | EBNA1BP2 EBP2 | GFGGKKKGSKWNtREsyDDVssFRAKTAHGRGLKRPGKKGS |
| Q99848 | S270 | Sugiyama | EBNA1BP2 EBP2 | FGGKKKGSKWNtREsyDDVssFRAKTAHGRGLKRPGKKGSN |
| Q99877 | S37 | Sugiyama | H2BC15 H2BFD HIST1H2BN | KAVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| Q99877 | S39 | Sugiyama | H2BC15 H2BFD HIST1H2BN | VTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| Q99879 | S37 | Sugiyama | H2BC14 H2BFE HIST1H2BM | KAINKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| Q99879 | S39 | Sugiyama | H2BC14 H2BFE HIST1H2BM | INKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| Q99880 | S37 | Sugiyama | H2BC13 H2BFC HIST1H2BL | KAVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| Q99880 | S39 | Sugiyama | H2BC13 H2BFC HIST1H2BL | VTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| Q9BYX7 | S368 | Sugiyama | POTEKP ACTBL3 FKSG30 | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| Q9H788 | S315 | Sugiyama | SH2D4A PPP1R38 SH2A | LNSGAYPQKPLRNQGVVRtLsssAQEDIIRWFKEEQLPLRA |
| Q9H788 | S316 | Sugiyama | SH2D4A PPP1R38 SH2A | NSGAYPQKPLRNQGVVRtLsssAQEDIIRWFKEEQLPLRAG |
| Q9NSB2 | S178 | Sugiyama | KRT84 KRTHB4 | AQRVKKDEKEQIKTLNNKFAsFIDKVRFLEQQNKLLETKWS |
| Q9UGV2 | T332 | Sugiyama | NDRG3 | GMGYIPSASMTRLARsRtHstsssLGsGEsPFsRsVtsNQs |
| Q9UHF1 | S43 | Sugiyama | EGFL7 MEGF7 UNQ187/PRO1449 | AYRPGRRVCAVRAHGDPVSEsFVQRVyQPFLTTCDGHRACS |
| Q9UI15 | S185 | Sugiyama | TAGLN3 NP25 | EQLRQGQNVIGLQMGSNKGAsQAGMtGyGMPRQIM______ |
| Q9UKV0 | S253 | EPSD|PSP | HDAC9 HDAC7 HDAC7B HDRP KIAA0744 MITR | KVAERRssPLLRRKDGNVVTsFKKRMFEVTESSVSSSSPGS |
| Q9UKV8 | S387 | Sugiyama | AGO2 EIF2C2 | ATARSAPDRQEEISKLMRsAsFNTDPyVREFGIMVKDEMTD |
| Q9ULL1 | S611 | Sugiyama | PLEKHG1 KIAA1209 | GQMESTETSSSGHRIVRRAssAGEsNtCPPEIGTSDRTREL |
| Q9UNX3 | S31 | Sugiyama | RPL26L1 RPL26P1 | RsKNRKRHFNAPSHVRRKIMssPLSKELRQKYNVRSMPIRK |
| Q9UPQ0 | S377 | Sugiyama | LIMCH1 KIAA1102 | LREEDDKWQDDLARWKSRRRsVsQDLIKKEEERKKMEKLLA |
| Q9UQ80 | T261 | EPSD | PA2G4 EBP1 | GQRTTIYKRDPSKQYGLKMKtSRAFFsEVERRFDAMPFtLR |
| Q9UQL6 | T292 | EPSD|PSP | HDAC5 KIAA0600 | KVAERRssPLLRRKDGTVIStFKKRAVEITGAGPGASSVCN |
| Q9Y2X7 | S508 | EPSD | GIT1 | AEHtPMAPGGstHRRDRQAFsMyEPGsALKPFGGPPGDELT |
| Q9Y2X7 | S700 | EPSD | GIT1 | LAVTEMASLFPKRPALEPVRsSLRLLNASAYRLQSECRKTV |
| Q9Y3B8 | S203 | Sugiyama | REXO2 SFN SMFN CGI-114 | EYEFAPKKAAsHRALDDIsEsIKELQFyRNNIFKKKIDEKK |
| Q9Y3C1 | S16 | Sugiyama | NOP16 CGI-117 HSPC111 | _____MPKAKGKTRRQKFGYsVNRKRLNRNARRKAAPRIEC |
| Q9Y5B9 | S650 | Sugiyama | SUPT16H FACT140 FACTP140 | KRYKTREAEEKEKEGIVKQDsLVINLNRsNPKLKDLYIRPN |
| Q9Y6X9 | S739 | EPSD | MORC2 KIAA0852 ZCWCC1 | VVKKtEsPIKLsPAtPsRKRsVAVsDEEEVEEEAERRKERC |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Signal Transduction | R-HSA-162582 | 3.419487e-14 | 13.466 | 1 | 0 |
| Axon guidance | R-HSA-422475 | 4.590506e-09 | 8.338 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 2.099348e-08 | 7.678 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 6.186821e-08 | 7.209 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 9.050667e-08 | 7.043 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 2.934739e-07 | 6.532 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 2.934739e-07 | 6.532 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 4.217063e-07 | 6.375 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 7.127429e-07 | 6.147 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 8.741008e-07 | 6.058 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 1.358450e-06 | 5.867 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 1.487390e-06 | 5.828 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 2.025173e-06 | 5.694 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 1.967450e-06 | 5.706 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 4.963656e-06 | 5.304 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 5.185623e-06 | 5.285 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 1.133135e-05 | 4.946 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 1.324520e-05 | 4.878 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 1.329158e-05 | 4.876 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 1.582613e-05 | 4.801 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 3.016786e-05 | 4.520 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 3.722427e-05 | 4.429 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 4.354724e-05 | 4.361 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 4.955517e-05 | 4.305 | 0 | 0 |
| M Phase | R-HSA-68886 | 5.442131e-05 | 4.264 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 5.356966e-05 | 4.271 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 7.815497e-05 | 4.107 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 7.599061e-05 | 4.119 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 9.675972e-05 | 4.014 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 1.099401e-04 | 3.959 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 1.185620e-04 | 3.926 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 1.199154e-04 | 3.921 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 1.745934e-04 | 3.758 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 2.129864e-04 | 3.672 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 2.899217e-04 | 3.538 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 3.174096e-04 | 3.498 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 3.274759e-04 | 3.485 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 3.675270e-04 | 3.435 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 4.046425e-04 | 3.393 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 4.409253e-04 | 3.356 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 4.924955e-04 | 3.308 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 4.955929e-04 | 3.305 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 7.057070e-04 | 3.151 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 7.498039e-04 | 3.125 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 7.331178e-04 | 3.135 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 8.057402e-04 | 3.094 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 7.854196e-04 | 3.105 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 9.114319e-04 | 3.040 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 9.588146e-04 | 3.018 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 9.826636e-04 | 3.008 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 1.064826e-03 | 2.973 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 1.224676e-03 | 2.912 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 1.284078e-03 | 2.891 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 1.456031e-03 | 2.837 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 1.501306e-03 | 2.824 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 1.563834e-03 | 2.806 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 1.992383e-03 | 2.701 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 2.226650e-03 | 2.652 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 2.226650e-03 | 2.652 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 2.082426e-03 | 2.681 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 2.082426e-03 | 2.681 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 2.197393e-03 | 2.658 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 2.067655e-03 | 2.685 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 1.919474e-03 | 2.717 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 1.764734e-03 | 2.753 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 2.228522e-03 | 2.652 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 1.924008e-03 | 2.716 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 1.737754e-03 | 2.760 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 1.960575e-03 | 2.708 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 2.243722e-03 | 2.649 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 1.637993e-03 | 2.786 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 1.800240e-03 | 2.745 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 2.333286e-03 | 2.632 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 2.433023e-03 | 2.614 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 2.548420e-03 | 2.594 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 2.655778e-03 | 2.576 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 2.852301e-03 | 2.545 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 2.926598e-03 | 2.534 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 2.969876e-03 | 2.527 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 3.099791e-03 | 2.509 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 3.134408e-03 | 2.504 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 3.715195e-03 | 2.430 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 3.755520e-03 | 2.425 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 3.890654e-03 | 2.410 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 3.952900e-03 | 2.403 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 4.089627e-03 | 2.388 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 4.501824e-03 | 2.347 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 4.621079e-03 | 2.335 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 4.723976e-03 | 2.326 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 4.796437e-03 | 2.319 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 4.850856e-03 | 2.314 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 5.107265e-03 | 2.292 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 5.164234e-03 | 2.287 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 5.353698e-03 | 2.271 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 5.427159e-03 | 2.265 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 5.500952e-03 | 2.260 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 5.500952e-03 | 2.260 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 5.963445e-03 | 2.225 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 5.682164e-03 | 2.245 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 5.951850e-03 | 2.225 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 5.963445e-03 | 2.225 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 6.405975e-03 | 2.193 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 6.405975e-03 | 2.193 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 6.643366e-03 | 2.178 | 0 | 0 |
| Signaling by MAPK mutants | R-HSA-9652817 | 6.643366e-03 | 2.178 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 6.882392e-03 | 2.162 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 6.882392e-03 | 2.162 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 6.512020e-03 | 2.186 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 6.701211e-03 | 2.174 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 7.177070e-03 | 2.144 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 7.243638e-03 | 2.140 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 7.776441e-03 | 2.109 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 8.701154e-03 | 2.060 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 8.732834e-03 | 2.059 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 8.732834e-03 | 2.059 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 9.293179e-03 | 2.032 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 9.293179e-03 | 2.032 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 8.764681e-03 | 2.057 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 9.132792e-03 | 2.039 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 9.575638e-03 | 2.019 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 9.888069e-03 | 2.005 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 1.000470e-02 | 2.000 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 1.046840e-02 | 1.980 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 1.030431e-02 | 1.987 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 1.031136e-02 | 1.987 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 9.888069e-03 | 2.005 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 9.888069e-03 | 2.005 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 9.896262e-03 | 2.005 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 9.896262e-03 | 2.005 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 1.077244e-02 | 1.968 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 1.087861e-02 | 1.963 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 1.181143e-02 | 1.928 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 1.181143e-02 | 1.928 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 1.187466e-02 | 1.925 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 1.187466e-02 | 1.925 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 1.187466e-02 | 1.925 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 1.253248e-02 | 1.902 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 1.296731e-02 | 1.887 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 1.352359e-02 | 1.869 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 1.347767e-02 | 1.870 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 1.314181e-02 | 1.881 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 1.278611e-02 | 1.893 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 1.387337e-02 | 1.858 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 1.391884e-02 | 1.856 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 1.401668e-02 | 1.853 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 1.401668e-02 | 1.853 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 1.401668e-02 | 1.853 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 1.401668e-02 | 1.853 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 1.455764e-02 | 1.837 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 1.512084e-02 | 1.820 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 1.512084e-02 | 1.820 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 1.512084e-02 | 1.820 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 1.523847e-02 | 1.817 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 1.610328e-02 | 1.793 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 1.610567e-02 | 1.793 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 1.545899e-02 | 1.811 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 1.509706e-02 | 1.821 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 1.465202e-02 | 1.834 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 1.617731e-02 | 1.791 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 1.702845e-02 | 1.769 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 1.763061e-02 | 1.754 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 1.817973e-02 | 1.740 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 1.831365e-02 | 1.737 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 1.845592e-02 | 1.734 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 1.848589e-02 | 1.733 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 1.867096e-02 | 1.729 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 1.879967e-02 | 1.726 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 2.098395e-02 | 1.678 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 2.098395e-02 | 1.678 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 2.098395e-02 | 1.678 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 2.098395e-02 | 1.678 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 2.098395e-02 | 1.678 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 2.098395e-02 | 1.678 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 2.098395e-02 | 1.678 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 2.098395e-02 | 1.678 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 2.098395e-02 | 1.678 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 2.098395e-02 | 1.678 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 2.098395e-02 | 1.678 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 1.967744e-02 | 1.706 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 1.967744e-02 | 1.706 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 1.967744e-02 | 1.706 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 2.044099e-02 | 1.689 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 2.003971e-02 | 1.698 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 2.097067e-02 | 1.678 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 1.963560e-02 | 1.707 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 1.967744e-02 | 1.706 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 2.175246e-02 | 1.662 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 2.306759e-02 | 1.637 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 2.306759e-02 | 1.637 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 2.333975e-02 | 1.632 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 2.333975e-02 | 1.632 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 2.518127e-02 | 1.599 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 2.517047e-02 | 1.599 | 1 | 1 |
| HDACs deacetylate histones | R-HSA-3214815 | 2.388667e-02 | 1.622 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 2.364980e-02 | 1.626 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 2.306759e-02 | 1.637 | 0 | 0 |
| Kinesins | R-HSA-983189 | 2.321474e-02 | 1.634 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 2.452043e-02 | 1.610 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 2.292950e-02 | 1.640 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 2.321474e-02 | 1.634 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 2.573218e-02 | 1.590 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 2.597923e-02 | 1.585 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 2.701549e-02 | 1.568 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 2.747655e-02 | 1.561 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 2.748129e-02 | 1.561 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 2.898364e-02 | 1.538 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 2.898364e-02 | 1.538 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 2.898364e-02 | 1.538 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 2.924638e-02 | 1.534 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 2.924638e-02 | 1.534 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 3.004551e-02 | 1.522 | 0 | 0 |
| GLI proteins bind promoters of Hh responsive genes to promote transcription | R-HSA-5635851 | 3.004551e-02 | 1.522 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 3.004551e-02 | 1.522 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 3.004551e-02 | 1.522 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 3.024594e-02 | 1.519 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 3.041588e-02 | 1.517 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 3.055901e-02 | 1.515 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 3.055901e-02 | 1.515 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 3.055901e-02 | 1.515 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 3.055901e-02 | 1.515 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 3.055901e-02 | 1.515 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 3.055901e-02 | 1.515 | 0 | 0 |
| Formation of editosomes by ADAR proteins | R-HSA-77042 | 3.451684e-02 | 1.462 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 3.376521e-02 | 1.472 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 3.200510e-02 | 1.495 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 3.144449e-02 | 1.502 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 3.177326e-02 | 1.498 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 3.296624e-02 | 1.482 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 3.296624e-02 | 1.482 | 0 | 0 |
| Depurination | R-HSA-73927 | 3.376521e-02 | 1.472 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 3.508275e-02 | 1.455 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 3.691550e-02 | 1.433 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 3.897256e-02 | 1.409 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 3.910023e-02 | 1.408 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 3.910023e-02 | 1.408 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 3.917077e-02 | 1.407 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 3.919007e-02 | 1.407 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 3.938843e-02 | 1.405 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 3.938843e-02 | 1.405 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 3.965954e-02 | 1.402 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 4.146702e-02 | 1.382 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 4.229551e-02 | 1.374 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 4.289701e-02 | 1.368 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 4.359743e-02 | 1.361 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 4.387182e-02 | 1.358 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 4.503600e-02 | 1.346 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 4.506548e-02 | 1.346 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 4.532817e-02 | 1.344 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 4.535161e-02 | 1.343 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 4.612315e-02 | 1.336 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 4.618067e-02 | 1.336 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 4.625965e-02 | 1.335 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 5.468201e-02 | 1.262 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 5.468201e-02 | 1.262 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 5.468201e-02 | 1.262 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 5.468201e-02 | 1.262 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 4.902157e-02 | 1.310 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 5.311250e-02 | 1.275 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 5.189894e-02 | 1.285 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 4.827688e-02 | 1.316 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 4.827688e-02 | 1.316 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 4.754468e-02 | 1.323 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 5.072331e-02 | 1.295 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 5.434469e-02 | 1.265 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 4.827688e-02 | 1.316 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 4.904593e-02 | 1.309 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 4.847067e-02 | 1.315 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 5.241756e-02 | 1.281 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 5.241756e-02 | 1.281 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 5.026255e-02 | 1.299 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 5.540715e-02 | 1.256 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 5.668157e-02 | 1.247 | 0 | 0 |
| Regulation of HMOX1 expression and activity | R-HSA-9707587 | 5.750717e-02 | 1.240 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 5.750717e-02 | 1.240 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 5.750717e-02 | 1.240 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 5.795243e-02 | 1.237 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 5.795243e-02 | 1.237 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 5.810293e-02 | 1.236 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 5.888161e-02 | 1.230 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 5.888161e-02 | 1.230 | 0 | 0 |
| Ca2+ activated K+ channels | R-HSA-1296052 | 5.888161e-02 | 1.230 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 5.888161e-02 | 1.230 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 5.888161e-02 | 1.230 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 5.897933e-02 | 1.229 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 6.019173e-02 | 1.220 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 6.035934e-02 | 1.219 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 6.035934e-02 | 1.219 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 6.035934e-02 | 1.219 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 6.035934e-02 | 1.219 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 6.035934e-02 | 1.219 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 6.089640e-02 | 1.215 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 6.125268e-02 | 1.213 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 7.074454e-02 | 1.150 | 0 | 0 |
| Interactions of Tat with host cellular proteins | R-HSA-176034 | 7.074454e-02 | 1.150 | 0 | 0 |
| TGFBR3 regulates FGF2 signaling | R-HSA-9839397 | 7.074454e-02 | 1.150 | 0 | 0 |
| Transport of glycerol from adipocytes to the liver by Aquaporins | R-HSA-432030 | 7.074454e-02 | 1.150 | 0 | 0 |
| SMAD4 MH2 Domain Mutants in Cancer | R-HSA-3311021 | 7.074454e-02 | 1.150 | 0 | 0 |
| Loss of Function of SMAD4 in Cancer | R-HSA-3304347 | 7.074454e-02 | 1.150 | 0 | 0 |
| TWIK-releated acid-sensitive K+ channel (TASK) | R-HSA-1299316 | 7.074454e-02 | 1.150 | 0 | 0 |
| SMAD2/3 MH2 Domain Mutants in Cancer | R-HSA-3315487 | 7.074454e-02 | 1.150 | 0 | 0 |
| MyD88 deficiency (TLR5) | R-HSA-5602680 | 7.074454e-02 | 1.150 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 6.894975e-02 | 1.161 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 7.312780e-02 | 1.136 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 6.224648e-02 | 1.206 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 6.145162e-02 | 1.211 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 6.271996e-02 | 1.203 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 6.393188e-02 | 1.194 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 7.171286e-02 | 1.144 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 7.192009e-02 | 1.143 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 6.389332e-02 | 1.195 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 7.029801e-02 | 1.153 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 6.148330e-02 | 1.211 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 7.357882e-02 | 1.133 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 7.357882e-02 | 1.133 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 6.894975e-02 | 1.161 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 6.894975e-02 | 1.161 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 6.237571e-02 | 1.205 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 6.148330e-02 | 1.211 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 7.417088e-02 | 1.130 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 7.430724e-02 | 1.129 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 7.509520e-02 | 1.124 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 7.659155e-02 | 1.116 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 7.668436e-02 | 1.115 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 7.731800e-02 | 1.112 | 0 | 0 |
| RSK activation | R-HSA-444257 | 7.731800e-02 | 1.112 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 7.731800e-02 | 1.112 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 7.731800e-02 | 1.112 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 7.731800e-02 | 1.112 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 7.731800e-02 | 1.112 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 7.866345e-02 | 1.104 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 7.866345e-02 | 1.104 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 8.060178e-02 | 1.094 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 8.187120e-02 | 1.087 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 8.187120e-02 | 1.087 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 8.239825e-02 | 1.084 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 8.239825e-02 | 1.084 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 8.410246e-02 | 1.075 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 8.472815e-02 | 1.072 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 8.507444e-02 | 1.070 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 8.507444e-02 | 1.070 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 8.507444e-02 | 1.070 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 8.553509e-02 | 1.068 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 8.612255e-02 | 1.065 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 8.664428e-02 | 1.062 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 8.664428e-02 | 1.062 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 8.853841e-02 | 1.053 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 1.110820e-01 | 0.954 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 9.828197e-02 | 1.008 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 9.828197e-02 | 1.008 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 9.828197e-02 | 1.008 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 9.828197e-02 | 1.008 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 1.029966e-01 | 0.987 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 1.029064e-01 | 0.988 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 9.285296e-02 | 1.032 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 1.101423e-01 | 0.958 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 9.374844e-02 | 1.028 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 9.902127e-02 | 1.004 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 9.574257e-02 | 1.019 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 1.092295e-01 | 0.962 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 9.675725e-02 | 1.014 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 9.675725e-02 | 1.014 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 1.024435e-01 | 0.990 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 1.060300e-01 | 0.975 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 1.101865e-01 | 0.958 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 9.723040e-02 | 1.012 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 9.828197e-02 | 1.008 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 1.101865e-01 | 0.958 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 9.914438e-02 | 1.004 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 1.107661e-01 | 0.956 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 9.828197e-02 | 1.008 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 1.046537e-01 | 0.980 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 9.696245e-02 | 1.013 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 9.666082e-02 | 1.015 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 1.029966e-01 | 0.987 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 1.011743e-01 | 0.995 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 9.666082e-02 | 1.015 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 9.914438e-02 | 1.004 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 9.914438e-02 | 1.004 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 1.029966e-01 | 0.987 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 9.302944e-02 | 1.031 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 1.020037e-01 | 0.991 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 8.915192e-02 | 1.050 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 1.005104e-01 | 0.998 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 1.032093e-01 | 0.986 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 9.429532e-02 | 1.026 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 1.029064e-01 | 0.988 | 0 | 0 |
| mRNA Editing: A to I Conversion | R-HSA-75064 | 1.147040e-01 | 0.940 | 0 | 0 |
| Regulation of TP53 Expression | R-HSA-6804754 | 1.147040e-01 | 0.940 | 0 | 0 |
| Diseases of Cellular Senescence | R-HSA-9630747 | 1.147040e-01 | 0.940 | 0 | 0 |
| Diseases of cellular response to stress | R-HSA-9675132 | 1.147040e-01 | 0.940 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 1.147040e-01 | 0.940 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 1.147040e-01 | 0.940 | 0 | 0 |
| C6 deamination of adenosine | R-HSA-75102 | 1.147040e-01 | 0.940 | 0 | 0 |
| Potassium transport channels | R-HSA-1296067 | 1.147040e-01 | 0.940 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 1.149508e-01 | 0.939 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 1.149508e-01 | 0.939 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 1.153622e-01 | 0.938 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 1.153622e-01 | 0.938 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 1.153622e-01 | 0.938 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 1.159410e-01 | 0.936 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 1.172625e-01 | 0.931 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 1.172625e-01 | 0.931 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 1.172625e-01 | 0.931 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 1.172625e-01 | 0.931 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 1.176426e-01 | 0.929 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 1.183317e-01 | 0.927 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 1.183317e-01 | 0.927 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 1.198413e-01 | 0.921 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 1.198413e-01 | 0.921 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 1.198413e-01 | 0.921 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 1.198413e-01 | 0.921 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 1.198413e-01 | 0.921 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 1.208747e-01 | 0.918 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 1.215841e-01 | 0.915 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 1.215841e-01 | 0.915 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 1.215841e-01 | 0.915 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 1.215841e-01 | 0.915 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 1.226257e-01 | 0.911 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 1.227531e-01 | 0.911 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 1.264946e-01 | 0.898 | 0 | 0 |
| Drug resistance of KIT mutants | R-HSA-9669937 | 1.345552e-01 | 0.871 | 0 | 0 |
| KIT mutants bind TKIs | R-HSA-9669921 | 1.345552e-01 | 0.871 | 0 | 0 |
| Sorafenib-resistant KIT mutants | R-HSA-9669936 | 1.345552e-01 | 0.871 | 0 | 0 |
| Dasatinib-resistant KIT mutants | R-HSA-9669914 | 1.345552e-01 | 0.871 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 1.345552e-01 | 0.871 | 0 | 0 |
| Loss of Function of TP53 in Cancer | R-HSA-9723907 | 1.345552e-01 | 0.871 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to p14ARF Defects | R-HSA-9646304 | 1.345552e-01 | 0.871 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to p14ARF Defects | R-HSA-9646303 | 1.345552e-01 | 0.871 | 0 | 0 |
| Loss of function of TP53 in cancer due to loss of tetramerization ability | R-HSA-9723905 | 1.345552e-01 | 0.871 | 0 | 0 |
| Sunitinib-resistant KIT mutants | R-HSA-9669934 | 1.345552e-01 | 0.871 | 0 | 0 |
| Regorafenib-resistant KIT mutants | R-HSA-9669929 | 1.345552e-01 | 0.871 | 0 | 0 |
| Defective translocation of RB1 mutants to the nucleus | R-HSA-9661070 | 1.345552e-01 | 0.871 | 0 | 0 |
| Nilotinib-resistant KIT mutants | R-HSA-9669926 | 1.345552e-01 | 0.871 | 0 | 0 |
| Masitinib-resistant KIT mutants | R-HSA-9669924 | 1.345552e-01 | 0.871 | 0 | 0 |
| Imatinib-resistant KIT mutants | R-HSA-9669917 | 1.345552e-01 | 0.871 | 0 | 0 |
| Activation of BIM and translocation to mitochondria | R-HSA-111446 | 1.636603e-01 | 0.786 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 1.636603e-01 | 0.786 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 1.636603e-01 | 0.786 | 0 | 0 |
| IRAK4 deficiency (TLR5) | R-HSA-5603037 | 1.636603e-01 | 0.786 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 1.429726e-01 | 0.845 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 1.469914e-01 | 0.833 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 1.438450e-01 | 0.842 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 1.380599e-01 | 0.860 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 1.665164e-01 | 0.779 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 1.312903e-01 | 0.882 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 1.574825e-01 | 0.803 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 1.574825e-01 | 0.803 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 1.574825e-01 | 0.803 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 1.574825e-01 | 0.803 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 1.574825e-01 | 0.803 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 1.392471e-01 | 0.856 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 1.306620e-01 | 0.884 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 1.448290e-01 | 0.839 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 1.448290e-01 | 0.839 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 1.426155e-01 | 0.846 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 1.329601e-01 | 0.876 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 1.658461e-01 | 0.780 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 1.733825e-01 | 0.761 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 1.324333e-01 | 0.878 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 1.306620e-01 | 0.884 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 1.514074e-01 | 0.820 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 1.392471e-01 | 0.856 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 1.663189e-01 | 0.779 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 1.542282e-01 | 0.812 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 1.358758e-01 | 0.867 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 1.380599e-01 | 0.860 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 1.426155e-01 | 0.846 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 1.665164e-01 | 0.779 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 1.551062e-01 | 0.809 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 1.636603e-01 | 0.786 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 1.682552e-01 | 0.774 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 1.438450e-01 | 0.842 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 1.661740e-01 | 0.779 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 1.535184e-01 | 0.814 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 1.416250e-01 | 0.849 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 1.392471e-01 | 0.856 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 1.441723e-01 | 0.841 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 1.542282e-01 | 0.812 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 1.663065e-01 | 0.779 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 1.353087e-01 | 0.869 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 1.343869e-01 | 0.872 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 1.489531e-01 | 0.827 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 1.647417e-01 | 0.783 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 1.742408e-01 | 0.759 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 1.753436e-01 | 0.756 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 1.774544e-01 | 0.751 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose | R-HSA-9031528 | 1.774544e-01 | 0.751 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 1.776910e-01 | 0.750 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 1.776910e-01 | 0.750 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 1.780167e-01 | 0.750 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 1.780167e-01 | 0.750 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 2.510121e-01 | 0.600 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 2.510121e-01 | 0.600 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 2.510121e-01 | 0.600 | 0 | 0 |
| Defective F8 binding to von Willebrand factor | R-HSA-9672393 | 2.510121e-01 | 0.600 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH6 | R-HSA-5632968 | 2.510121e-01 | 0.600 | 0 | 0 |
| Defective Mismatch Repair Associated With PMS2 | R-HSA-5632987 | 2.510121e-01 | 0.600 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 2.510121e-01 | 0.600 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 2.510121e-01 | 0.600 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 | R-HSA-9632697 | 2.510121e-01 | 0.600 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 2.510121e-01 | 0.600 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis Due to p14ARF Loss of Function | R-HSA-9645722 | 2.510121e-01 | 0.600 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 2.510121e-01 | 0.600 | 0 | 0 |
| Defective Mismatch Repair Associated With MLH1 | R-HSA-5545483 | 2.510121e-01 | 0.600 | 0 | 0 |
| Defective SLC26A4 causes Pendred syndrome (PDS) | R-HSA-5619046 | 2.510121e-01 | 0.600 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 | R-HSA-9630791 | 2.510121e-01 | 0.600 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 2.154742e-01 | 0.667 | 0 | 0 |
| HCN channels | R-HSA-1296061 | 2.154742e-01 | 0.667 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 2.154742e-01 | 0.667 | 0 | 0 |
| ATP sensitive Potassium channels | R-HSA-1296025 | 2.154742e-01 | 0.667 | 0 | 0 |
| RUNX2 regulates genes involved in differentiation of myeloid cells | R-HSA-8941333 | 2.154742e-01 | 0.667 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 2.154742e-01 | 0.667 | 0 | 0 |
| Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling | R-HSA-2644607 | 2.154742e-01 | 0.667 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 2.154742e-01 | 0.667 | 0 | 0 |
| FBXW7 Mutants and NOTCH1 in Cancer | R-HSA-2644605 | 2.154742e-01 | 0.667 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 2.154742e-01 | 0.667 | 0 | 0 |
| PI and PC transport between ER and Golgi membranes | R-HSA-1483196 | 3.518040e-01 | 0.454 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to p16INK4A Defects | R-HSA-9630750 | 3.518040e-01 | 0.454 | 0 | 0 |
| Signaling by extracellular domain mutants of KIT | R-HSA-9680187 | 3.518040e-01 | 0.454 | 0 | 0 |
| Abasic sugar-phosphate removal via the single-nucleotide replacement pathway | R-HSA-73930 | 3.518040e-01 | 0.454 | 0 | 0 |
| Signaling by juxtamembrane domain KIT mutants | R-HSA-9669935 | 3.518040e-01 | 0.454 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to p16INK4A Defects | R-HSA-9632693 | 3.518040e-01 | 0.454 | 0 | 0 |
| NFG and proNGF binds to p75NTR | R-HSA-205017 | 3.518040e-01 | 0.454 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 3.518040e-01 | 0.454 | 0 | 0 |
| Defective ABCC9 causes CMD10, ATFB12 and Cantu syndrome | R-HSA-5678420 | 3.518040e-01 | 0.454 | 0 | 0 |
| Signaling by kinase domain mutants of KIT | R-HSA-9669933 | 3.518040e-01 | 0.454 | 0 | 0 |
| Intestinal infectious diseases | R-HSA-8942233 | 3.518040e-01 | 0.454 | 0 | 0 |
| TALDO1 deficiency: failed conversion of Fru(6)P, E4P to SH7P, GA3P | R-HSA-6791462 | 3.518040e-01 | 0.454 | 0 | 0 |
| Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS) | R-HSA-5619081 | 3.518040e-01 | 0.454 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9632700 | 3.518040e-01 | 0.454 | 0 | 0 |
| Defective SLC20A2 causes idiopathic basal ganglia calcification 1 (IBGC1) | R-HSA-5619111 | 3.518040e-01 | 0.454 | 0 | 0 |
| TALDO1 deficiency: failed conversion of SH7P, GA3P to Fru(6)P, E4P | R-HSA-6791055 | 3.518040e-01 | 0.454 | 0 | 0 |
| Defective VWF binding to collagen type I | R-HSA-9845622 | 3.518040e-01 | 0.454 | 0 | 0 |
| Defective SLC12A3 causes Gitelman syndrome (GS) | R-HSA-5619087 | 3.518040e-01 | 0.454 | 0 | 0 |
| Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4), distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA) | R-HSA-5619050 | 3.518040e-01 | 0.454 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 3.518040e-01 | 0.454 | 0 | 0 |
| Defective MMADHC causes MMAHCD | R-HSA-3359473 | 3.518040e-01 | 0.454 | 0 | 0 |
| MPS IIID - Sanfilippo syndrome D | R-HSA-2206305 | 3.518040e-01 | 0.454 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 3.518040e-01 | 0.454 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9630794 | 3.518040e-01 | 0.454 | 0 | 0 |
| Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS) | R-HSA-5660724 | 3.518040e-01 | 0.454 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 2.684912e-01 | 0.571 | 0 | 0 |
| IRS activation | R-HSA-74713 | 2.684912e-01 | 0.571 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 2.684912e-01 | 0.571 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 2.684912e-01 | 0.571 | 0 | 0 |
| Enhanced binding of GP1BA variant to VWF multimer:collagen | R-HSA-9845620 | 2.684912e-01 | 0.571 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 2.684912e-01 | 0.571 | 0 | 0 |
| Defective binding of VWF variant to GPIb:IX:V | R-HSA-9846298 | 2.684912e-01 | 0.571 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 2.139160e-01 | 0.670 | 0 | 0 |
| FGFR1b ligand binding and activation | R-HSA-190370 | 2.139160e-01 | 0.670 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 2.517745e-01 | 0.599 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 2.517745e-01 | 0.599 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 2.517745e-01 | 0.599 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 2.517745e-01 | 0.599 | 0 | 0 |
| Defects of platelet adhesion to exposed collagen | R-HSA-9823587 | 3.214500e-01 | 0.493 | 0 | 0 |
| PKA-mediated phosphorylation of key metabolic factors | R-HSA-163358 | 3.214500e-01 | 0.493 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 3.214500e-01 | 0.493 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 3.214500e-01 | 0.493 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 3.214500e-01 | 0.493 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 3.214500e-01 | 0.493 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 3.214500e-01 | 0.493 | 0 | 0 |
| RUNX3 regulates RUNX1-mediated transcription | R-HSA-8951911 | 4.390372e-01 | 0.357 | 0 | 0 |
| Defective F8 cleavage by thrombin | R-HSA-9672391 | 4.390372e-01 | 0.357 | 0 | 0 |
| Enhanced cleavage of VWF variant by ADAMTS13 | R-HSA-9845619 | 4.390372e-01 | 0.357 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 4.390372e-01 | 0.357 | 0 | 0 |
| Defective VWF cleavage by ADAMTS13 variant | R-HSA-9845621 | 4.390372e-01 | 0.357 | 0 | 0 |
| HHAT G278V doesn't palmitoylate Hh-Np | R-HSA-5658034 | 4.390372e-01 | 0.357 | 0 | 0 |
| Mitotic Metaphase/Anaphase Transition | R-HSA-68881 | 4.390372e-01 | 0.357 | 0 | 0 |
| TWIK related potassium channel (TREK) | R-HSA-1299503 | 4.390372e-01 | 0.357 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 2.331321e-01 | 0.632 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 2.904909e-01 | 0.537 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 2.904909e-01 | 0.537 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 2.904909e-01 | 0.537 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 2.155862e-01 | 0.666 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 2.641957e-01 | 0.578 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 2.641957e-01 | 0.578 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 3.734068e-01 | 0.428 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 3.734068e-01 | 0.428 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 3.734068e-01 | 0.428 | 0 | 0 |
| Highly sodium permeable postsynaptic acetylcholine nicotinic receptors | R-HSA-629587 | 3.734068e-01 | 0.428 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 3.734068e-01 | 0.428 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 2.416450e-01 | 0.617 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 2.220006e-01 | 0.654 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 3.295788e-01 | 0.482 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 3.295788e-01 | 0.482 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 2.046671e-01 | 0.689 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 2.959602e-01 | 0.529 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 2.959602e-01 | 0.529 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 2.959602e-01 | 0.529 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 2.684852e-01 | 0.571 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 2.452222e-01 | 0.610 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 2.073674e-01 | 0.683 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 1.916178e-01 | 0.718 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 2.261646e-01 | 0.646 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 2.261646e-01 | 0.646 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 2.691042e-01 | 0.570 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 2.691042e-01 | 0.570 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 3.281574e-01 | 0.484 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 3.281574e-01 | 0.484 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 3.686095e-01 | 0.433 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 3.686095e-01 | 0.433 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 3.686095e-01 | 0.433 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 4.236726e-01 | 0.373 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 4.236726e-01 | 0.373 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 4.236726e-01 | 0.373 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 4.236726e-01 | 0.373 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 4.236726e-01 | 0.373 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 4.236726e-01 | 0.373 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 4.236726e-01 | 0.373 | 0 | 0 |
| Defective MMACHC causes MAHCC | R-HSA-3359474 | 5.145351e-01 | 0.289 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of other transcription factors | R-HSA-8866906 | 5.145351e-01 | 0.289 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 5.145351e-01 | 0.289 | 0 | 0 |
| Invadopodia formation | R-HSA-8941237 | 5.145351e-01 | 0.289 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 5.145351e-01 | 0.289 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 5.145351e-01 | 0.289 | 0 | 0 |
| Classical Kir channels | R-HSA-1296053 | 5.145351e-01 | 0.289 | 0 | 0 |
| Defective ABCA1 causes TGD | R-HSA-5682113 | 5.145351e-01 | 0.289 | 0 | 0 |
| Defective GCLC causes HAGGSD | R-HSA-5578999 | 5.145351e-01 | 0.289 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 2.935244e-01 | 0.532 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 2.935244e-01 | 0.532 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 3.238075e-01 | 0.490 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 3.605361e-01 | 0.443 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 3.605361e-01 | 0.443 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 3.605361e-01 | 0.443 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 3.605361e-01 | 0.443 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 2.899579e-01 | 0.538 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 2.899579e-01 | 0.538 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 4.072126e-01 | 0.390 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 4.072126e-01 | 0.390 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 4.072126e-01 | 0.390 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 4.072126e-01 | 0.390 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 4.072126e-01 | 0.390 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 4.072126e-01 | 0.390 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 4.072126e-01 | 0.390 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 2.392062e-01 | 0.621 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 3.519493e-01 | 0.454 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 3.124992e-01 | 0.505 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 3.434930e-01 | 0.464 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 3.434930e-01 | 0.464 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 3.434930e-01 | 0.464 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 3.928651e-01 | 0.406 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 3.928651e-01 | 0.406 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 3.928651e-01 | 0.406 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 4.717617e-01 | 0.326 | 0 | 0 |
| Activation of RAS in B cells | R-HSA-1169092 | 4.717617e-01 | 0.326 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 4.717617e-01 | 0.326 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 4.717617e-01 | 0.326 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 1.922961e-01 | 0.716 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 3.353468e-01 | 0.475 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 3.801965e-01 | 0.420 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 1.799808e-01 | 0.745 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 3.688045e-01 | 0.433 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 3.688045e-01 | 0.433 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 3.688045e-01 | 0.433 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 4.450751e-01 | 0.352 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 3.584109e-01 | 0.446 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 3.488224e-01 | 0.457 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 3.488224e-01 | 0.457 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 4.249352e-01 | 0.372 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 4.249352e-01 | 0.372 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 3.941830e-01 | 0.404 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 3.941830e-01 | 0.404 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 3.941830e-01 | 0.404 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 3.702569e-01 | 0.431 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 3.702569e-01 | 0.431 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 3.702569e-01 | 0.431 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 3.702569e-01 | 0.431 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 3.702569e-01 | 0.431 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 2.067777e-01 | 0.684 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 2.792764e-01 | 0.554 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 2.975877e-01 | 0.526 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 3.591867e-01 | 0.445 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 3.691776e-01 | 0.433 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 4.195216e-01 | 0.377 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 4.364204e-01 | 0.360 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 4.364204e-01 | 0.360 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 4.364204e-01 | 0.360 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 4.565600e-01 | 0.341 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 4.819385e-01 | 0.317 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 4.819385e-01 | 0.317 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 5.173497e-01 | 0.286 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 5.173497e-01 | 0.286 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 3.881785e-01 | 0.411 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 4.133501e-01 | 0.384 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 2.820818e-01 | 0.550 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 4.447200e-01 | 0.352 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 4.875762e-01 | 0.312 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 4.875762e-01 | 0.312 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 4.133240e-01 | 0.384 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 5.175946e-01 | 0.286 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 5.175946e-01 | 0.286 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 4.606316e-01 | 0.337 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 4.531946e-01 | 0.344 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 5.178436e-01 | 0.286 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 5.178436e-01 | 0.286 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 5.178436e-01 | 0.286 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 5.178436e-01 | 0.286 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 4.966801e-01 | 0.304 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 5.181804e-01 | 0.286 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 5.018895e-01 | 0.299 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 5.018895e-01 | 0.299 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 3.604122e-01 | 0.443 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 5.056507e-01 | 0.296 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 5.056507e-01 | 0.296 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 4.380497e-01 | 0.358 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 4.564637e-01 | 0.341 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 2.912914e-01 | 0.536 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 2.001794e-01 | 0.699 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 4.793100e-01 | 0.319 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 5.236373e-01 | 0.281 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 3.498797e-01 | 0.456 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 4.133501e-01 | 0.384 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 2.213843e-01 | 0.655 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 2.684852e-01 | 0.571 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 4.943302e-01 | 0.306 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 4.986577e-01 | 0.302 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 4.249352e-01 | 0.372 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 4.563098e-01 | 0.341 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 2.959602e-01 | 0.529 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 3.201105e-01 | 0.495 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 3.065206e-01 | 0.514 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 4.450751e-01 | 0.352 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 2.079774e-01 | 0.682 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 5.147635e-01 | 0.288 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 2.857944e-01 | 0.544 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 2.959304e-01 | 0.529 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 3.686095e-01 | 0.433 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 3.928651e-01 | 0.406 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 4.594076e-01 | 0.338 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 1.952691e-01 | 0.709 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 3.183607e-01 | 0.497 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 3.917884e-01 | 0.407 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 2.517745e-01 | 0.599 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 1.850054e-01 | 0.733 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 2.046671e-01 | 0.689 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 3.605361e-01 | 0.443 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 3.941830e-01 | 0.404 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 2.726846e-01 | 0.564 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 3.398999e-01 | 0.469 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 3.398999e-01 | 0.469 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 1.993490e-01 | 0.700 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 3.688045e-01 | 0.433 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 5.173497e-01 | 0.286 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 4.641316e-01 | 0.333 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 1.918695e-01 | 0.717 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 1.833666e-01 | 0.737 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 3.702569e-01 | 0.431 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 3.129992e-01 | 0.504 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 3.129992e-01 | 0.504 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 2.904909e-01 | 0.537 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 3.238075e-01 | 0.490 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 4.819385e-01 | 0.317 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 4.696848e-01 | 0.328 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 4.531946e-01 | 0.344 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 3.669445e-01 | 0.435 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 3.737915e-01 | 0.427 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 2.641957e-01 | 0.578 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 2.691042e-01 | 0.570 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 2.079774e-01 | 0.682 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 4.717617e-01 | 0.326 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 3.353468e-01 | 0.475 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 2.442429e-01 | 0.612 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 5.213487e-01 | 0.283 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 3.605361e-01 | 0.443 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 1.927746e-01 | 0.715 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 1.982839e-01 | 0.703 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 2.154742e-01 | 0.667 | 0 | 0 |
| Formation of lateral plate mesoderm | R-HSA-9758920 | 3.214500e-01 | 0.493 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 3.214500e-01 | 0.493 | 0 | 0 |
| Toxicity of botulinum toxin type E (botE) | R-HSA-5250992 | 3.214500e-01 | 0.493 | 0 | 0 |
| Small interfering RNA (siRNA) biogenesis | R-HSA-426486 | 3.734068e-01 | 0.428 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 2.959602e-01 | 0.529 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 4.236726e-01 | 0.373 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 4.717617e-01 | 0.326 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 4.819385e-01 | 0.317 | 0 | 0 |
| Toxicity of botulinum toxin type A (botA) | R-HSA-5250968 | 5.173497e-01 | 0.286 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 4.641316e-01 | 0.333 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 4.641316e-01 | 0.333 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 5.175946e-01 | 0.286 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 5.178436e-01 | 0.286 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 3.816042e-01 | 0.418 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 5.173497e-01 | 0.286 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 3.519493e-01 | 0.454 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 3.584109e-01 | 0.446 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 4.249352e-01 | 0.372 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 3.702569e-01 | 0.431 | 0 | 0 |
| S Phase | R-HSA-69242 | 4.450356e-01 | 0.352 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 2.326978e-01 | 0.633 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 3.434930e-01 | 0.464 | 0 | 0 |
| Dopamine receptors | R-HSA-390651 | 2.154742e-01 | 0.667 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 2.139160e-01 | 0.670 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 2.517745e-01 | 0.599 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 1.904855e-01 | 0.720 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 3.686095e-01 | 0.433 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 3.686095e-01 | 0.433 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 4.072126e-01 | 0.390 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 4.717617e-01 | 0.326 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 3.353468e-01 | 0.475 | 0 | 0 |
| PKA activation | R-HSA-163615 | 4.249352e-01 | 0.372 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 4.083997e-01 | 0.389 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 3.957494e-01 | 0.403 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 3.295788e-01 | 0.482 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 2.193658e-01 | 0.659 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 2.934252e-01 | 0.533 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 2.447966e-01 | 0.611 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 4.914189e-01 | 0.309 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 3.917884e-01 | 0.407 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 4.133240e-01 | 0.384 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 4.775235e-01 | 0.321 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 2.654462e-01 | 0.576 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 2.461575e-01 | 0.609 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 4.072126e-01 | 0.390 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 3.574126e-01 | 0.447 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 3.957494e-01 | 0.403 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 4.013615e-01 | 0.396 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 2.590574e-01 | 0.587 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 2.326978e-01 | 0.633 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 3.591101e-01 | 0.445 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 2.737496e-01 | 0.563 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 2.687882e-01 | 0.571 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 4.048420e-01 | 0.393 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 3.711329e-01 | 0.430 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 2.252244e-01 | 0.647 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 1.892192e-01 | 0.723 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 1.952691e-01 | 0.709 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 2.517745e-01 | 0.599 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 2.073674e-01 | 0.683 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 3.686095e-01 | 0.433 | 0 | 0 |
| Astrocytic Glutamate-Glutamine Uptake And Metabolism | R-HSA-210455 | 4.717617e-01 | 0.326 | 0 | 0 |
| Neurotransmitter uptake and metabolism In glial cells | R-HSA-112313 | 4.717617e-01 | 0.326 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 4.717617e-01 | 0.326 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 4.450751e-01 | 0.352 | 0 | 0 |
| FGFR1c ligand binding and activation | R-HSA-190373 | 4.450751e-01 | 0.352 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 3.598770e-01 | 0.444 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 3.952175e-01 | 0.403 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 3.952175e-01 | 0.403 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 3.952175e-01 | 0.403 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 3.952175e-01 | 0.403 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 4.641316e-01 | 0.333 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 3.088544e-01 | 0.510 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 3.516821e-01 | 0.454 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 2.052919e-01 | 0.688 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 2.439778e-01 | 0.613 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 3.605361e-01 | 0.443 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 4.195216e-01 | 0.377 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 3.673390e-01 | 0.435 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 2.760523e-01 | 0.559 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 4.263271e-01 | 0.370 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 2.331321e-01 | 0.632 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 2.250793e-01 | 0.648 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 2.333228e-01 | 0.632 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 2.333228e-01 | 0.632 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 3.916000e-01 | 0.407 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 2.590574e-01 | 0.587 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 2.590574e-01 | 0.587 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 3.799849e-01 | 0.420 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 3.244631e-01 | 0.489 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 4.286352e-01 | 0.368 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 2.684912e-01 | 0.571 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 2.030509e-01 | 0.692 | 0 | 0 |
| Release of Hh-Np from the secreting cell | R-HSA-5362798 | 3.214500e-01 | 0.493 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 3.214500e-01 | 0.493 | 0 | 0 |
| Formation of intermediate mesoderm | R-HSA-9761174 | 2.904909e-01 | 0.537 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 2.959602e-01 | 0.529 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 3.281574e-01 | 0.484 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 3.281574e-01 | 0.484 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 3.928651e-01 | 0.406 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 2.029990e-01 | 0.693 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 3.275535e-01 | 0.485 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 3.280706e-01 | 0.484 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 5.175946e-01 | 0.286 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 4.943302e-01 | 0.306 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 4.953653e-01 | 0.305 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 1.927746e-01 | 0.715 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 3.353468e-01 | 0.475 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 1.882341e-01 | 0.725 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 2.684912e-01 | 0.571 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 3.734068e-01 | 0.428 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 3.734068e-01 | 0.428 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 2.073674e-01 | 0.683 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 3.941830e-01 | 0.404 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 4.048420e-01 | 0.393 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 5.185780e-01 | 0.285 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 2.402089e-01 | 0.619 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 4.280403e-01 | 0.369 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 4.594648e-01 | 0.338 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 2.139787e-01 | 0.670 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 4.594648e-01 | 0.338 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 4.989260e-01 | 0.302 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 3.353468e-01 | 0.475 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 5.204056e-01 | 0.284 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 4.989260e-01 | 0.302 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 3.172367e-01 | 0.499 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 3.737915e-01 | 0.427 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 2.043748e-01 | 0.690 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 2.673223e-01 | 0.573 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 3.172367e-01 | 0.499 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 3.172367e-01 | 0.499 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 2.510121e-01 | 0.600 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 3.518040e-01 | 0.454 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH2 | R-HSA-5632928 | 3.518040e-01 | 0.454 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 2.684912e-01 | 0.571 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 2.517745e-01 | 0.599 | 0 | 0 |
| Acetylcholine inhibits contraction of outer hair cells | R-HSA-9667769 | 3.214500e-01 | 0.493 | 0 | 0 |
| Defective ABCC8 can cause hypo- and hyper-glycemias | R-HSA-5683177 | 4.390372e-01 | 0.357 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 3.295788e-01 | 0.482 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 3.295788e-01 | 0.482 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 2.959304e-01 | 0.529 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 4.236726e-01 | 0.373 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 5.145351e-01 | 0.289 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 2.455465e-01 | 0.610 | 0 | 0 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | R-HSA-8866904 | 4.717617e-01 | 0.326 | 0 | 0 |
| Co-stimulation by ICOS | R-HSA-9927354 | 4.717617e-01 | 0.326 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 4.083997e-01 | 0.389 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 3.816042e-01 | 0.418 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 3.383370e-01 | 0.471 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 4.280431e-01 | 0.369 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 2.990289e-01 | 0.524 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 4.914189e-01 | 0.309 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 5.178436e-01 | 0.286 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 4.966801e-01 | 0.304 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 5.190124e-01 | 0.285 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 5.190124e-01 | 0.285 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 5.266086e-01 | 0.279 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 3.275535e-01 | 0.485 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 4.067943e-01 | 0.391 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 3.398999e-01 | 0.469 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 3.952175e-01 | 0.403 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 2.691042e-01 | 0.570 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 3.104531e-01 | 0.508 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 3.329369e-01 | 0.478 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 4.966222e-01 | 0.304 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 4.920904e-01 | 0.308 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 4.966222e-01 | 0.304 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 5.236373e-01 | 0.281 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 3.295788e-01 | 0.482 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 2.678137e-01 | 0.572 | 0 | 0 |
| Toxicity of botulinum toxin type C (botC) | R-HSA-5250971 | 2.684912e-01 | 0.571 | 0 | 0 |
| LGI-ADAM interactions | R-HSA-5682910 | 3.295788e-01 | 0.482 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 4.236726e-01 | 0.373 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 5.173497e-01 | 0.286 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 4.875762e-01 | 0.312 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 4.380497e-01 | 0.358 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 5.003717e-01 | 0.301 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 5.386984e-01 | 0.269 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 5.380218e-01 | 0.269 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 3.214500e-01 | 0.493 | 0 | 0 |
| DSCAM interactions | R-HSA-376172 | 4.390372e-01 | 0.357 | 0 | 0 |
| Tandem pore domain potassium channels | R-HSA-1296346 | 2.904909e-01 | 0.537 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 2.416450e-01 | 0.617 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 3.295788e-01 | 0.482 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 2.073674e-01 | 0.683 | 0 | 0 |
| CASP5-mediated substrate cleavage | R-HSA-9960525 | 5.145351e-01 | 0.289 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 4.072126e-01 | 0.390 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 4.450751e-01 | 0.352 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 4.072386e-01 | 0.390 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 3.799849e-01 | 0.420 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 4.531946e-01 | 0.344 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 2.641957e-01 | 0.578 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 4.195216e-01 | 0.377 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 3.238075e-01 | 0.490 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 5.181804e-01 | 0.286 | 0 | 0 |
| Histamine receptors | R-HSA-390650 | 5.145351e-01 | 0.289 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 3.519493e-01 | 0.454 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 4.740321e-01 | 0.324 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 1.973642e-01 | 0.705 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 5.175946e-01 | 0.286 | 0 | 0 |
| Co-inhibition by BTLA | R-HSA-9927353 | 2.684912e-01 | 0.571 | 0 | 0 |
| Sodium-coupled phosphate cotransporters | R-HSA-427652 | 3.214500e-01 | 0.493 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 4.390372e-01 | 0.357 | 0 | 0 |
| Phase 3 - rapid repolarisation | R-HSA-5576890 | 4.236726e-01 | 0.373 | 0 | 0 |
| CASP4-mediated substrate cleavage | R-HSA-9960519 | 5.145351e-01 | 0.289 | 0 | 0 |
| Interleukin-18 signaling | R-HSA-9012546 | 4.717617e-01 | 0.326 | 0 | 0 |
| Butyrophilin (BTN) family interactions | R-HSA-8851680 | 5.173497e-01 | 0.286 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 2.684852e-01 | 0.571 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 2.641957e-01 | 0.578 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 5.178436e-01 | 0.286 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 2.861380e-01 | 0.543 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 5.003717e-01 | 0.301 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 2.904909e-01 | 0.537 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 2.684852e-01 | 0.571 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 2.959602e-01 | 0.529 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 4.236726e-01 | 0.373 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 5.173497e-01 | 0.286 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 4.641316e-01 | 0.333 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 1.926964e-01 | 0.715 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 4.249352e-01 | 0.372 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 4.083997e-01 | 0.389 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 3.816042e-01 | 0.418 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 4.525675e-01 | 0.344 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 5.423582e-01 | 0.266 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 5.423582e-01 | 0.266 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 5.423582e-01 | 0.266 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 5.443267e-01 | 0.264 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 5.443267e-01 | 0.264 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 5.443267e-01 | 0.264 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 5.443267e-01 | 0.264 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 5.443267e-01 | 0.264 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 5.443267e-01 | 0.264 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 5.443267e-01 | 0.264 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 5.472438e-01 | 0.262 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 5.472438e-01 | 0.262 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 5.472438e-01 | 0.262 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 5.512961e-01 | 0.259 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 5.518814e-01 | 0.258 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 5.518814e-01 | 0.258 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 5.518814e-01 | 0.258 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 5.518814e-01 | 0.258 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 5.518814e-01 | 0.258 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 5.523752e-01 | 0.258 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 5.544964e-01 | 0.256 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 5.567357e-01 | 0.254 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 5.582447e-01 | 0.253 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 5.601240e-01 | 0.252 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 5.602389e-01 | 0.252 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 5.602389e-01 | 0.252 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 5.602389e-01 | 0.252 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 5.602389e-01 | 0.252 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 5.602389e-01 | 0.252 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 5.602389e-01 | 0.252 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 5.602389e-01 | 0.252 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 5.602389e-01 | 0.252 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 5.602389e-01 | 0.252 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 5.602389e-01 | 0.252 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 5.623540e-01 | 0.250 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 5.651931e-01 | 0.248 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 5.656086e-01 | 0.247 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 5.660154e-01 | 0.247 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 5.697809e-01 | 0.244 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 5.697809e-01 | 0.244 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 5.697809e-01 | 0.244 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 5.697809e-01 | 0.244 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 5.724599e-01 | 0.242 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 5.744879e-01 | 0.241 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 5.756796e-01 | 0.240 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 5.769217e-01 | 0.239 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 5.769217e-01 | 0.239 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 5.787584e-01 | 0.238 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 5.787584e-01 | 0.238 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 5.789257e-01 | 0.237 | 0 | 0 |
| Drug-mediated inhibition of CDK4/CDK6 activity | R-HSA-9754119 | 5.798758e-01 | 0.237 | 0 | 0 |
| Defective LFNG causes SCDO3 | R-HSA-5083630 | 5.798758e-01 | 0.237 | 0 | 0 |
| Defective MAT1A causes MATD | R-HSA-5579024 | 5.798758e-01 | 0.237 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 5.798758e-01 | 0.237 | 0 | 0 |
| Alanine metabolism | R-HSA-8964540 | 5.798758e-01 | 0.237 | 0 | 0 |
| p75NTR negatively regulates cell cycle via SC1 | R-HSA-193670 | 5.798758e-01 | 0.237 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 5.798758e-01 | 0.237 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 5.846779e-01 | 0.233 | 0 | 0 |
| Phase 2 - plateau phase | R-HSA-5576893 | 5.846779e-01 | 0.233 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 5.846779e-01 | 0.233 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 5.846779e-01 | 0.233 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 5.846779e-01 | 0.233 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 5.846779e-01 | 0.233 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 5.867583e-01 | 0.232 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 5.882747e-01 | 0.230 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 5.882747e-01 | 0.230 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 5.919276e-01 | 0.228 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 5.944778e-01 | 0.226 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 5.944778e-01 | 0.226 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 5.944778e-01 | 0.226 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 5.952378e-01 | 0.225 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 5.992274e-01 | 0.222 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 6.003299e-01 | 0.222 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 6.003299e-01 | 0.222 | 0 | 0 |
| FGFR2b ligand binding and activation | R-HSA-190377 | 6.003299e-01 | 0.222 | 0 | 0 |
| Presynaptic depolarization and calcium channel opening | R-HSA-112308 | 6.003299e-01 | 0.222 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 6.003299e-01 | 0.222 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 6.003299e-01 | 0.222 | 0 | 0 |
| Transport of RCbl within the body | R-HSA-9758890 | 6.003299e-01 | 0.222 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 6.103101e-01 | 0.214 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 6.103101e-01 | 0.214 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 6.158993e-01 | 0.210 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 6.158993e-01 | 0.210 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 6.162990e-01 | 0.210 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 6.165730e-01 | 0.210 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 6.183638e-01 | 0.209 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 6.183638e-01 | 0.209 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 6.183638e-01 | 0.209 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 6.215850e-01 | 0.206 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 6.272819e-01 | 0.203 | 0 | 0 |
| Immune System | R-HSA-168256 | 6.289740e-01 | 0.201 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 6.293657e-01 | 0.201 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 6.293657e-01 | 0.201 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 6.293657e-01 | 0.201 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 6.306794e-01 | 0.200 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 6.312408e-01 | 0.200 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 6.316755e-01 | 0.200 | 0 | 0 |
| Activation of AMPA receptors | R-HSA-399710 | 6.364253e-01 | 0.196 | 0 | 0 |
| NFE2L2 regulating TCA cycle genes | R-HSA-9818025 | 6.364253e-01 | 0.196 | 0 | 0 |
| NOSIP mediated eNOS trafficking | R-HSA-203754 | 6.364253e-01 | 0.196 | 0 | 0 |
| Defective F9 activation | R-HSA-9673221 | 6.364253e-01 | 0.196 | 0 | 0 |
| Defective SLC1A3 causes episodic ataxia 6 (EA6) | R-HSA-5619062 | 6.364253e-01 | 0.196 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 6.364253e-01 | 0.196 | 0 | 0 |
| Activation of AKT2 | R-HSA-165158 | 6.364253e-01 | 0.196 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 6.364253e-01 | 0.196 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 6.364253e-01 | 0.196 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 6.364253e-01 | 0.196 | 0 | 0 |
| Suppression of autophagy | R-HSA-9636569 | 6.364253e-01 | 0.196 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 6.364253e-01 | 0.196 | 0 | 0 |
| Biosynthesis of DPAn-3-derived 13-series resolvins | R-HSA-9026403 | 6.364253e-01 | 0.196 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 6.364253e-01 | 0.196 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 6.375990e-01 | 0.195 | 0 | 0 |
| Presynaptic nicotinic acetylcholine receptors | R-HSA-622323 | 6.375990e-01 | 0.195 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 6.375990e-01 | 0.195 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 6.375990e-01 | 0.195 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 6.375990e-01 | 0.195 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 6.375990e-01 | 0.195 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 6.375990e-01 | 0.195 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 6.375990e-01 | 0.195 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 6.375990e-01 | 0.195 | 0 | 0 |
| Signaling by activated point mutants of FGFR1 | R-HSA-1839122 | 6.375990e-01 | 0.195 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 6.375990e-01 | 0.195 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 6.395819e-01 | 0.194 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 6.413960e-01 | 0.193 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 6.419880e-01 | 0.192 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 6.435784e-01 | 0.191 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 6.435784e-01 | 0.191 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 6.454925e-01 | 0.190 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 6.454925e-01 | 0.190 | 0 | 0 |
| FGFR1 ligand binding and activation | R-HSA-190242 | 6.454925e-01 | 0.190 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 6.454925e-01 | 0.190 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 6.501770e-01 | 0.187 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 6.523388e-01 | 0.186 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 6.544088e-01 | 0.184 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 6.544088e-01 | 0.184 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 6.545138e-01 | 0.184 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 6.581033e-01 | 0.182 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 6.631841e-01 | 0.178 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 6.635417e-01 | 0.178 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 6.635417e-01 | 0.178 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 6.643848e-01 | 0.178 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 6.671997e-01 | 0.176 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 6.684307e-01 | 0.175 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 6.720795e-01 | 0.173 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 6.720795e-01 | 0.173 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 6.720795e-01 | 0.173 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 6.720795e-01 | 0.173 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 6.720795e-01 | 0.173 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 6.720795e-01 | 0.173 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 6.720795e-01 | 0.173 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 6.720795e-01 | 0.173 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 6.722747e-01 | 0.172 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 6.722747e-01 | 0.172 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 6.734313e-01 | 0.172 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 6.734313e-01 | 0.172 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 6.734313e-01 | 0.172 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 6.784896e-01 | 0.168 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 6.784896e-01 | 0.168 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 6.784896e-01 | 0.168 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 6.784896e-01 | 0.168 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 6.784896e-01 | 0.168 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 6.794581e-01 | 0.168 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 6.842154e-01 | 0.165 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 6.847772e-01 | 0.164 | 0 | 0 |
| TRAIL signaling | R-HSA-75158 | 6.853660e-01 | 0.164 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 6.853660e-01 | 0.164 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 6.853660e-01 | 0.164 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 6.853660e-01 | 0.164 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 6.853660e-01 | 0.164 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 6.853660e-01 | 0.164 | 0 | 0 |
| Defective CSF2RB causes SMDP5 | R-HSA-5688849 | 6.853660e-01 | 0.164 | 0 | 0 |
| Defective CSF2RA causes SMDP4 | R-HSA-5688890 | 6.853660e-01 | 0.164 | 0 | 0 |
| Phase 1 - inactivation of fast Na+ channels | R-HSA-5576894 | 6.853660e-01 | 0.164 | 0 | 0 |
| Signaling by RNF43 mutants | R-HSA-5340588 | 6.853660e-01 | 0.164 | 0 | 0 |
| Terminal pathway of complement | R-HSA-166665 | 6.853660e-01 | 0.164 | 0 | 0 |
| Signaling by MST1 | R-HSA-8852405 | 6.853660e-01 | 0.164 | 0 | 0 |
| NGF-independant TRKA activation | R-HSA-187024 | 6.853660e-01 | 0.164 | 0 | 0 |
| Pentose phosphate pathway disease | R-HSA-6791465 | 6.853660e-01 | 0.164 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 6.853660e-01 | 0.164 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 6.853660e-01 | 0.164 | 0 | 0 |
| Formation of the Editosome | R-HSA-75094 | 6.853660e-01 | 0.164 | 0 | 0 |
| Ceramide signalling | R-HSA-193681 | 6.853660e-01 | 0.164 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 6.853660e-01 | 0.164 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 6.853660e-01 | 0.164 | 0 | 0 |
| Release of apoptotic factors from the mitochondria | R-HSA-111457 | 6.853660e-01 | 0.164 | 0 | 0 |
| Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660826 | 6.853660e-01 | 0.164 | 0 | 0 |
| Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660825 | 6.853660e-01 | 0.164 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 6.853660e-01 | 0.164 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 6.886083e-01 | 0.162 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 6.887879e-01 | 0.162 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 6.887879e-01 | 0.162 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 6.905105e-01 | 0.161 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 6.914643e-01 | 0.160 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 6.938927e-01 | 0.159 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 6.982159e-01 | 0.156 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 6.997126e-01 | 0.155 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 6.997126e-01 | 0.155 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 6.997126e-01 | 0.155 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 6.997126e-01 | 0.155 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 6.997126e-01 | 0.155 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 7.012787e-01 | 0.154 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 7.012787e-01 | 0.154 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 7.012787e-01 | 0.154 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 7.034825e-01 | 0.153 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 7.034825e-01 | 0.153 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 7.034825e-01 | 0.153 | 0 | 0 |
| Acetylcholine binding and downstream events | R-HSA-181431 | 7.038466e-01 | 0.153 | 0 | 0 |
| Adenylate cyclase activating pathway | R-HSA-170660 | 7.038466e-01 | 0.153 | 0 | 0 |
| Postsynaptic nicotinic acetylcholine receptors | R-HSA-622327 | 7.038466e-01 | 0.153 | 0 | 0 |
| FGFR2c ligand binding and activation | R-HSA-190375 | 7.038466e-01 | 0.153 | 0 | 0 |
| TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway | R-HSA-5676594 | 7.038466e-01 | 0.153 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 7.038466e-01 | 0.153 | 0 | 0 |
| FGFR4 ligand binding and activation | R-HSA-190322 | 7.038466e-01 | 0.153 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 7.038466e-01 | 0.153 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 7.038466e-01 | 0.153 | 0 | 0 |
| Signaling by activated point mutants of FGFR3 | R-HSA-1839130 | 7.038466e-01 | 0.153 | 0 | 0 |
| FGFR3 mutant receptor activation | R-HSA-2033514 | 7.038466e-01 | 0.153 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 7.038466e-01 | 0.153 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 7.038466e-01 | 0.153 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 7.038466e-01 | 0.153 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 7.050878e-01 | 0.152 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 7.050878e-01 | 0.152 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 7.050878e-01 | 0.152 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 7.050878e-01 | 0.152 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 7.055741e-01 | 0.151 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 7.055741e-01 | 0.151 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 7.098943e-01 | 0.149 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 7.098943e-01 | 0.149 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 7.113997e-01 | 0.148 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 7.151530e-01 | 0.146 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 7.171985e-01 | 0.144 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 7.205963e-01 | 0.142 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 7.228779e-01 | 0.141 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 7.243521e-01 | 0.140 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 7.244662e-01 | 0.140 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 7.244662e-01 | 0.140 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 7.244662e-01 | 0.140 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 7.275571e-01 | 0.138 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 7.277212e-01 | 0.138 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 7.277212e-01 | 0.138 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 7.277212e-01 | 0.138 | 0 | 0 |
| Toxicity of botulinum toxin type F (botF) | R-HSA-5250981 | 7.277212e-01 | 0.138 | 0 | 0 |
| Toxicity of botulinum toxin type D (botD) | R-HSA-5250955 | 7.277212e-01 | 0.138 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 7.277212e-01 | 0.138 | 0 | 0 |
| Intracellular metabolism of fatty acids regulates insulin secretion | R-HSA-434313 | 7.277212e-01 | 0.138 | 0 | 0 |
| Abacavir transmembrane transport | R-HSA-2161517 | 7.277212e-01 | 0.138 | 0 | 0 |
| Defective factor VIII causes hemophilia A | R-HSA-9662001 | 7.277212e-01 | 0.138 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 7.277212e-01 | 0.138 | 0 | 0 |
| Lipid particle organization | R-HSA-8964572 | 7.277212e-01 | 0.138 | 0 | 0 |
| Leukotriene receptors | R-HSA-391906 | 7.277212e-01 | 0.138 | 0 | 0 |
| VLDL assembly | R-HSA-8866423 | 7.277212e-01 | 0.138 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 7.277212e-01 | 0.138 | 0 | 0 |
| CREB3 factors activate genes | R-HSA-8874211 | 7.277212e-01 | 0.138 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 7.330061e-01 | 0.135 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 7.330061e-01 | 0.135 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR3 | R-HSA-5654227 | 7.330061e-01 | 0.135 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 7.330061e-01 | 0.135 | 0 | 0 |
| Prolactin receptor signaling | R-HSA-1170546 | 7.330061e-01 | 0.135 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 7.330061e-01 | 0.135 | 0 | 0 |
| FGFR3c ligand binding and activation | R-HSA-190372 | 7.330061e-01 | 0.135 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 7.330061e-01 | 0.135 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 7.330061e-01 | 0.135 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 7.330061e-01 | 0.135 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 7.335652e-01 | 0.135 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 7.348597e-01 | 0.134 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 7.356926e-01 | 0.133 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 7.357397e-01 | 0.133 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 7.393270e-01 | 0.131 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 7.429121e-01 | 0.129 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 7.432947e-01 | 0.129 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 7.448801e-01 | 0.128 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 7.473812e-01 | 0.126 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 7.473812e-01 | 0.126 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 7.487714e-01 | 0.126 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 7.542294e-01 | 0.122 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 7.577689e-01 | 0.120 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 7.588762e-01 | 0.120 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 7.596841e-01 | 0.119 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 7.596841e-01 | 0.119 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 7.596841e-01 | 0.119 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR4 | R-HSA-5654228 | 7.596841e-01 | 0.119 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 7.596841e-01 | 0.119 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 7.596841e-01 | 0.119 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 7.596841e-01 | 0.119 | 0 | 0 |
| FGFR3 ligand binding and activation | R-HSA-190239 | 7.596841e-01 | 0.119 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 7.596841e-01 | 0.119 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 7.596841e-01 | 0.119 | 0 | 0 |
| Signaling by Activin | R-HSA-1502540 | 7.596841e-01 | 0.119 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 7.604313e-01 | 0.119 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 7.617284e-01 | 0.118 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 7.625448e-01 | 0.118 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 7.625448e-01 | 0.118 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 7.625448e-01 | 0.118 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 7.643086e-01 | 0.117 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 7.643768e-01 | 0.117 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 7.643768e-01 | 0.117 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 7.643768e-01 | 0.117 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 7.643768e-01 | 0.117 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 7.643768e-01 | 0.117 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake | R-HSA-9031525 | 7.643768e-01 | 0.117 | 0 | 0 |
| Pre-NOTCH Processing in the Endoplasmic Reticulum | R-HSA-1912399 | 7.643768e-01 | 0.117 | 0 | 0 |
| FGFR3b ligand binding and activation | R-HSA-190371 | 7.643768e-01 | 0.117 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 7.643768e-01 | 0.117 | 0 | 0 |
| mRNA Editing: C to U Conversion | R-HSA-72200 | 7.643768e-01 | 0.117 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 7.643768e-01 | 0.117 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 7.643768e-01 | 0.117 | 0 | 0 |
| Synthesis of PIPs in the nucleus | R-HSA-8847453 | 7.643768e-01 | 0.117 | 0 | 0 |
| LDL remodeling | R-HSA-8964041 | 7.643768e-01 | 0.117 | 0 | 0 |
| Activation of TRKA receptors | R-HSA-187015 | 7.643768e-01 | 0.117 | 0 | 0 |
| Defective HLCS causes multiple carboxylase deficiency | R-HSA-3371599 | 7.643768e-01 | 0.117 | 0 | 0 |
| Glycoprotein hormones | R-HSA-209822 | 7.643768e-01 | 0.117 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 7.643768e-01 | 0.117 | 0 | 0 |
| Maturation of replicase proteins | R-HSA-9694301 | 7.643768e-01 | 0.117 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 7.671031e-01 | 0.115 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 7.688435e-01 | 0.114 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 7.688435e-01 | 0.114 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 7.688435e-01 | 0.114 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 7.688435e-01 | 0.114 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 7.688435e-01 | 0.114 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 7.697755e-01 | 0.114 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 7.711002e-01 | 0.113 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 7.715160e-01 | 0.113 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 7.723236e-01 | 0.112 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 7.759371e-01 | 0.110 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 7.759371e-01 | 0.110 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 7.806518e-01 | 0.108 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 7.806518e-01 | 0.108 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 7.812593e-01 | 0.107 | 0 | 0 |
| Entry of Influenza Virion into Host Cell via Endocytosis | R-HSA-168275 | 7.840204e-01 | 0.106 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 7.840204e-01 | 0.106 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 7.840204e-01 | 0.106 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 7.840204e-01 | 0.106 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 7.840204e-01 | 0.106 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 7.840204e-01 | 0.106 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 7.840204e-01 | 0.106 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 7.840204e-01 | 0.106 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 7.840204e-01 | 0.106 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 7.840204e-01 | 0.106 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 7.840204e-01 | 0.106 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 7.873173e-01 | 0.104 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 7.875737e-01 | 0.104 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 7.887926e-01 | 0.103 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 7.887926e-01 | 0.103 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 7.887926e-01 | 0.103 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 7.905464e-01 | 0.102 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 7.905464e-01 | 0.102 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 7.927394e-01 | 0.101 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 7.928373e-01 | 0.101 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 7.960994e-01 | 0.099 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 7.960994e-01 | 0.099 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 7.960994e-01 | 0.099 | 0 | 0 |
| Highly calcium permeable nicotinic acetylcholine receptors | R-HSA-629597 | 7.960994e-01 | 0.099 | 0 | 0 |
| Interleukin-9 signaling | R-HSA-8985947 | 7.960994e-01 | 0.099 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 7.960994e-01 | 0.099 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 7.960994e-01 | 0.099 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 7.960994e-01 | 0.099 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 7.960994e-01 | 0.099 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 7.960994e-01 | 0.099 | 0 | 0 |
| Interleukin-23 signaling | R-HSA-9020933 | 7.960994e-01 | 0.099 | 0 | 0 |
| Alpha-defensins | R-HSA-1462054 | 7.960994e-01 | 0.099 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 8.015507e-01 | 0.096 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 8.035388e-01 | 0.095 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 8.044153e-01 | 0.095 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 8.061616e-01 | 0.094 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 8.061616e-01 | 0.094 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 8.061616e-01 | 0.094 | 0 | 0 |
| Defects of contact activation system (CAS) and kallikrein/kinin system (KKS) | R-HSA-9651496 | 8.061616e-01 | 0.094 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 8.065701e-01 | 0.093 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 8.072895e-01 | 0.093 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 8.072895e-01 | 0.093 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 8.072895e-01 | 0.093 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 8.075642e-01 | 0.093 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 8.075642e-01 | 0.093 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 8.075642e-01 | 0.093 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 8.075642e-01 | 0.093 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 8.075642e-01 | 0.093 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 8.075642e-01 | 0.093 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 8.075642e-01 | 0.093 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 8.135584e-01 | 0.090 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 8.153771e-01 | 0.089 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 8.154648e-01 | 0.089 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 8.175590e-01 | 0.087 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 8.215327e-01 | 0.085 | 0 | 0 |
| Estrogen-stimulated signaling through PRKCZ | R-HSA-9634635 | 8.235527e-01 | 0.084 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 8.235527e-01 | 0.084 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 8.235527e-01 | 0.084 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 8.235527e-01 | 0.084 | 0 | 0 |
| Degradation of GABA | R-HSA-916853 | 8.235527e-01 | 0.084 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 8.235527e-01 | 0.084 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 8.235527e-01 | 0.084 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 8.235527e-01 | 0.084 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 8.235527e-01 | 0.084 | 0 | 0 |
| Defects in biotin (Btn) metabolism | R-HSA-3323169 | 8.235527e-01 | 0.084 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 8.235527e-01 | 0.084 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 8.244001e-01 | 0.084 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 8.244001e-01 | 0.084 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 8.244001e-01 | 0.084 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 8.244001e-01 | 0.084 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 8.244001e-01 | 0.084 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 8.244001e-01 | 0.084 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 8.244001e-01 | 0.084 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 8.244001e-01 | 0.084 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 8.262578e-01 | 0.083 | 0 | 0 |
| Phospholipase C-mediated cascade: FGFR1 | R-HSA-5654219 | 8.262578e-01 | 0.083 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 8.262578e-01 | 0.083 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 8.262578e-01 | 0.083 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 8.262578e-01 | 0.083 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 8.262578e-01 | 0.083 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 8.262578e-01 | 0.083 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 8.272858e-01 | 0.082 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 8.284308e-01 | 0.082 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 8.284308e-01 | 0.082 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 8.304817e-01 | 0.081 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 8.320076e-01 | 0.080 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 8.327421e-01 | 0.079 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 8.346708e-01 | 0.078 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 8.346708e-01 | 0.078 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 8.346708e-01 | 0.078 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 8.346708e-01 | 0.078 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 8.346708e-01 | 0.078 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 8.355441e-01 | 0.078 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 8.374500e-01 | 0.077 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 8.401944e-01 | 0.076 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 8.415828e-01 | 0.075 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 8.423033e-01 | 0.075 | 0 | 0 |
| Activated point mutants of FGFR2 | R-HSA-2033519 | 8.444580e-01 | 0.073 | 0 | 0 |
| Vitamin D (calciferol) metabolism | R-HSA-196791 | 8.444580e-01 | 0.073 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 8.444580e-01 | 0.073 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 8.466511e-01 | 0.072 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 8.470070e-01 | 0.072 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 8.470070e-01 | 0.072 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 8.473111e-01 | 0.072 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 8.473111e-01 | 0.072 | 0 | 0 |
| Highly calcium permeable postsynaptic nicotinic acetylcholine receptors | R-HSA-629594 | 8.473111e-01 | 0.072 | 0 | 0 |
| TET1,2,3 and TDG demethylate DNA | R-HSA-5221030 | 8.473111e-01 | 0.072 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 8.473111e-01 | 0.072 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 8.473111e-01 | 0.072 | 0 | 0 |
| Maturation of spike protein | R-HSA-9683686 | 8.473111e-01 | 0.072 | 0 | 0 |
| Sperm Motility And Taxes | R-HSA-1300642 | 8.473111e-01 | 0.072 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 8.473111e-01 | 0.072 | 0 | 0 |
| Defective factor IX causes hemophilia B | R-HSA-9668250 | 8.473111e-01 | 0.072 | 0 | 0 |
| Metal sequestration by antimicrobial proteins | R-HSA-6799990 | 8.473111e-01 | 0.072 | 0 | 0 |
| Peptide hormone biosynthesis | R-HSA-209952 | 8.473111e-01 | 0.072 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 8.473111e-01 | 0.072 | 0 | 0 |
| Serotonin receptors | R-HSA-390666 | 8.473111e-01 | 0.072 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 8.473111e-01 | 0.072 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 8.490450e-01 | 0.071 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 8.490450e-01 | 0.071 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 8.490450e-01 | 0.071 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 8.528242e-01 | 0.069 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 8.562897e-01 | 0.067 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 8.585710e-01 | 0.066 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 8.589917e-01 | 0.066 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 8.589917e-01 | 0.066 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 8.601615e-01 | 0.065 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 8.609085e-01 | 0.065 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 8.609085e-01 | 0.065 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 8.609085e-01 | 0.065 | 0 | 0 |
| Diseases of hemostasis | R-HSA-9671793 | 8.609085e-01 | 0.065 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 8.609085e-01 | 0.065 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 8.609085e-01 | 0.065 | 0 | 0 |
| Crosslinking of collagen fibrils | R-HSA-2243919 | 8.609085e-01 | 0.065 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 8.609085e-01 | 0.065 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 8.612975e-01 | 0.065 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 8.632610e-01 | 0.064 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 8.632610e-01 | 0.064 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 8.672238e-01 | 0.062 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 8.672238e-01 | 0.062 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 8.672238e-01 | 0.062 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 8.678716e-01 | 0.062 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 8.678716e-01 | 0.062 | 0 | 0 |
| FGFRL1 modulation of FGFR1 signaling | R-HSA-5658623 | 8.678716e-01 | 0.062 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 8.678716e-01 | 0.062 | 0 | 0 |
| vRNA Synthesis | R-HSA-192814 | 8.678716e-01 | 0.062 | 0 | 0 |
| Chylomicron assembly | R-HSA-8963888 | 8.678716e-01 | 0.062 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 8.678716e-01 | 0.062 | 0 | 0 |
| Biosynthesis of DPAn-3-derived maresins | R-HSA-9026290 | 8.678716e-01 | 0.062 | 0 | 0 |
| Synthesis of PIPs at the ER membrane | R-HSA-1483248 | 8.678716e-01 | 0.062 | 0 | 0 |
| Inorganic anion exchange by SLC26 transporters | R-HSA-427601 | 8.678716e-01 | 0.062 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 8.678716e-01 | 0.062 | 0 | 0 |
| Prostanoid ligand receptors | R-HSA-391908 | 8.678716e-01 | 0.062 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 8.681214e-01 | 0.061 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 8.685627e-01 | 0.061 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 8.693942e-01 | 0.061 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 8.693942e-01 | 0.061 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 8.697340e-01 | 0.061 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 8.714677e-01 | 0.060 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 8.730770e-01 | 0.059 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR2 | R-HSA-5654221 | 8.757503e-01 | 0.058 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 8.757503e-01 | 0.058 | 0 | 0 |
| Mitochondrial iron-sulfur cluster biogenesis | R-HSA-1362409 | 8.757503e-01 | 0.058 | 0 | 0 |
| Eicosanoid ligand-binding receptors | R-HSA-391903 | 8.757503e-01 | 0.058 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 8.765897e-01 | 0.057 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 8.775143e-01 | 0.057 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 8.775143e-01 | 0.057 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 8.775143e-01 | 0.057 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 8.778221e-01 | 0.057 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 8.783623e-01 | 0.056 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 8.783624e-01 | 0.056 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 8.795087e-01 | 0.056 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 8.795087e-01 | 0.056 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 8.803991e-01 | 0.055 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 8.803991e-01 | 0.055 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 8.827567e-01 | 0.054 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 8.851557e-01 | 0.053 | 0 | 0 |
| Endosomal/Vacuolar pathway | R-HSA-1236977 | 8.856646e-01 | 0.053 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by WNT ligand antagonists | R-HSA-3772470 | 8.856646e-01 | 0.053 | 0 | 0 |
| Synthesis of diphthamide-EEF2 | R-HSA-5358493 | 8.856646e-01 | 0.053 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 8.856646e-01 | 0.053 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 8.884292e-01 | 0.051 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 8.886812e-01 | 0.051 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 8.889470e-01 | 0.051 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 8.889470e-01 | 0.051 | 0 | 0 |
| FGFR2 ligand binding and activation | R-HSA-190241 | 8.891183e-01 | 0.051 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 8.891183e-01 | 0.051 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 8.891183e-01 | 0.051 | 0 | 0 |
| Intrinsic Pathway of Fibrin Clot Formation | R-HSA-140837 | 8.891183e-01 | 0.051 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 8.904428e-01 | 0.050 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 8.909439e-01 | 0.050 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 8.916485e-01 | 0.050 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 8.977419e-01 | 0.047 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 8.990445e-01 | 0.046 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 9.010623e-01 | 0.045 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 9.010623e-01 | 0.045 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 9.010623e-01 | 0.045 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 9.010623e-01 | 0.045 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 9.010623e-01 | 0.045 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 9.010623e-01 | 0.045 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 9.010623e-01 | 0.045 | 0 | 0 |
| Biosynthesis of DPAn-3-derived protectins and resolvins | R-HSA-9026286 | 9.010623e-01 | 0.045 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 9.010623e-01 | 0.045 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 9.010623e-01 | 0.045 | 0 | 0 |
| Diseases associated with surfactant metabolism | R-HSA-5687613 | 9.010623e-01 | 0.045 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 9.010623e-01 | 0.045 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 9.010623e-01 | 0.045 | 0 | 0 |
| Estrogen biosynthesis | R-HSA-193144 | 9.010623e-01 | 0.045 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 9.010623e-01 | 0.045 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 9.011402e-01 | 0.045 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 9.011402e-01 | 0.045 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 9.013719e-01 | 0.045 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 9.019393e-01 | 0.045 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 9.047587e-01 | 0.043 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.050157e-01 | 0.043 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 9.059263e-01 | 0.043 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.077170e-01 | 0.042 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 9.108016e-01 | 0.041 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 9.108016e-01 | 0.041 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 9.113389e-01 | 0.040 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 9.119361e-01 | 0.040 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 9.119361e-01 | 0.040 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 9.119361e-01 | 0.040 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 9.119361e-01 | 0.040 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 9.119361e-01 | 0.040 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 9.119361e-01 | 0.040 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 9.135326e-01 | 0.039 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 9.135326e-01 | 0.039 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 9.143872e-01 | 0.039 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 9.143872e-01 | 0.039 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 9.143872e-01 | 0.039 | 0 | 0 |
| Chylomicron remodeling | R-HSA-8963901 | 9.143872e-01 | 0.039 | 0 | 0 |
| Mtb iron assimilation by chelation | R-HSA-1222449 | 9.143872e-01 | 0.039 | 0 | 0 |
| Reversible hydration of carbon dioxide | R-HSA-1475029 | 9.143872e-01 | 0.039 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 9.143872e-01 | 0.039 | 0 | 0 |
| rRNA modification in the mitochondrion | R-HSA-6793080 | 9.143872e-01 | 0.039 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 9.143872e-01 | 0.039 | 0 | 0 |
| Acyl chain remodeling of DAG and TAG | R-HSA-1482883 | 9.143872e-01 | 0.039 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 9.151727e-01 | 0.038 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 9.199122e-01 | 0.036 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.203159e-01 | 0.036 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 9.205926e-01 | 0.036 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 9.216181e-01 | 0.035 | 0 | 0 |
| Protein folding | R-HSA-391251 | 9.219149e-01 | 0.035 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 9.219149e-01 | 0.035 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 9.226624e-01 | 0.035 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 9.226624e-01 | 0.035 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 9.226624e-01 | 0.035 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 9.259182e-01 | 0.033 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 9.259182e-01 | 0.033 | 0 | 0 |
| Biosynthesis of E-series 18(R)-resolvins | R-HSA-9023661 | 9.259182e-01 | 0.033 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 9.259182e-01 | 0.033 | 0 | 0 |
| Glycerophospholipid catabolism | R-HSA-6814848 | 9.259182e-01 | 0.033 | 0 | 0 |
| Non-canonical inflammasome activation | R-HSA-9686114 | 9.259182e-01 | 0.033 | 0 | 0 |
| P2Y receptors | R-HSA-417957 | 9.259182e-01 | 0.033 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 9.259182e-01 | 0.033 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.264786e-01 | 0.033 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 9.271376e-01 | 0.033 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.271376e-01 | 0.033 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 9.277212e-01 | 0.033 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 9.295523e-01 | 0.032 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 9.297528e-01 | 0.032 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.300004e-01 | 0.032 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 9.302903e-01 | 0.031 | 0 | 0 |
| Assembly of active LPL and LIPC lipase complexes | R-HSA-8963889 | 9.302903e-01 | 0.031 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 9.302903e-01 | 0.031 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 9.302903e-01 | 0.031 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.316968e-01 | 0.031 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 9.331981e-01 | 0.030 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 9.331981e-01 | 0.030 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 9.348248e-01 | 0.029 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 9.348248e-01 | 0.029 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 9.348248e-01 | 0.029 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 9.358828e-01 | 0.029 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 9.358966e-01 | 0.029 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 9.358966e-01 | 0.029 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 9.358966e-01 | 0.029 | 0 | 0 |
| Protein lipoylation | R-HSA-9857492 | 9.358966e-01 | 0.029 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 9.358966e-01 | 0.029 | 0 | 0 |
| Protein repair | R-HSA-5676934 | 9.358966e-01 | 0.029 | 0 | 0 |
| Biotin transport and metabolism | R-HSA-196780 | 9.358966e-01 | 0.029 | 0 | 0 |
| Dopamine clearance from the synaptic cleft | R-HSA-379401 | 9.358966e-01 | 0.029 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 9.358966e-01 | 0.029 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 9.358966e-01 | 0.029 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.375314e-01 | 0.028 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 9.375568e-01 | 0.028 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 9.379578e-01 | 0.028 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 9.380490e-01 | 0.028 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 9.380490e-01 | 0.028 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 9.383639e-01 | 0.028 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 9.388034e-01 | 0.027 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 9.416922e-01 | 0.026 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 9.427006e-01 | 0.026 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 9.443815e-01 | 0.025 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 9.445316e-01 | 0.025 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 9.445316e-01 | 0.025 | 0 | 0 |
| Fructose catabolism | R-HSA-70350 | 9.445316e-01 | 0.025 | 0 | 0 |
| Induction of Cell-Cell Fusion | R-HSA-9733458 | 9.445316e-01 | 0.025 | 0 | 0 |
| Synthesis of wybutosine at G37 of tRNA(Phe) | R-HSA-6782861 | 9.445316e-01 | 0.025 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 9.445316e-01 | 0.025 | 0 | 0 |
| Atorvastatin ADME | R-HSA-9754706 | 9.445316e-01 | 0.025 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 9.449830e-01 | 0.025 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 9.471360e-01 | 0.024 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 9.471360e-01 | 0.024 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 9.471360e-01 | 0.024 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 9.471360e-01 | 0.024 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 9.487617e-01 | 0.023 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 9.511735e-01 | 0.022 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 9.511735e-01 | 0.022 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 9.511735e-01 | 0.022 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 9.511735e-01 | 0.022 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 9.511735e-01 | 0.022 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 9.511735e-01 | 0.022 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 9.520038e-01 | 0.021 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 9.520038e-01 | 0.021 | 0 | 0 |
| Glycine degradation | R-HSA-6783984 | 9.520038e-01 | 0.021 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 9.520038e-01 | 0.021 | 0 | 0 |
| Scavenging by Class B Receptors | R-HSA-3000471 | 9.520038e-01 | 0.021 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 9.520038e-01 | 0.021 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) | R-HSA-400511 | 9.520038e-01 | 0.021 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 9.524454e-01 | 0.021 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.558699e-01 | 0.020 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 9.563537e-01 | 0.019 | 0 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 9.566951e-01 | 0.019 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 9.567777e-01 | 0.019 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 9.572531e-01 | 0.019 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 9.584697e-01 | 0.018 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 9.584697e-01 | 0.018 | 0 | 0 |
| Biosynthesis of aspirin-triggered D-series resolvins | R-HSA-9020265 | 9.584697e-01 | 0.018 | 0 | 0 |
| Catecholamine biosynthesis | R-HSA-209905 | 9.584697e-01 | 0.018 | 0 | 0 |
| Sulfide oxidation to sulfate | R-HSA-1614517 | 9.584697e-01 | 0.018 | 0 | 0 |
| GDP-fucose biosynthesis | R-HSA-6787639 | 9.584697e-01 | 0.018 | 0 | 0 |
| Choline catabolism | R-HSA-6798163 | 9.584697e-01 | 0.018 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 9.607500e-01 | 0.017 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.609610e-01 | 0.017 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 9.616021e-01 | 0.017 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 9.616021e-01 | 0.017 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 9.616021e-01 | 0.017 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 9.616155e-01 | 0.017 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.629949e-01 | 0.016 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 9.640650e-01 | 0.016 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 9.640650e-01 | 0.016 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 9.640650e-01 | 0.016 | 0 | 0 |
| Biosynthesis of Lipoxins (LX) | R-HSA-2142700 | 9.640650e-01 | 0.016 | 0 | 0 |
| Cytosolic iron-sulfur cluster assembly | R-HSA-2564830 | 9.640650e-01 | 0.016 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 9.640650e-01 | 0.016 | 0 | 0 |
| Nucleotide-like (purinergic) receptors | R-HSA-418038 | 9.640650e-01 | 0.016 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 9.640650e-01 | 0.016 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 9.643280e-01 | 0.016 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 9.655324e-01 | 0.015 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 9.659965e-01 | 0.015 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 9.659965e-01 | 0.015 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.659965e-01 | 0.015 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.671676e-01 | 0.014 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.671907e-01 | 0.014 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 9.689066e-01 | 0.014 | 0 | 0 |
| Pyrimidine biosynthesis | R-HSA-500753 | 9.689066e-01 | 0.014 | 0 | 0 |
| mRNA decay by 3' to 5' exoribonuclease | R-HSA-429958 | 9.689066e-01 | 0.014 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 9.689066e-01 | 0.014 | 0 | 0 |
| Synthesis of 5-eicosatetraenoic acids | R-HSA-2142688 | 9.689066e-01 | 0.014 | 0 | 0 |
| Strand-asynchronous mitochondrial DNA replication | R-HSA-9913635 | 9.689066e-01 | 0.014 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 9.690809e-01 | 0.014 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.690809e-01 | 0.014 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 9.698942e-01 | 0.013 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 9.698942e-01 | 0.013 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 9.722377e-01 | 0.012 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 9.730924e-01 | 0.012 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 9.730962e-01 | 0.012 | 0 | 0 |
| Keratan sulfate degradation | R-HSA-2022857 | 9.730962e-01 | 0.012 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 9.730962e-01 | 0.012 | 0 | 0 |
| Pregnenolone biosynthesis | R-HSA-196108 | 9.730962e-01 | 0.012 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 9.730962e-01 | 0.012 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 9.736498e-01 | 0.012 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 9.758156e-01 | 0.011 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.760074e-01 | 0.011 | 0 | 0 |
| Defective B3GALTL causes PpS | R-HSA-5083635 | 9.764371e-01 | 0.010 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 9.767215e-01 | 0.010 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 9.767215e-01 | 0.010 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 9.767215e-01 | 0.010 | 0 | 0 |
| Biosynthesis of E-series 18(S)-resolvins | R-HSA-9018896 | 9.767215e-01 | 0.010 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 9.767215e-01 | 0.010 | 0 | 0 |
| Phenylalanine metabolism | R-HSA-8964208 | 9.767215e-01 | 0.010 | 0 | 0 |
| Synthesis, secretion, and deacylation of Ghrelin | R-HSA-422085 | 9.767215e-01 | 0.010 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 9.767215e-01 | 0.010 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 9.777649e-01 | 0.010 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 9.777649e-01 | 0.010 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 9.779745e-01 | 0.010 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.785496e-01 | 0.009 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 9.791410e-01 | 0.009 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 9.791696e-01 | 0.009 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.791696e-01 | 0.009 | 0 | 0 |
| Glutamate and glutamine metabolism | R-HSA-8964539 | 9.791696e-01 | 0.009 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 9.791696e-01 | 0.009 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 9.791696e-01 | 0.009 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 9.791922e-01 | 0.009 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.793947e-01 | 0.009 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 9.798137e-01 | 0.009 | 0 | 0 |
| Eicosanoids | R-HSA-211979 | 9.798584e-01 | 0.009 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 9.798584e-01 | 0.009 | 0 | 0 |
| Miscellaneous substrates | R-HSA-211958 | 9.798584e-01 | 0.009 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 9.798584e-01 | 0.009 | 0 | 0 |
| Serine metabolism | R-HSA-977347 | 9.798584e-01 | 0.009 | 0 | 0 |
| Glutathione synthesis and recycling | R-HSA-174403 | 9.798584e-01 | 0.009 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 9.798584e-01 | 0.009 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.801026e-01 | 0.009 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.801026e-01 | 0.009 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 9.802412e-01 | 0.009 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 9.802412e-01 | 0.009 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 9.802412e-01 | 0.009 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 9.815937e-01 | 0.008 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 9.815937e-01 | 0.008 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.815937e-01 | 0.008 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 9.822046e-01 | 0.008 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 9.825728e-01 | 0.008 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 9.825728e-01 | 0.008 | 0 | 0 |
| Biosynthesis of D-series resolvins | R-HSA-9018676 | 9.825728e-01 | 0.008 | 0 | 0 |
| WNT ligand biogenesis and trafficking | R-HSA-3238698 | 9.825728e-01 | 0.008 | 0 | 0 |
| Fructose metabolism | R-HSA-5652084 | 9.825728e-01 | 0.008 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 9.829917e-01 | 0.007 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.831894e-01 | 0.007 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 9.837429e-01 | 0.007 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 9.840932e-01 | 0.007 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.841009e-01 | 0.007 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.846719e-01 | 0.007 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 9.849215e-01 | 0.007 | 0 | 0 |
| Fatty acids | R-HSA-211935 | 9.849215e-01 | 0.007 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 9.849215e-01 | 0.007 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 9.849215e-01 | 0.007 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 9.849215e-01 | 0.007 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 9.849215e-01 | 0.007 | 0 | 0 |
| Biosynthesis of maresins | R-HSA-9018682 | 9.849215e-01 | 0.007 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 9.849215e-01 | 0.007 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 9.857889e-01 | 0.006 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 9.869538e-01 | 0.006 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 9.869538e-01 | 0.006 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.873103e-01 | 0.006 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 9.873113e-01 | 0.006 | 0 | 0 |
| O-glycosylation of TSR domain-containing proteins | R-HSA-5173214 | 9.873339e-01 | 0.006 | 0 | 0 |
| Beta-oxidation of very long chain fatty acids | R-HSA-390247 | 9.873339e-01 | 0.006 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.873339e-01 | 0.006 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.875859e-01 | 0.005 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.883911e-01 | 0.005 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.883911e-01 | 0.005 | 0 | 0 |
| Alpha-oxidation of phytanate | R-HSA-389599 | 9.887123e-01 | 0.005 | 0 | 0 |
| Defects in cobalamin (B12) metabolism | R-HSA-3296469 | 9.887123e-01 | 0.005 | 0 | 0 |
| Beta-oxidation of pristanoyl-CoA | R-HSA-389887 | 9.887123e-01 | 0.005 | 0 | 0 |
| Biosynthesis of electrophilic ω-3 PUFA oxo-derivatives | R-HSA-9027604 | 9.887123e-01 | 0.005 | 0 | 0 |
| Fertilization | R-HSA-1187000 | 9.887123e-01 | 0.005 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 9.887123e-01 | 0.005 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 9.888266e-01 | 0.005 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 9.889584e-01 | 0.005 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 9.895573e-01 | 0.005 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 9.897082e-01 | 0.004 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 9.898441e-01 | 0.004 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 9.901472e-01 | 0.004 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 9.901472e-01 | 0.004 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 9.902338e-01 | 0.004 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 9.902338e-01 | 0.004 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 9.902338e-01 | 0.004 | 0 | 0 |
| Abacavir ADME | R-HSA-2161522 | 9.902338e-01 | 0.004 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 9.902338e-01 | 0.004 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 9.906111e-01 | 0.004 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 9.909914e-01 | 0.004 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.911612e-01 | 0.004 | 0 | 0 |
| Maturation of TCA enzymes and regulation of TCA cycle | R-HSA-9854311 | 9.913149e-01 | 0.004 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 9.915504e-01 | 0.004 | 0 | 0 |
| Cobalamin (Cbl) metabolism | R-HSA-9759218 | 9.915504e-01 | 0.004 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 9.915504e-01 | 0.004 | 0 | 0 |
| Biosynthesis of DPAn-3 SPMs | R-HSA-9025094 | 9.915504e-01 | 0.004 | 0 | 0 |
| Synthesis of PE | R-HSA-1483213 | 9.915504e-01 | 0.004 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 9.919711e-01 | 0.004 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 9.923469e-01 | 0.003 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.926441e-01 | 0.003 | 0 | 0 |
| Prednisone ADME | R-HSA-9757110 | 9.926895e-01 | 0.003 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 9.926895e-01 | 0.003 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.928474e-01 | 0.003 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 9.932586e-01 | 0.003 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 9.932586e-01 | 0.003 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 9.936308e-01 | 0.003 | 0 | 0 |
| Thyroxine biosynthesis | R-HSA-209968 | 9.936751e-01 | 0.003 | 0 | 0 |
| Activation of Matrix Metalloproteinases | R-HSA-1592389 | 9.936751e-01 | 0.003 | 0 | 0 |
| Biosynthesis of EPA-derived SPMs | R-HSA-9018679 | 9.936751e-01 | 0.003 | 0 | 0 |
| Regulation of pyruvate dehydrogenase (PDH) complex | R-HSA-204174 | 9.936751e-01 | 0.003 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.938942e-01 | 0.003 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.940636e-01 | 0.003 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.944625e-01 | 0.002 | 0 | 0 |
| Mucopolysaccharidoses | R-HSA-2206281 | 9.945279e-01 | 0.002 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.950895e-01 | 0.002 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.952029e-01 | 0.002 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 9.952657e-01 | 0.002 | 0 | 0 |
| Biosynthesis of DPA-derived SPMs | R-HSA-9018683 | 9.952657e-01 | 0.002 | 0 | 0 |
| Aspartate and asparagine metabolism | R-HSA-8963693 | 9.952657e-01 | 0.002 | 0 | 0 |
| Synthesis of glycosylphosphatidylinositol (GPI) | R-HSA-162710 | 9.952657e-01 | 0.002 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.953095e-01 | 0.002 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.953890e-01 | 0.002 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.954010e-01 | 0.002 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 9.959041e-01 | 0.002 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 9.959539e-01 | 0.002 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 9.959539e-01 | 0.002 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 9.959539e-01 | 0.002 | 0 | 0 |
| Degradation of cysteine and homocysteine | R-HSA-1614558 | 9.959539e-01 | 0.002 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.960676e-01 | 0.002 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.961863e-01 | 0.002 | 0 | 0 |
| Recycling of bile acids and salts | R-HSA-159418 | 9.964564e-01 | 0.002 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.964696e-01 | 0.002 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.967057e-01 | 0.001 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.972035e-01 | 0.001 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.972035e-01 | 0.001 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 9.972495e-01 | 0.001 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 9.973478e-01 | 0.001 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 9.973478e-01 | 0.001 | 0 | 0 |
| RA biosynthesis pathway | R-HSA-5365859 | 9.973478e-01 | 0.001 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 9.973478e-01 | 0.001 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.974709e-01 | 0.001 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.975219e-01 | 0.001 | 0 | 0 |
| Glyoxylate metabolism and glycine degradation | R-HSA-389661 | 9.975828e-01 | 0.001 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 9.977055e-01 | 0.001 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 9.977055e-01 | 0.001 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 9.977055e-01 | 0.001 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.977055e-01 | 0.001 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 9.977055e-01 | 0.001 | 0 | 0 |
| Metabolism of ingested SeMet, Sec, MeSec into H2Se | R-HSA-2408508 | 9.977055e-01 | 0.001 | 0 | 0 |
| Synthesis of bile acids and bile salts via 24-hydroxycholesterol | R-HSA-193775 | 9.977055e-01 | 0.001 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.977387e-01 | 0.001 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.978416e-01 | 0.001 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.979042e-01 | 0.001 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 9.980150e-01 | 0.001 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.981346e-01 | 0.001 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 9.982827e-01 | 0.001 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 9.982827e-01 | 0.001 | 0 | 0 |
| Phenylalanine and tyrosine metabolism | R-HSA-8963691 | 9.982827e-01 | 0.001 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 9.982827e-01 | 0.001 | 0 | 0 |
| Lysine catabolism | R-HSA-71064 | 9.982827e-01 | 0.001 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 9.982827e-01 | 0.001 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 9.983736e-01 | 0.001 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.983873e-01 | 0.001 | 0 | 0 |
| alpha-linolenic acid (ALA) metabolism | R-HSA-2046106 | 9.985144e-01 | 0.001 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 9.985144e-01 | 0.001 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.986378e-01 | 0.001 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 9.987148e-01 | 0.001 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.987148e-01 | 0.001 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 9.987640e-01 | 0.001 | 0 | 0 |
| rRNA processing in the mitochondrion | R-HSA-8868766 | 9.988882e-01 | 0.000 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 9.988882e-01 | 0.000 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.988922e-01 | 0.000 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 9.990280e-01 | 0.000 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 9.990382e-01 | 0.000 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.991618e-01 | 0.000 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.991618e-01 | 0.000 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.991680e-01 | 0.000 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.992098e-01 | 0.000 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 9.992233e-01 | 0.000 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.992581e-01 | 0.000 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 9.992802e-01 | 0.000 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.993443e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.993550e-01 | 0.000 | 0 | 0 |
| Defensins | R-HSA-1461973 | 9.993774e-01 | 0.000 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.994194e-01 | 0.000 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 9.994614e-01 | 0.000 | 0 | 0 |
| Methylation | R-HSA-156581 | 9.994614e-01 | 0.000 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.994865e-01 | 0.000 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 9.995970e-01 | 0.000 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 9.996514e-01 | 0.000 | 0 | 0 |
| alpha-linolenic (omega3) and linoleic (omega6) acid metabolism | R-HSA-2046104 | 9.996514e-01 | 0.000 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.996514e-01 | 0.000 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 9.996867e-01 | 0.000 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.997161e-01 | 0.000 | 0 | 0 |
| Keratan sulfate/keratin metabolism | R-HSA-1638074 | 9.997391e-01 | 0.000 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.997391e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.997394e-01 | 0.000 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.997465e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 9.997724e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.997724e-01 | 0.000 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.997724e-01 | 0.000 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 9.997744e-01 | 0.000 | 0 | 0 |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | R-HSA-2162123 | 9.997744e-01 | 0.000 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.997949e-01 | 0.000 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.998386e-01 | 0.000 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.998473e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid catabolism | R-HSA-9840310 | 9.998473e-01 | 0.000 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.998664e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.998757e-01 | 0.000 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.998831e-01 | 0.000 | 0 | 0 |
| Sulfur amino acid metabolism | R-HSA-1614635 | 9.998846e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.998918e-01 | 0.000 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.998977e-01 | 0.000 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.998983e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.999021e-01 | 0.000 | 0 | 0 |
| Digestion | R-HSA-8935690 | 9.999055e-01 | 0.000 | 0 | 0 |
| Translation | R-HSA-72766 | 9.999057e-01 | 0.000 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.999057e-01 | 0.000 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.999057e-01 | 0.000 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.999117e-01 | 0.000 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.999183e-01 | 0.000 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.999316e-01 | 0.000 | 0 | 0 |
| Sialic acid metabolism | R-HSA-4085001 | 9.999389e-01 | 0.000 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.999389e-01 | 0.000 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 9.999471e-01 | 0.000 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.999471e-01 | 0.000 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 9.999543e-01 | 0.000 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 9.999543e-01 | 0.000 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.999577e-01 | 0.000 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.999651e-01 | 0.000 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.999658e-01 | 0.000 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 9.999658e-01 | 0.000 | 0 | 0 |
| Digestion and absorption | R-HSA-8963743 | 9.999658e-01 | 0.000 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.999704e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid biosynthesis | R-HSA-9840309 | 9.999704e-01 | 0.000 | 0 | 0 |
| Xenobiotics | R-HSA-211981 | 9.999704e-01 | 0.000 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.999716e-01 | 0.000 | 0 | 0 |
| Latent infection - Other responses of Mtb to phagocytosis | R-HSA-1222499 | 9.999744e-01 | 0.000 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.999748e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.999748e-01 | 0.000 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.999767e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.999798e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.999805e-01 | 0.000 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.999821e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.999862e-01 | 0.000 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 9.999865e-01 | 0.000 | 0 | 0 |
| Class C/3 (Metabotropic glutamate/pheromone receptors) | R-HSA-420499 | 9.999882e-01 | 0.000 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.999893e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.999897e-01 | 0.000 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.999910e-01 | 0.000 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.999920e-01 | 0.000 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 9.999921e-01 | 0.000 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.999954e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.999959e-01 | 0.000 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.999961e-01 | 0.000 | 0 | 0 |
| Biosynthesis of DHA-derived SPMs | R-HSA-9018677 | 9.999975e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999983e-01 | 0.000 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.999989e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.999994e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid metabolism | R-HSA-1660662 | 9.999995e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.999995e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999996e-01 | 0.000 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.999997e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999997e-01 | 0.000 | 0 | 0 |
| Mitochondrial Fatty Acid Beta-Oxidation | R-HSA-77289 | 9.999998e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.999998e-01 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.999999e-01 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.999999e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 1.000000e+00 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 1.000000e+00 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 1.000000e+00 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 1.000000e+00 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 1.000000e+00 | 0.000 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 1.000000e+00 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 1.000000e+00 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of specialized proresolving mediators (SPMs) | R-HSA-9018678 | 1.000000e+00 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 1.000000e+00 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 1.000000e+00 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 1.000000e+00 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Expression and translocation of olfactory receptors | R-HSA-9752946 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | -0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Cell Cycle Checkpoints | R-HSA-69620 | 1.110223e-16 | 15.955 | 0 | 0 |
| M Phase | R-HSA-68886 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 1.110223e-16 | 15.955 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 7.540635e-13 | 12.123 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 1.257883e-12 | 11.900 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 1.421419e-12 | 11.847 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 3.438583e-12 | 11.464 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 4.278911e-12 | 11.369 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 4.137468e-12 | 11.383 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 3.807399e-12 | 11.419 | 1 | 0 |
| Axon guidance | R-HSA-422475 | 6.228573e-12 | 11.206 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 8.101964e-12 | 11.091 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 7.987500e-12 | 11.098 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 1.238143e-11 | 10.907 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 1.365064e-11 | 10.865 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 1.598011e-11 | 10.796 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 4.838485e-11 | 10.315 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 5.389300e-11 | 10.268 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 5.016421e-11 | 10.300 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 5.364142e-11 | 10.270 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 4.646328e-11 | 10.333 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 5.702394e-11 | 10.244 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 1.110528e-10 | 9.954 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 1.165088e-10 | 9.934 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 1.618331e-10 | 9.791 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 1.730940e-10 | 9.762 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 2.724769e-10 | 9.565 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 2.584226e-10 | 9.588 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 2.651817e-10 | 9.576 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 3.015569e-10 | 9.521 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 2.980863e-10 | 9.526 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 3.150671e-10 | 9.502 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 3.631068e-10 | 9.440 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 3.922621e-10 | 9.406 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 5.696436e-10 | 9.244 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 5.696436e-10 | 9.244 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 7.721337e-10 | 9.112 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 7.566677e-10 | 9.121 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 7.566677e-10 | 9.121 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 8.173686e-10 | 9.088 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 8.972832e-10 | 9.047 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 1.393027e-09 | 8.856 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 1.498907e-09 | 8.824 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 1.692100e-09 | 8.772 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 1.769514e-09 | 8.752 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 1.954214e-09 | 8.709 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 2.067193e-09 | 8.685 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 2.260624e-09 | 8.646 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 2.377947e-09 | 8.624 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 2.379933e-09 | 8.623 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 2.697367e-09 | 8.569 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 3.216129e-09 | 8.493 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 3.578058e-09 | 8.446 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 3.849350e-09 | 8.415 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 3.758715e-09 | 8.425 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 3.985193e-09 | 8.400 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 4.420057e-09 | 8.355 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 4.460332e-09 | 8.351 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 6.265982e-09 | 8.203 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 7.299189e-09 | 8.137 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 8.113160e-09 | 8.091 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 1.183593e-08 | 7.927 | 1 | 1 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 1.385951e-08 | 7.858 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 1.453924e-08 | 7.837 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 1.565761e-08 | 7.805 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 1.811104e-08 | 7.742 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 1.811104e-08 | 7.742 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 1.897593e-08 | 7.722 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 1.908817e-08 | 7.719 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 2.144739e-08 | 7.669 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 2.298280e-08 | 7.639 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 2.528214e-08 | 7.597 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 2.610316e-08 | 7.583 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 3.569152e-08 | 7.447 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 3.494076e-08 | 7.457 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 3.773940e-08 | 7.423 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 4.069292e-08 | 7.390 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 5.587638e-08 | 7.253 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 5.680078e-08 | 7.246 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 6.695089e-08 | 7.174 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 6.784189e-08 | 7.169 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 6.733319e-08 | 7.172 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 6.691811e-08 | 7.174 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 7.031367e-08 | 7.153 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 8.507082e-08 | 7.070 | 0 | 0 |
| Depurination | R-HSA-73927 | 9.882168e-08 | 7.005 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 1.082936e-07 | 6.965 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 1.082936e-07 | 6.965 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 1.080273e-07 | 6.966 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 1.080273e-07 | 6.966 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 1.121474e-07 | 6.950 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 1.502685e-07 | 6.823 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 1.585651e-07 | 6.800 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 1.718166e-07 | 6.765 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 1.830068e-07 | 6.738 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 1.862864e-07 | 6.730 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 2.125785e-07 | 6.672 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 2.144316e-07 | 6.669 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 2.798242e-07 | 6.553 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 2.958047e-07 | 6.529 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 2.969093e-07 | 6.527 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 3.092828e-07 | 6.510 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 3.319249e-07 | 6.479 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 3.335090e-07 | 6.477 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 3.463502e-07 | 6.460 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 3.824416e-07 | 6.417 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 3.824416e-07 | 6.417 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 3.859071e-07 | 6.414 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 4.666215e-07 | 6.331 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 4.976430e-07 | 6.303 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 4.976430e-07 | 6.303 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 6.484635e-07 | 6.188 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 8.403542e-07 | 6.076 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 9.096947e-07 | 6.041 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 1.018399e-06 | 5.992 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 1.355646e-06 | 5.868 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 1.475010e-06 | 5.831 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 1.488409e-06 | 5.827 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 1.517427e-06 | 5.819 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 1.607448e-06 | 5.794 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 1.740756e-06 | 5.759 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 2.010483e-06 | 5.697 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 2.006325e-06 | 5.698 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 2.085911e-06 | 5.681 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 2.820850e-06 | 5.550 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 2.820850e-06 | 5.550 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 2.847794e-06 | 5.545 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 3.454785e-06 | 5.462 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 3.523809e-06 | 5.453 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 4.354705e-06 | 5.361 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 4.477342e-06 | 5.349 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 4.922186e-06 | 5.308 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 4.922186e-06 | 5.308 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 4.933461e-06 | 5.307 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 5.173598e-06 | 5.286 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 5.239114e-06 | 5.281 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 6.264953e-06 | 5.203 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 6.436233e-06 | 5.191 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 6.544861e-06 | 5.184 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 6.572935e-06 | 5.182 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 6.969733e-06 | 5.157 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 7.222516e-06 | 5.141 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 8.434056e-06 | 5.074 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 8.434056e-06 | 5.074 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 9.477726e-06 | 5.023 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 9.985093e-06 | 5.001 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 1.060111e-05 | 4.975 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 1.070830e-05 | 4.970 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 1.237757e-05 | 4.907 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 1.308504e-05 | 4.883 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 1.330361e-05 | 4.876 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 1.413112e-05 | 4.850 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 1.495264e-05 | 4.825 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 1.495264e-05 | 4.825 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 1.529833e-05 | 4.815 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 1.757538e-05 | 4.755 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 2.232096e-05 | 4.651 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 2.248974e-05 | 4.648 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 2.383191e-05 | 4.623 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 2.484326e-05 | 4.605 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 2.546141e-05 | 4.594 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 2.571596e-05 | 4.590 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 2.859877e-05 | 4.544 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 2.859877e-05 | 4.544 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 3.062562e-05 | 4.514 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 3.195934e-05 | 4.495 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 3.455731e-05 | 4.461 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 3.338993e-05 | 4.476 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 3.569327e-05 | 4.447 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 3.434450e-05 | 4.464 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 3.920977e-05 | 4.407 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 4.396563e-05 | 4.357 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 4.401506e-05 | 4.356 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 4.505124e-05 | 4.346 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 4.594661e-05 | 4.338 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 5.305535e-05 | 4.275 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 6.143022e-05 | 4.212 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 6.600556e-05 | 4.180 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 6.631368e-05 | 4.178 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 6.708418e-05 | 4.173 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 7.167962e-05 | 4.145 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 8.363828e-05 | 4.078 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 9.580181e-05 | 4.019 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 9.605323e-05 | 4.017 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 9.863757e-05 | 4.006 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 1.184230e-04 | 3.927 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 1.205760e-04 | 3.919 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 1.507293e-04 | 3.822 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 1.507293e-04 | 3.822 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 1.586623e-04 | 3.800 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 1.608956e-04 | 3.793 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 1.732876e-04 | 3.761 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 1.871896e-04 | 3.728 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 1.882256e-04 | 3.725 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 1.940680e-04 | 3.712 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 2.259208e-04 | 3.646 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 2.310116e-04 | 3.636 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 2.325670e-04 | 3.633 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 2.350737e-04 | 3.629 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 2.350737e-04 | 3.629 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 2.350737e-04 | 3.629 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 2.350737e-04 | 3.629 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 2.414101e-04 | 3.617 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 2.479960e-04 | 3.606 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 2.591385e-04 | 3.586 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 2.636312e-04 | 3.579 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 2.720767e-04 | 3.565 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 3.147862e-04 | 3.502 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 3.514116e-04 | 3.454 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 3.517589e-04 | 3.454 | 0 | 0 |
| Kinesins | R-HSA-983189 | 3.138662e-04 | 3.503 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 3.114303e-04 | 3.507 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 3.615734e-04 | 3.442 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 3.767790e-04 | 3.424 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 3.896314e-04 | 3.409 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 3.947107e-04 | 3.404 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 4.089623e-04 | 3.388 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 4.216386e-04 | 3.375 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 4.216386e-04 | 3.375 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 4.483221e-04 | 3.348 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 4.483221e-04 | 3.348 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 4.483221e-04 | 3.348 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 4.920438e-04 | 3.308 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 4.978160e-04 | 3.303 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 4.978160e-04 | 3.303 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 5.000805e-04 | 3.301 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 5.000805e-04 | 3.301 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 5.000805e-04 | 3.301 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 5.057077e-04 | 3.296 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 5.064988e-04 | 3.295 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 5.064988e-04 | 3.295 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 5.064988e-04 | 3.295 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 5.064988e-04 | 3.295 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 5.083572e-04 | 3.294 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 5.710568e-04 | 3.243 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 5.721565e-04 | 3.242 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 7.166507e-04 | 3.145 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 7.480287e-04 | 3.126 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 6.936621e-04 | 3.159 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 7.151559e-04 | 3.146 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 6.714292e-04 | 3.173 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 7.931883e-04 | 3.101 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 8.185338e-04 | 3.087 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 8.617135e-04 | 3.065 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 8.918245e-04 | 3.050 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 8.918245e-04 | 3.050 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 8.990934e-04 | 3.046 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 9.489156e-04 | 3.023 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 9.555023e-04 | 3.020 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 1.071752e-03 | 2.970 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 1.106915e-03 | 2.956 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 1.106915e-03 | 2.956 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 1.171340e-03 | 2.931 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 1.178444e-03 | 2.929 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 1.201170e-03 | 2.920 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 1.203269e-03 | 2.920 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 1.224390e-03 | 2.912 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 1.269135e-03 | 2.896 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 1.269135e-03 | 2.896 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 1.291706e-03 | 2.889 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 1.313816e-03 | 2.881 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 1.349048e-03 | 2.870 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 1.349048e-03 | 2.870 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 1.350628e-03 | 2.869 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 1.362405e-03 | 2.866 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 1.441892e-03 | 2.841 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 1.480001e-03 | 2.830 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 1.495143e-03 | 2.825 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 1.498297e-03 | 2.824 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 1.505513e-03 | 2.822 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 1.538680e-03 | 2.813 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 1.565167e-03 | 2.805 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 1.725797e-03 | 2.763 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 1.641169e-03 | 2.785 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 1.910617e-03 | 2.719 | 0 | 0 |
| Protein folding | R-HSA-391251 | 1.910617e-03 | 2.719 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 1.671405e-03 | 2.777 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 1.904172e-03 | 2.720 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 1.641169e-03 | 2.785 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 1.969869e-03 | 2.706 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 1.983012e-03 | 2.703 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 1.995544e-03 | 2.700 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 2.172175e-03 | 2.663 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 2.207415e-03 | 2.656 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 2.332651e-03 | 2.632 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 2.332651e-03 | 2.632 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 2.437340e-03 | 2.613 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 2.502872e-03 | 2.602 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 2.660319e-03 | 2.575 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 2.709565e-03 | 2.567 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 2.774538e-03 | 2.557 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 2.845365e-03 | 2.546 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 2.954312e-03 | 2.530 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 2.991411e-03 | 2.524 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 3.064436e-03 | 2.514 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 3.069222e-03 | 2.513 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 3.162721e-03 | 2.500 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 3.288774e-03 | 2.483 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 3.505399e-03 | 2.455 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 3.694844e-03 | 2.432 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 3.994339e-03 | 2.399 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 4.028339e-03 | 2.395 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 4.046415e-03 | 2.393 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 4.046415e-03 | 2.393 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 4.046415e-03 | 2.393 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 4.046415e-03 | 2.393 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 4.235700e-03 | 2.373 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 4.249101e-03 | 2.372 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 4.269522e-03 | 2.370 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 4.311652e-03 | 2.365 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 4.311652e-03 | 2.365 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 4.495226e-03 | 2.347 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 4.662252e-03 | 2.331 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 4.816820e-03 | 2.317 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 4.839917e-03 | 2.315 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 4.901851e-03 | 2.310 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 5.003109e-03 | 2.301 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 5.003109e-03 | 2.301 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 5.045635e-03 | 2.297 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 5.290465e-03 | 2.277 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 5.420405e-03 | 2.266 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 5.649000e-03 | 2.248 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 6.485321e-03 | 2.188 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 6.485321e-03 | 2.188 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 7.131899e-03 | 2.147 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 5.798385e-03 | 2.237 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 6.986491e-03 | 2.156 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 5.808792e-03 | 2.236 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 6.661267e-03 | 2.176 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 6.494332e-03 | 2.187 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 6.320940e-03 | 2.199 | 0 | 0 |
| Maturation of protein E | R-HSA-9683683 | 7.131899e-03 | 2.147 | 0 | 0 |
| Maturation of protein E | R-HSA-9694493 | 7.131899e-03 | 2.147 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 7.307582e-03 | 2.136 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 8.026000e-03 | 2.096 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 8.026000e-03 | 2.096 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 8.077580e-03 | 2.093 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 8.077580e-03 | 2.093 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 8.208783e-03 | 2.086 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 8.946723e-03 | 2.048 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 8.956762e-03 | 2.048 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 9.596353e-03 | 2.018 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 9.596353e-03 | 2.018 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 9.596353e-03 | 2.018 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 9.596353e-03 | 2.018 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 9.940553e-03 | 2.003 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 1.064948e-02 | 1.973 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 1.078681e-02 | 1.967 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 1.083810e-02 | 1.965 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 1.099875e-02 | 1.959 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 1.145292e-02 | 1.941 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 1.158011e-02 | 1.936 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 1.177909e-02 | 1.929 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 1.209107e-02 | 1.918 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 1.209107e-02 | 1.918 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 1.221639e-02 | 1.913 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 1.255285e-02 | 1.901 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 1.280315e-02 | 1.893 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 1.353557e-02 | 1.869 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 1.372525e-02 | 1.862 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 1.383668e-02 | 1.859 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 1.383668e-02 | 1.859 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 1.413418e-02 | 1.850 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 1.413418e-02 | 1.850 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 1.457545e-02 | 1.836 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 1.457545e-02 | 1.836 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 1.500984e-02 | 1.824 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 1.500984e-02 | 1.824 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 1.500984e-02 | 1.824 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 1.507143e-02 | 1.822 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 1.520072e-02 | 1.818 | 0 | 0 |
| S Phase | R-HSA-69242 | 1.521107e-02 | 1.818 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 1.535338e-02 | 1.814 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 1.535338e-02 | 1.814 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 1.535338e-02 | 1.814 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 1.535338e-02 | 1.814 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 1.535338e-02 | 1.814 | 0 | 0 |
| Loss of MECP2 binding ability to 5hmC-DNA | R-HSA-9022534 | 1.535338e-02 | 1.814 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 1.544405e-02 | 1.811 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 1.588184e-02 | 1.799 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 1.635056e-02 | 1.786 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 1.638318e-02 | 1.786 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 1.638318e-02 | 1.786 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 1.687193e-02 | 1.773 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 1.739406e-02 | 1.760 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 1.739406e-02 | 1.760 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 1.800882e-02 | 1.745 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 1.811620e-02 | 1.742 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 1.838435e-02 | 1.736 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 1.838435e-02 | 1.736 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 1.850865e-02 | 1.733 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 1.910912e-02 | 1.719 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 2.053770e-02 | 1.687 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 2.277498e-02 | 1.643 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 2.224377e-02 | 1.653 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 2.057622e-02 | 1.687 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 2.414236e-02 | 1.617 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 2.143228e-02 | 1.669 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 2.414236e-02 | 1.617 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 2.144668e-02 | 1.669 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 2.466825e-02 | 1.608 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 2.436098e-02 | 1.613 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 2.432979e-02 | 1.614 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 2.640003e-02 | 1.578 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 2.093893e-02 | 1.679 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 2.144668e-02 | 1.669 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 2.144668e-02 | 1.669 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 2.690428e-02 | 1.570 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 2.216658e-02 | 1.654 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 2.234394e-02 | 1.651 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 2.053770e-02 | 1.687 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 2.053770e-02 | 1.687 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 2.093893e-02 | 1.679 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 2.661440e-02 | 1.575 | 0 | 0 |
| Modulation by Mtb of host immune system | R-HSA-9637628 | 2.053770e-02 | 1.687 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 2.708007e-02 | 1.567 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 2.708007e-02 | 1.567 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 2.708007e-02 | 1.567 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 2.811134e-02 | 1.551 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 2.814601e-02 | 1.551 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 2.814601e-02 | 1.551 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 2.814601e-02 | 1.551 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 2.855311e-02 | 1.544 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 2.855836e-02 | 1.544 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 2.855836e-02 | 1.544 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 2.855836e-02 | 1.544 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 2.855836e-02 | 1.544 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 2.855836e-02 | 1.544 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 2.855836e-02 | 1.544 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 2.948207e-02 | 1.530 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 2.948207e-02 | 1.530 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 2.961867e-02 | 1.528 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 3.086425e-02 | 1.511 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 3.137241e-02 | 1.503 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 3.213446e-02 | 1.493 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 3.213446e-02 | 1.493 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 3.213446e-02 | 1.493 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 3.213446e-02 | 1.493 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 3.250591e-02 | 1.488 | 0 | 0 |
| Transport of glycerol from adipocytes to the liver by Aquaporins | R-HSA-432030 | 3.250591e-02 | 1.488 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 3.250591e-02 | 1.488 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 3.425778e-02 | 1.465 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 3.425778e-02 | 1.465 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 3.425778e-02 | 1.465 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 3.473449e-02 | 1.459 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 3.473449e-02 | 1.459 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 3.639060e-02 | 1.439 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 3.697815e-02 | 1.432 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 3.697815e-02 | 1.432 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 3.697815e-02 | 1.432 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 3.726598e-02 | 1.429 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 3.750217e-02 | 1.426 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 3.819205e-02 | 1.418 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 3.883513e-02 | 1.411 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 3.883513e-02 | 1.411 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 3.989505e-02 | 1.399 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 3.989505e-02 | 1.399 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 3.989505e-02 | 1.399 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 4.101064e-02 | 1.387 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 4.101064e-02 | 1.387 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 4.113160e-02 | 1.386 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 4.137782e-02 | 1.383 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 4.259644e-02 | 1.371 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 4.300690e-02 | 1.366 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 4.300690e-02 | 1.366 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 4.300690e-02 | 1.366 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 4.300690e-02 | 1.366 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 4.300690e-02 | 1.366 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 4.351941e-02 | 1.361 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 4.435490e-02 | 1.353 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 4.435490e-02 | 1.353 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 4.435490e-02 | 1.353 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 4.567242e-02 | 1.340 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 5.440404e-02 | 1.264 | 0 | 0 |
| Regulation of TP53 Expression | R-HSA-6804754 | 5.440404e-02 | 1.264 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 5.440404e-02 | 1.264 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 5.440404e-02 | 1.264 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 5.440404e-02 | 1.264 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 5.440404e-02 | 1.264 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 5.440404e-02 | 1.264 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 5.440404e-02 | 1.264 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 5.440404e-02 | 1.264 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 5.440404e-02 | 1.264 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 5.440404e-02 | 1.264 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 5.440404e-02 | 1.264 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 6.819277e-02 | 1.166 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 5.343695e-02 | 1.272 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 6.447428e-02 | 1.191 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 4.878152e-02 | 1.312 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 4.878152e-02 | 1.312 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 6.461579e-02 | 1.190 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 6.119934e-02 | 1.213 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 5.838125e-02 | 1.234 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 6.996886e-02 | 1.155 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 6.363335e-02 | 1.196 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 6.363335e-02 | 1.196 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 4.961779e-02 | 1.304 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 5.714430e-02 | 1.243 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 5.343695e-02 | 1.272 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 5.137995e-02 | 1.289 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 4.878152e-02 | 1.312 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 6.835002e-02 | 1.165 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 5.868577e-02 | 1.231 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 6.505521e-02 | 1.187 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 4.961779e-02 | 1.304 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 4.832766e-02 | 1.316 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 6.996886e-02 | 1.155 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 4.789894e-02 | 1.320 | 0 | 0 |
| Translation | R-HSA-72766 | 7.083538e-02 | 1.150 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 7.138476e-02 | 1.146 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 6.119934e-02 | 1.213 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 6.394632e-02 | 1.194 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 5.782277e-02 | 1.238 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 5.555462e-02 | 1.255 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 5.440404e-02 | 1.264 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 5.826303e-02 | 1.235 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 6.998396e-02 | 1.155 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 6.447428e-02 | 1.191 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 7.103261e-02 | 1.149 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 5.313021e-02 | 1.275 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 6.819277e-02 | 1.166 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 6.819277e-02 | 1.166 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 5.721448e-02 | 1.242 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 4.961779e-02 | 1.304 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 6.163994e-02 | 1.210 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 7.095349e-02 | 1.149 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 5.783902e-02 | 1.238 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 6.447428e-02 | 1.191 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 6.447428e-02 | 1.191 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 5.838125e-02 | 1.234 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 4.949544e-02 | 1.305 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 6.118038e-02 | 1.213 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 6.447428e-02 | 1.191 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 6.447428e-02 | 1.191 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 6.447428e-02 | 1.191 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 5.291545e-02 | 1.276 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 6.621144e-02 | 1.179 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 7.300823e-02 | 1.137 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 7.300823e-02 | 1.137 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 7.300823e-02 | 1.137 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 7.319201e-02 | 1.136 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 7.349862e-02 | 1.134 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 7.453054e-02 | 1.128 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 7.502425e-02 | 1.125 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 7.502425e-02 | 1.125 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 7.598011e-02 | 1.119 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 7.633305e-02 | 1.117 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 7.642280e-02 | 1.117 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 7.642280e-02 | 1.117 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 7.642280e-02 | 1.117 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 7.642280e-02 | 1.117 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 7.660518e-02 | 1.116 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 7.681443e-02 | 1.115 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 7.681443e-02 | 1.115 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 7.681443e-02 | 1.115 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 7.839609e-02 | 1.106 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 8.006827e-02 | 1.097 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 8.006827e-02 | 1.097 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 8.116735e-02 | 1.091 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 8.116735e-02 | 1.091 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 8.116735e-02 | 1.091 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 8.140637e-02 | 1.089 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 8.199364e-02 | 1.086 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 8.199364e-02 | 1.086 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 8.199364e-02 | 1.086 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 8.199364e-02 | 1.086 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 8.495759e-02 | 1.071 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 8.495759e-02 | 1.071 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 8.495759e-02 | 1.071 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 8.495759e-02 | 1.071 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 8.628401e-02 | 1.064 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 8.717867e-02 | 1.060 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 8.717867e-02 | 1.060 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 8.738074e-02 | 1.059 | 0 | 0 |
| Drug resistance of KIT mutants | R-HSA-9669937 | 8.900269e-02 | 1.051 | 0 | 0 |
| KIT mutants bind TKIs | R-HSA-9669921 | 8.900269e-02 | 1.051 | 0 | 0 |
| Nilotinib-resistant KIT mutants | R-HSA-9669926 | 8.900269e-02 | 1.051 | 0 | 0 |
| Imatinib-resistant KIT mutants | R-HSA-9669917 | 8.900269e-02 | 1.051 | 0 | 0 |
| Masitinib-resistant KIT mutants | R-HSA-9669924 | 8.900269e-02 | 1.051 | 0 | 0 |
| Sorafenib-resistant KIT mutants | R-HSA-9669936 | 8.900269e-02 | 1.051 | 0 | 0 |
| Loss of function of TP53 in cancer due to loss of tetramerization ability | R-HSA-9723905 | 8.900269e-02 | 1.051 | 0 | 0 |
| Regorafenib-resistant KIT mutants | R-HSA-9669929 | 8.900269e-02 | 1.051 | 0 | 0 |
| Loss of Function of TP53 in Cancer | R-HSA-9723907 | 8.900269e-02 | 1.051 | 0 | 0 |
| Sunitinib-resistant KIT mutants | R-HSA-9669934 | 8.900269e-02 | 1.051 | 0 | 0 |
| Dasatinib-resistant KIT mutants | R-HSA-9669914 | 8.900269e-02 | 1.051 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 8.942307e-02 | 1.049 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 8.979169e-02 | 1.047 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 9.009028e-02 | 1.045 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 9.156550e-02 | 1.038 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 9.156550e-02 | 1.038 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 9.156550e-02 | 1.038 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 9.192556e-02 | 1.037 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 9.267308e-02 | 1.033 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 9.267308e-02 | 1.033 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 9.491079e-02 | 1.023 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 9.523812e-02 | 1.021 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 9.599465e-02 | 1.018 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 9.642173e-02 | 1.016 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 9.738174e-02 | 1.012 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 9.738174e-02 | 1.012 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 9.748238e-02 | 1.011 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 9.867942e-02 | 1.006 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 12 | R-HSA-392170 | 9.867942e-02 | 1.006 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 9.867942e-02 | 1.006 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 9.867942e-02 | 1.006 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 9.919943e-02 | 1.003 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 1.004040e-01 | 0.998 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 1.017139e-01 | 0.993 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 1.017139e-01 | 0.993 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 1.017139e-01 | 0.993 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 1.017275e-01 | 0.993 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 1.017275e-01 | 0.993 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 1.017275e-01 | 0.993 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 1.032803e-01 | 0.986 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 1.032803e-01 | 0.986 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 1.032803e-01 | 0.986 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 1.039857e-01 | 0.983 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 1.039857e-01 | 0.983 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 1.039857e-01 | 0.983 | 0 | 0 |
| MECP2 regulates transcription of genes involved in GABA signaling | R-HSA-9022927 | 1.086556e-01 | 0.964 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 1.086556e-01 | 0.964 | 0 | 0 |
| HCN channels | R-HSA-1296061 | 1.086556e-01 | 0.964 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 1.086556e-01 | 0.964 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 1.086556e-01 | 0.964 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 1.112446e-01 | 0.954 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 1.122402e-01 | 0.950 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 1.124256e-01 | 0.949 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 1.155490e-01 | 0.937 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 1.163680e-01 | 0.934 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 1.174139e-01 | 0.930 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 1.183089e-01 | 0.927 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 1.191307e-01 | 0.924 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 1.191307e-01 | 0.924 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 1.191307e-01 | 0.924 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 1.191307e-01 | 0.924 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 1.212148e-01 | 0.916 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 1.212148e-01 | 0.916 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 1.220050e-01 | 0.914 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 1.230039e-01 | 0.910 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 1.230039e-01 | 0.910 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 1.230039e-01 | 0.910 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 1.230039e-01 | 0.910 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 1.230039e-01 | 0.910 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 1.240621e-01 | 0.906 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 1.242930e-01 | 0.906 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 1.255457e-01 | 0.901 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 1.258071e-01 | 0.900 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 1.258071e-01 | 0.900 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 1.265138e-01 | 0.898 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 1.265138e-01 | 0.898 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 1.268608e-01 | 0.897 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 1.304100e-01 | 0.885 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 1.700887e-01 | 0.769 | 0 | 0 |
| TICAM1 deficiency - HSE | R-HSA-5602566 | 1.700887e-01 | 0.769 | 0 | 0 |
| Defective Mismatch Repair Associated With PMS2 | R-HSA-5632987 | 1.700887e-01 | 0.769 | 0 | 0 |
| Defective F8 binding to von Willebrand factor | R-HSA-9672393 | 1.700887e-01 | 0.769 | 0 | 0 |
| Defective Mismatch Repair Associated With MLH1 | R-HSA-5545483 | 1.700887e-01 | 0.769 | 0 | 0 |
| SARS-CoV-1 targets PDZ proteins in cell-cell junction | R-HSA-9692912 | 1.700887e-01 | 0.769 | 0 | 0 |
| Signaling by extracellular domain mutants of KIT | R-HSA-9680187 | 2.439618e-01 | 0.613 | 0 | 0 |
| Signaling by juxtamembrane domain KIT mutants | R-HSA-9669935 | 2.439618e-01 | 0.613 | 0 | 0 |
| Signaling by kinase domain mutants of KIT | R-HSA-9669933 | 2.439618e-01 | 0.613 | 0 | 0 |
| Defective VWF binding to collagen type I | R-HSA-9845622 | 2.439618e-01 | 0.613 | 0 | 0 |
| Loss of Function of SMAD4 in Cancer | R-HSA-3304347 | 2.439618e-01 | 0.613 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 2.439618e-01 | 0.613 | 0 | 0 |
| SMAD4 MH2 Domain Mutants in Cancer | R-HSA-3311021 | 2.439618e-01 | 0.613 | 0 | 0 |
| TRAF3 deficiency - HSE | R-HSA-5602571 | 2.439618e-01 | 0.613 | 0 | 0 |
| TWIK-releated acid-sensitive K+ channel (TASK) | R-HSA-1299316 | 2.439618e-01 | 0.613 | 0 | 0 |
| Defective POMGNT1 causes MDDGA3, MDDGB3 and MDDGC3 | R-HSA-5083628 | 2.439618e-01 | 0.613 | 0 | 0 |
| Defective MMADHC causes MMAHCD | R-HSA-3359473 | 2.439618e-01 | 0.613 | 0 | 0 |
| SMAD2/3 MH2 Domain Mutants in Cancer | R-HSA-3315487 | 2.439618e-01 | 0.613 | 0 | 0 |
| Defective SLC20A2 causes idiopathic basal ganglia calcification 1 (IBGC1) | R-HSA-5619111 | 2.439618e-01 | 0.613 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 2.439618e-01 | 0.613 | 0 | 0 |
| IRS activation | R-HSA-74713 | 1.394433e-01 | 0.856 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 1.394433e-01 | 0.856 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 2.052418e-01 | 0.688 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 2.052418e-01 | 0.688 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 1.659965e-01 | 0.780 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 2.392832e-01 | 0.621 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 2.392832e-01 | 0.621 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 2.392832e-01 | 0.621 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 2.392832e-01 | 0.621 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 2.392832e-01 | 0.621 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 2.392832e-01 | 0.621 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 1.351632e-01 | 0.869 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 1.351632e-01 | 0.869 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 1.351632e-01 | 0.869 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 1.351632e-01 | 0.869 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 1.889340e-01 | 0.724 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 1.889340e-01 | 0.724 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 1.889340e-01 | 0.724 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 1.889340e-01 | 0.724 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 2.126160e-01 | 0.672 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 1.696110e-01 | 0.771 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 1.975033e-01 | 0.704 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 1.874380e-01 | 0.727 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 1.874380e-01 | 0.727 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 2.304460e-01 | 0.637 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 1.897817e-01 | 0.722 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 2.424878e-01 | 0.615 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 2.563414e-01 | 0.591 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 2.563414e-01 | 0.591 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 2.510150e-01 | 0.600 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 2.228665e-01 | 0.652 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 1.607469e-01 | 0.794 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 1.572470e-01 | 0.803 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 2.368872e-01 | 0.625 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 1.677019e-01 | 0.775 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 2.457850e-01 | 0.609 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 2.261101e-01 | 0.646 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 1.773957e-01 | 0.751 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 2.159345e-01 | 0.666 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 1.394433e-01 | 0.856 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 2.454561e-01 | 0.610 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 1.989508e-01 | 0.701 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 2.304460e-01 | 0.637 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 2.067366e-01 | 0.685 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 1.584805e-01 | 0.800 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 2.210453e-01 | 0.656 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 1.485787e-01 | 0.828 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 1.653684e-01 | 0.782 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 2.015012e-01 | 0.696 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 2.015012e-01 | 0.696 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 2.304460e-01 | 0.637 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 1.515850e-01 | 0.819 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 1.605416e-01 | 0.794 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 1.889340e-01 | 0.724 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 1.874380e-01 | 0.727 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 1.718137e-01 | 0.765 | 0 | 0 |
| Prostacyclin signalling through prostacyclin receptor | R-HSA-392851 | 1.878776e-01 | 0.726 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 1.773957e-01 | 0.751 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 2.457850e-01 | 0.609 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 1.394433e-01 | 0.856 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 1.515850e-01 | 0.819 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 1.424664e-01 | 0.846 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 2.015012e-01 | 0.696 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 2.288817e-01 | 0.640 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 1.605416e-01 | 0.794 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 1.880684e-01 | 0.726 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 2.077737e-01 | 0.682 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 1.696110e-01 | 0.771 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 2.563414e-01 | 0.591 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 1.368389e-01 | 0.864 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 1.365412e-01 | 0.865 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 1.316265e-01 | 0.881 | 0 | 0 |
| Transport of connexins along the secretory pathway | R-HSA-190827 | 2.439618e-01 | 0.613 | 0 | 0 |
| TGFBR3 regulates FGF2 signaling | R-HSA-9839397 | 2.439618e-01 | 0.613 | 0 | 0 |
| Inhibition of Host mRNA Processing and RNA Silencing | R-HSA-168315 | 2.439618e-01 | 0.613 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 1.718137e-01 | 0.765 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 1.696110e-01 | 0.771 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 1.515850e-01 | 0.819 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 1.569735e-01 | 0.804 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 2.159345e-01 | 0.666 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 2.307064e-01 | 0.637 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 2.288817e-01 | 0.640 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 1.975266e-01 | 0.704 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 2.025059e-01 | 0.694 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 2.017738e-01 | 0.695 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 1.537192e-01 | 0.813 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 2.023417e-01 | 0.694 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 1.663646e-01 | 0.779 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 1.663646e-01 | 0.779 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 1.537192e-01 | 0.813 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 1.487917e-01 | 0.827 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 1.439647e-01 | 0.842 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 1.874380e-01 | 0.727 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 1.397306e-01 | 0.855 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 1.569735e-01 | 0.804 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 1.897817e-01 | 0.722 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 1.925733e-01 | 0.715 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 1.999777e-01 | 0.699 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 2.392832e-01 | 0.621 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 2.067366e-01 | 0.685 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 1.605416e-01 | 0.794 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 1.737751e-01 | 0.760 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 2.459203e-01 | 0.609 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 1.537192e-01 | 0.813 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 1.654809e-01 | 0.781 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 2.508919e-01 | 0.601 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 2.474767e-01 | 0.606 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 2.424878e-01 | 0.615 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 2.137724e-01 | 0.670 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 1.605416e-01 | 0.794 | 0 | 0 |
| Oligomerization of connexins into connexons | R-HSA-190704 | 2.439618e-01 | 0.613 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 1.696110e-01 | 0.771 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 1.354714e-01 | 0.868 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 2.261101e-01 | 0.646 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 1.737751e-01 | 0.760 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 2.288817e-01 | 0.640 | 0 | 0 |
| Disease | R-HSA-1643685 | 1.990223e-01 | 0.701 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 2.337589e-01 | 0.631 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 2.182557e-01 | 0.661 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 1.881446e-01 | 0.726 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 2.510150e-01 | 0.600 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 1.605416e-01 | 0.794 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 1.874380e-01 | 0.727 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 2.510150e-01 | 0.600 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 1.639502e-01 | 0.785 | 0 | 0 |
| Sodium-coupled phosphate cotransporters | R-HSA-427652 | 1.718137e-01 | 0.765 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 2.304460e-01 | 0.637 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 1.515850e-01 | 0.819 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 1.515850e-01 | 0.819 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 2.365138e-01 | 0.626 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 1.520143e-01 | 0.818 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 1.351632e-01 | 0.869 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 2.459203e-01 | 0.609 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 2.261101e-01 | 0.646 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 2.126160e-01 | 0.672 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 2.355165e-01 | 0.628 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 2.510150e-01 | 0.600 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 2.611378e-01 | 0.583 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 2.125765e-01 | 0.672 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 2.616000e-01 | 0.582 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 2.616000e-01 | 0.582 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 2.648169e-01 | 0.577 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 2.657707e-01 | 0.575 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 2.660905e-01 | 0.575 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 2.663783e-01 | 0.575 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 2.704184e-01 | 0.568 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 2.722579e-01 | 0.565 | 0 | 0 |
| Alpha-defensins | R-HSA-1462054 | 2.735642e-01 | 0.563 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 2.735642e-01 | 0.563 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 2.735642e-01 | 0.563 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 2.767318e-01 | 0.558 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 2.824192e-01 | 0.549 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 2.824192e-01 | 0.549 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 2.824192e-01 | 0.549 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 2.850683e-01 | 0.545 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 2.865457e-01 | 0.543 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 2.865457e-01 | 0.543 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 2.866153e-01 | 0.543 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 2.866153e-01 | 0.543 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 2.866153e-01 | 0.543 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 2.866153e-01 | 0.543 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 2.866153e-01 | 0.543 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 2.901916e-01 | 0.537 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 2.925343e-01 | 0.534 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 2.925343e-01 | 0.534 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 2.925343e-01 | 0.534 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 2.925343e-01 | 0.534 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 2.998510e-01 | 0.523 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 3.002367e-01 | 0.523 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 3.002367e-01 | 0.523 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 3.002367e-01 | 0.523 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 3.006127e-01 | 0.522 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 3.046366e-01 | 0.516 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 3.065657e-01 | 0.513 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 3.077728e-01 | 0.512 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 3.077728e-01 | 0.512 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 3.077728e-01 | 0.512 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 3.077728e-01 | 0.512 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 3.077728e-01 | 0.512 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 3.077728e-01 | 0.512 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 3.077728e-01 | 0.512 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 3.077728e-01 | 0.512 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 3.077728e-01 | 0.512 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 3.077728e-01 | 0.512 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 3.077728e-01 | 0.512 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 3.077728e-01 | 0.512 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 3.077728e-01 | 0.512 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 3.085124e-01 | 0.511 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 3.085124e-01 | 0.511 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 3.085124e-01 | 0.511 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 3.085446e-01 | 0.511 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 3.112632e-01 | 0.507 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 3.112632e-01 | 0.507 | 0 | 0 |
| Defective ALG9 causes CDG-1l | R-HSA-4720454 | 3.112632e-01 | 0.507 | 0 | 0 |
| TWIK related potassium channel (TREK) | R-HSA-1299503 | 3.112632e-01 | 0.507 | 0 | 0 |
| Glycogen storage disease type XV (GYG1) | R-HSA-3814836 | 3.112632e-01 | 0.507 | 0 | 0 |
| Defective F8 cleavage by thrombin | R-HSA-9672391 | 3.112632e-01 | 0.507 | 0 | 0 |
| Glycogen storage disease type 0 (muscle GYS1) | R-HSA-3828062 | 3.112632e-01 | 0.507 | 0 | 0 |
| Defective POMT1 causes MDDGA1, MDDGB1 and MDDGC1 | R-HSA-5083633 | 3.112632e-01 | 0.507 | 0 | 0 |
| Defective POMT2 causes MDDGA2, MDDGB2 and MDDGC2 | R-HSA-5083629 | 3.112632e-01 | 0.507 | 0 | 0 |
| Defective VWF cleavage by ADAMTS13 variant | R-HSA-9845621 | 3.112632e-01 | 0.507 | 0 | 0 |
| Enhanced cleavage of VWF variant by ADAMTS13 | R-HSA-9845619 | 3.112632e-01 | 0.507 | 0 | 0 |
| Defective SLC40A1 causes hemochromatosis 4 (HFE4) (duodenum) | R-HSA-5655799 | 3.112632e-01 | 0.507 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 3.112632e-01 | 0.507 | 0 | 0 |
| Interleukin-33 signaling | R-HSA-9014843 | 3.112632e-01 | 0.507 | 0 | 0 |
| Signalling to ERK5 | R-HSA-198765 | 3.112632e-01 | 0.507 | 0 | 0 |
| Activation, myristolyation of BID and translocation to mitochondria | R-HSA-75108 | 3.112632e-01 | 0.507 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 3.118038e-01 | 0.506 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 3.137462e-01 | 0.503 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 3.137462e-01 | 0.503 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 3.170980e-01 | 0.499 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 3.182233e-01 | 0.497 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 3.182233e-01 | 0.497 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 3.246338e-01 | 0.489 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 3.277254e-01 | 0.484 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 3.280239e-01 | 0.484 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 3.280239e-01 | 0.484 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 3.280239e-01 | 0.484 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 3.280239e-01 | 0.484 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 3.284730e-01 | 0.484 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 3.290262e-01 | 0.483 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 3.363339e-01 | 0.473 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 3.363339e-01 | 0.473 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 3.363339e-01 | 0.473 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 3.370459e-01 | 0.472 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 3.370459e-01 | 0.472 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 3.391699e-01 | 0.470 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 3.408664e-01 | 0.467 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 3.408664e-01 | 0.467 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 3.416504e-01 | 0.466 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 3.416504e-01 | 0.466 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 3.416504e-01 | 0.466 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 3.416504e-01 | 0.466 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 3.416504e-01 | 0.466 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 3.416504e-01 | 0.466 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 3.416504e-01 | 0.466 | 0 | 0 |
| Tandem pore domain potassium channels | R-HSA-1296346 | 3.416504e-01 | 0.466 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 3.416504e-01 | 0.466 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 3.433013e-01 | 0.464 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 3.489104e-01 | 0.457 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 3.571789e-01 | 0.447 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 3.582593e-01 | 0.446 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 3.622322e-01 | 0.441 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 3.622322e-01 | 0.441 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 3.622322e-01 | 0.441 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 3.622322e-01 | 0.441 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 3.658068e-01 | 0.437 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 3.698097e-01 | 0.432 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 3.698097e-01 | 0.432 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 3.706491e-01 | 0.431 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 3.725772e-01 | 0.429 | 0 | 0 |
| Defective MMACHC causes MAHCC | R-HSA-3359474 | 3.725772e-01 | 0.429 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 3.725772e-01 | 0.429 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 3.725772e-01 | 0.429 | 0 | 0 |
| FasL/ CD95L signaling | R-HSA-75157 | 3.725772e-01 | 0.429 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 3.725772e-01 | 0.429 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 3.725772e-01 | 0.429 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 3.725772e-01 | 0.429 | 0 | 0 |
| CASP5-mediated substrate cleavage | R-HSA-9960525 | 3.725772e-01 | 0.429 | 0 | 0 |
| CASP4-mediated substrate cleavage | R-HSA-9960519 | 3.725772e-01 | 0.429 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 3.727544e-01 | 0.429 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 3.727544e-01 | 0.429 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 3.727544e-01 | 0.429 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 3.727544e-01 | 0.429 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 3.735407e-01 | 0.428 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 3.735407e-01 | 0.428 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 3.735407e-01 | 0.428 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 3.735407e-01 | 0.428 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 3.749851e-01 | 0.426 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 3.749851e-01 | 0.426 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 3.749851e-01 | 0.426 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 3.749851e-01 | 0.426 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 3.749851e-01 | 0.426 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 3.749851e-01 | 0.426 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 3.808745e-01 | 0.419 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 3.808745e-01 | 0.419 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 3.810960e-01 | 0.419 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 3.811712e-01 | 0.419 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 3.816595e-01 | 0.418 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 3.871596e-01 | 0.412 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 3.872635e-01 | 0.412 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 3.872635e-01 | 0.412 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 3.881602e-01 | 0.411 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 3.899221e-01 | 0.409 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 3.899221e-01 | 0.409 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 3.899221e-01 | 0.409 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 3.899221e-01 | 0.409 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 3.906624e-01 | 0.408 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 4.017582e-01 | 0.396 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 4.057721e-01 | 0.392 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 4.076052e-01 | 0.390 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 4.076052e-01 | 0.390 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 4.076052e-01 | 0.390 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 4.076052e-01 | 0.390 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 4.076052e-01 | 0.390 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 4.076052e-01 | 0.390 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 4.076052e-01 | 0.390 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 4.076052e-01 | 0.390 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 4.076052e-01 | 0.390 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 4.077923e-01 | 0.390 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 4.091680e-01 | 0.388 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 4.094545e-01 | 0.388 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 4.114130e-01 | 0.386 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 4.120506e-01 | 0.385 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 4.120506e-01 | 0.385 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 4.120506e-01 | 0.385 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 4.120506e-01 | 0.385 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 4.120506e-01 | 0.385 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 4.120506e-01 | 0.385 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 4.120506e-01 | 0.385 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 4.120506e-01 | 0.385 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 4.120506e-01 | 0.385 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 4.120506e-01 | 0.385 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 4.138514e-01 | 0.383 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 4.181498e-01 | 0.379 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 4.226301e-01 | 0.374 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 4.272771e-01 | 0.369 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 4.272771e-01 | 0.369 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 4.284360e-01 | 0.368 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 4.284360e-01 | 0.368 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 4.284360e-01 | 0.368 | 0 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 4.284360e-01 | 0.368 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 4.284360e-01 | 0.368 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 4.284360e-01 | 0.368 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 4.284360e-01 | 0.368 | 0 | 0 |
| Alanine metabolism | R-HSA-8964540 | 4.284360e-01 | 0.368 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 4.284360e-01 | 0.368 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 4.284360e-01 | 0.368 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 4.284360e-01 | 0.368 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 4.284360e-01 | 0.368 | 0 | 0 |
| Dopamine receptors | R-HSA-390651 | 4.284360e-01 | 0.368 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 4.320097e-01 | 0.365 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 4.320097e-01 | 0.365 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 4.359162e-01 | 0.361 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 4.365140e-01 | 0.360 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 4.365140e-01 | 0.360 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 4.370565e-01 | 0.359 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 4.393738e-01 | 0.357 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 4.393738e-01 | 0.357 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 4.393738e-01 | 0.357 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 4.393738e-01 | 0.357 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 4.393738e-01 | 0.357 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 4.393738e-01 | 0.357 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 4.393738e-01 | 0.357 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 4.393738e-01 | 0.357 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 4.393738e-01 | 0.357 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 4.393738e-01 | 0.357 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 4.393738e-01 | 0.357 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 4.393738e-01 | 0.357 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 4.393738e-01 | 0.357 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 4.416303e-01 | 0.355 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 4.452741e-01 | 0.351 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 4.452741e-01 | 0.351 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 4.482301e-01 | 0.348 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 4.605835e-01 | 0.337 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 4.613574e-01 | 0.336 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 4.652083e-01 | 0.332 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 4.652083e-01 | 0.332 | 0 | 0 |
| Immune System | R-HSA-168256 | 4.656197e-01 | 0.332 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 4.701841e-01 | 0.328 | 0 | 0 |
| PDH complex synthesizes acetyl-CoA from PYR | R-HSA-9861559 | 4.701841e-01 | 0.328 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 4.701841e-01 | 0.328 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 4.701841e-01 | 0.328 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 4.701841e-01 | 0.328 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 4.701841e-01 | 0.328 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 4.701841e-01 | 0.328 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 4.701841e-01 | 0.328 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 4.711586e-01 | 0.327 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 4.719998e-01 | 0.326 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 4.725555e-01 | 0.326 | 0 | 0 |
| Activation of AMPA receptors | R-HSA-399710 | 4.793249e-01 | 0.319 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 4.793249e-01 | 0.319 | 0 | 0 |
| NOSIP mediated eNOS trafficking | R-HSA-203754 | 4.793249e-01 | 0.319 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 4.793249e-01 | 0.319 | 0 | 0 |
| Enhanced binding of GP1BA variant to VWF multimer:collagen | R-HSA-9845620 | 4.793249e-01 | 0.319 | 0 | 0 |
| Defective binding of VWF variant to GPIb:IX:V | R-HSA-9846298 | 4.793249e-01 | 0.319 | 0 | 0 |
| IRF3 mediated activation of type 1 IFN | R-HSA-1606341 | 4.793249e-01 | 0.319 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 4.793249e-01 | 0.319 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 4.793249e-01 | 0.319 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 4.793249e-01 | 0.319 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 4.793249e-01 | 0.319 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 4.793249e-01 | 0.319 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 4.793249e-01 | 0.319 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 4.793249e-01 | 0.319 | 0 | 0 |
| Interleukin-36 pathway | R-HSA-9014826 | 4.793249e-01 | 0.319 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 4.793249e-01 | 0.319 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 4.793249e-01 | 0.319 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 4.829059e-01 | 0.316 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 4.841980e-01 | 0.315 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 4.870955e-01 | 0.312 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 4.870955e-01 | 0.312 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 4.968090e-01 | 0.304 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 4.968090e-01 | 0.304 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 4.968090e-01 | 0.304 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 4.982793e-01 | 0.303 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 4.982793e-01 | 0.303 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 4.999549e-01 | 0.301 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 4.999549e-01 | 0.301 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 4.999549e-01 | 0.301 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 4.999549e-01 | 0.301 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 5.028762e-01 | 0.299 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 5.040333e-01 | 0.298 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 5.073046e-01 | 0.295 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 5.143024e-01 | 0.289 | 0 | 0 |
| Defects of platelet adhesion to exposed collagen | R-HSA-9823587 | 5.256856e-01 | 0.279 | 0 | 0 |
| Plus-strand DNA synthesis | R-HSA-164525 | 5.256856e-01 | 0.279 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 5.256856e-01 | 0.279 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 5.256856e-01 | 0.279 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 5.256856e-01 | 0.279 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 5.256856e-01 | 0.279 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 5.256856e-01 | 0.279 | 0 | 0 |
| Signaling by RNF43 mutants | R-HSA-5340588 | 5.256856e-01 | 0.279 | 0 | 0 |
| Phase 1 - inactivation of fast Na+ channels | R-HSA-5576894 | 5.256856e-01 | 0.279 | 0 | 0 |
| GLI proteins bind promoters of Hh responsive genes to promote transcription | R-HSA-5635851 | 5.256856e-01 | 0.279 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 5.256856e-01 | 0.279 | 0 | 0 |
| TRAIL signaling | R-HSA-75158 | 5.256856e-01 | 0.279 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 5.256856e-01 | 0.279 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 5.256856e-01 | 0.279 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 5.256856e-01 | 0.279 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 5.256856e-01 | 0.279 | 0 | 0 |
| Release of apoptotic factors from the mitochondria | R-HSA-111457 | 5.256856e-01 | 0.279 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 5.256856e-01 | 0.279 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 5.256856e-01 | 0.279 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 5.286272e-01 | 0.277 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 5.286272e-01 | 0.277 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 5.286272e-01 | 0.277 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 5.286272e-01 | 0.277 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 5.286272e-01 | 0.277 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 5.286272e-01 | 0.277 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 5.286272e-01 | 0.277 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 5.286272e-01 | 0.277 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 5.298586e-01 | 0.276 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 5.298586e-01 | 0.276 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 5.309388e-01 | 0.275 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 5.311599e-01 | 0.275 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 5.311599e-01 | 0.275 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 5.338909e-01 | 0.273 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 5.391869e-01 | 0.268 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 5.518223e-01 | 0.258 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 5.518223e-01 | 0.258 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 5.518223e-01 | 0.258 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 5.561605e-01 | 0.255 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 5.561605e-01 | 0.255 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 5.561605e-01 | 0.255 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 5.561605e-01 | 0.255 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 5.624224e-01 | 0.250 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 5.624251e-01 | 0.250 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 5.624251e-01 | 0.250 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 5.624251e-01 | 0.250 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 5.624251e-01 | 0.250 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 5.625792e-01 | 0.250 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 5.626278e-01 | 0.250 | 0 | 0 |
| Small interfering RNA (siRNA) biogenesis | R-HSA-426486 | 5.679209e-01 | 0.246 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 5.679209e-01 | 0.246 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 5.679209e-01 | 0.246 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 5.679209e-01 | 0.246 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 5.679209e-01 | 0.246 | 0 | 0 |
| Uncoating of the HIV Virion | R-HSA-162585 | 5.679209e-01 | 0.246 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 5.679209e-01 | 0.246 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 5.679209e-01 | 0.246 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 5.679209e-01 | 0.246 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 5.679209e-01 | 0.246 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 5.679209e-01 | 0.246 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 5.679209e-01 | 0.246 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 5.679209e-01 | 0.246 | 0 | 0 |
| Defective factor VIII causes hemophilia A | R-HSA-9662001 | 5.679209e-01 | 0.246 | 0 | 0 |
| HDL clearance | R-HSA-8964011 | 5.679209e-01 | 0.246 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 5.679209e-01 | 0.246 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 5.731652e-01 | 0.242 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 5.731652e-01 | 0.242 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 5.734393e-01 | 0.242 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 5.734901e-01 | 0.241 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 5.825304e-01 | 0.235 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 5.825304e-01 | 0.235 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 5.825304e-01 | 0.235 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 5.827141e-01 | 0.235 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 5.836425e-01 | 0.234 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 5.863617e-01 | 0.232 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 5.938630e-01 | 0.226 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 5.938630e-01 | 0.226 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 5.938630e-01 | 0.226 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 5.975638e-01 | 0.224 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 6.010132e-01 | 0.221 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 6.063976e-01 | 0.217 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 6.063976e-01 | 0.217 | 0 | 0 |
| DAG1 core M1 glycosylations | R-HSA-8932506 | 6.063976e-01 | 0.217 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 6.063976e-01 | 0.217 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 6.063976e-01 | 0.217 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 6.063976e-01 | 0.217 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 6.063976e-01 | 0.217 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 6.063976e-01 | 0.217 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 6.063976e-01 | 0.217 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 6.077258e-01 | 0.216 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 6.077258e-01 | 0.216 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 6.077258e-01 | 0.216 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 6.077258e-01 | 0.216 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 6.077258e-01 | 0.216 | 0 | 0 |
| Choline catabolism | R-HSA-6798163 | 6.077258e-01 | 0.216 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 6.130106e-01 | 0.213 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 6.159258e-01 | 0.210 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 6.209760e-01 | 0.207 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 6.209760e-01 | 0.207 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 6.209760e-01 | 0.207 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 6.214007e-01 | 0.207 | 0 | 0 |
| PKA activation | R-HSA-163615 | 6.317467e-01 | 0.199 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 6.317467e-01 | 0.199 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 6.317467e-01 | 0.199 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 6.317467e-01 | 0.199 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 6.317467e-01 | 0.199 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 6.317467e-01 | 0.199 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 6.332537e-01 | 0.198 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 6.332537e-01 | 0.198 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 6.350446e-01 | 0.197 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 6.375817e-01 | 0.195 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 6.375817e-01 | 0.195 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 6.395505e-01 | 0.194 | 0 | 0 |
| Reverse Transcription of HIV RNA | R-HSA-162589 | 6.414500e-01 | 0.193 | 0 | 0 |
| Minus-strand DNA synthesis | R-HSA-164516 | 6.414500e-01 | 0.193 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 6.414500e-01 | 0.193 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 6.414500e-01 | 0.193 | 0 | 0 |
| DAG1 core M2 glycosylations | R-HSA-8932504 | 6.414500e-01 | 0.193 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 6.414500e-01 | 0.193 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 6.414500e-01 | 0.193 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 6.414500e-01 | 0.193 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 6.414500e-01 | 0.193 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 6.414500e-01 | 0.193 | 0 | 0 |
| Interleukin-9 signaling | R-HSA-8985947 | 6.414500e-01 | 0.193 | 0 | 0 |
| FGFR1b ligand binding and activation | R-HSA-190370 | 6.414500e-01 | 0.193 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 6.414500e-01 | 0.193 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 6.414500e-01 | 0.193 | 0 | 0 |
| SLC-mediated bile acid transport | R-HSA-9958517 | 6.414500e-01 | 0.193 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 6.414500e-01 | 0.193 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 6.417249e-01 | 0.193 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 6.515003e-01 | 0.186 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 6.519246e-01 | 0.186 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 6.519246e-01 | 0.186 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 6.519246e-01 | 0.186 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 6.519246e-01 | 0.186 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 6.519246e-01 | 0.186 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 6.519246e-01 | 0.186 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 6.537064e-01 | 0.185 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 6.539967e-01 | 0.184 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 6.546024e-01 | 0.184 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 6.546024e-01 | 0.184 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 6.546024e-01 | 0.184 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 6.693431e-01 | 0.174 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 6.699053e-01 | 0.174 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 6.710170e-01 | 0.173 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 6.711874e-01 | 0.173 | 0 | 0 |
| Estrogen-stimulated signaling through PRKCZ | R-HSA-9634635 | 6.733828e-01 | 0.172 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 6.733828e-01 | 0.172 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 6.733828e-01 | 0.172 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 6.733828e-01 | 0.172 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 6.733828e-01 | 0.172 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 6.733828e-01 | 0.172 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 6.733828e-01 | 0.172 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 6.733828e-01 | 0.172 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 6.733828e-01 | 0.172 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 6.733828e-01 | 0.172 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 6.733828e-01 | 0.172 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 6.733828e-01 | 0.172 | 0 | 0 |
| Butyrophilin (BTN) family interactions | R-HSA-8851680 | 6.733828e-01 | 0.172 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 6.763099e-01 | 0.170 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 6.763099e-01 | 0.170 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 6.763099e-01 | 0.170 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 6.777717e-01 | 0.169 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 6.801331e-01 | 0.167 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 6.871953e-01 | 0.163 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 6.939685e-01 | 0.159 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 6.939685e-01 | 0.159 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 6.958002e-01 | 0.158 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 6.968925e-01 | 0.157 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 6.968925e-01 | 0.157 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 6.968925e-01 | 0.157 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 6.968925e-01 | 0.157 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 6.980763e-01 | 0.156 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 6.991359e-01 | 0.155 | 0 | 0 |
| DNA replication initiation | R-HSA-68952 | 7.024733e-01 | 0.153 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 7.024733e-01 | 0.153 | 0 | 0 |
| Ion influx/efflux at host-pathogen interface | R-HSA-6803544 | 7.024733e-01 | 0.153 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 7.024733e-01 | 0.153 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 7.024733e-01 | 0.153 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 7.024733e-01 | 0.153 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 7.024733e-01 | 0.153 | 0 | 0 |
| Sperm Motility And Taxes | R-HSA-1300642 | 7.024733e-01 | 0.153 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 7.024733e-01 | 0.153 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 7.024733e-01 | 0.153 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 7.028882e-01 | 0.153 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 7.037973e-01 | 0.153 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 7.037973e-01 | 0.153 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 7.132889e-01 | 0.147 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 7.132889e-01 | 0.147 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 7.132889e-01 | 0.147 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 7.132889e-01 | 0.147 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 7.140499e-01 | 0.146 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 7.163782e-01 | 0.145 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 7.163782e-01 | 0.145 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 7.163782e-01 | 0.145 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 7.197171e-01 | 0.143 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 7.197171e-01 | 0.143 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 7.205900e-01 | 0.142 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 7.205900e-01 | 0.142 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 7.269474e-01 | 0.138 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 7.289744e-01 | 0.137 | 0 | 0 |
| DAG1 core M3 glycosylations | R-HSA-8932505 | 7.289744e-01 | 0.137 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 7.289744e-01 | 0.137 | 0 | 0 |
| LGI-ADAM interactions | R-HSA-5682910 | 7.289744e-01 | 0.137 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 7.289744e-01 | 0.137 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 7.289744e-01 | 0.137 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 7.289744e-01 | 0.137 | 0 | 0 |
| Synthesis of PIPs at the ER membrane | R-HSA-1483248 | 7.289744e-01 | 0.137 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 7.289744e-01 | 0.137 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 7.289744e-01 | 0.137 | 0 | 0 |
| Prostanoid ligand receptors | R-HSA-391908 | 7.289744e-01 | 0.137 | 0 | 0 |
| Transport of RCbl within the body | R-HSA-9758890 | 7.289744e-01 | 0.137 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 7.289744e-01 | 0.137 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 7.291248e-01 | 0.137 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 7.331557e-01 | 0.135 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 7.347992e-01 | 0.134 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 7.347992e-01 | 0.134 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 7.349630e-01 | 0.134 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 7.349630e-01 | 0.134 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 7.401142e-01 | 0.131 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 7.470046e-01 | 0.127 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 7.470046e-01 | 0.127 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 7.477459e-01 | 0.126 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 7.495458e-01 | 0.125 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 7.518112e-01 | 0.124 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 7.521905e-01 | 0.124 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 7.521905e-01 | 0.124 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 7.521905e-01 | 0.124 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 7.521905e-01 | 0.124 | 0 | 0 |
| Synthesis of diphthamide-EEF2 | R-HSA-5358493 | 7.531164e-01 | 0.123 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 7.531164e-01 | 0.123 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 7.531164e-01 | 0.123 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 7.531164e-01 | 0.123 | 0 | 0 |
| Uptake of dietary cobalamins into enterocytes | R-HSA-9758881 | 7.531164e-01 | 0.123 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 7.531164e-01 | 0.123 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 7.545049e-01 | 0.122 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 7.545049e-01 | 0.122 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 7.582856e-01 | 0.120 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 7.634780e-01 | 0.117 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 7.649915e-01 | 0.116 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 7.689116e-01 | 0.114 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 7.738808e-01 | 0.111 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 7.745792e-01 | 0.111 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 7.751092e-01 | 0.111 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 7.751092e-01 | 0.111 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 7.751092e-01 | 0.111 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 7.751092e-01 | 0.111 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 7.751092e-01 | 0.111 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 7.751092e-01 | 0.111 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 7.751092e-01 | 0.111 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 7.751092e-01 | 0.111 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 7.751092e-01 | 0.111 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 7.751092e-01 | 0.111 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 7.797050e-01 | 0.108 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 7.805143e-01 | 0.108 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 7.840344e-01 | 0.106 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 7.840344e-01 | 0.106 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 7.840344e-01 | 0.106 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 7.840344e-01 | 0.106 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 7.840344e-01 | 0.106 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 7.841436e-01 | 0.106 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 7.850675e-01 | 0.105 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 7.894486e-01 | 0.103 | 0 | 0 |
| IL-6-type cytokine receptor ligand interactions | R-HSA-6788467 | 7.951441e-01 | 0.100 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 7.951441e-01 | 0.100 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 7.951441e-01 | 0.100 | 0 | 0 |
| FGFR1c ligand binding and activation | R-HSA-190373 | 7.951441e-01 | 0.100 | 0 | 0 |
| Reversible hydration of carbon dioxide | R-HSA-1475029 | 7.951441e-01 | 0.100 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 7.951441e-01 | 0.100 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 7.985655e-01 | 0.098 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 7.985655e-01 | 0.098 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 7.985655e-01 | 0.098 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 7.987678e-01 | 0.098 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 8.007944e-01 | 0.096 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 8.015195e-01 | 0.096 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 8.049558e-01 | 0.094 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 8.091165e-01 | 0.092 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 8.103264e-01 | 0.091 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 8.109847e-01 | 0.091 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 8.122229e-01 | 0.090 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 8.122229e-01 | 0.090 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 8.122229e-01 | 0.090 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 8.122229e-01 | 0.090 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 8.122229e-01 | 0.090 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 8.122229e-01 | 0.090 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 8.130038e-01 | 0.090 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 8.133952e-01 | 0.090 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 8.133952e-01 | 0.090 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 8.133952e-01 | 0.090 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 8.133952e-01 | 0.090 | 0 | 0 |
| Prolactin receptor signaling | R-HSA-1170546 | 8.133952e-01 | 0.090 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 8.133952e-01 | 0.090 | 0 | 0 |
| Non-canonical inflammasome activation | R-HSA-9686114 | 8.133952e-01 | 0.090 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 8.133952e-01 | 0.090 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 8.133952e-01 | 0.090 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 8.140467e-01 | 0.089 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 8.190267e-01 | 0.087 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 8.239200e-01 | 0.084 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 8.250468e-01 | 0.084 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 8.250468e-01 | 0.084 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 8.250468e-01 | 0.084 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 8.250468e-01 | 0.084 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 8.250468e-01 | 0.084 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 8.300213e-01 | 0.081 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 8.300213e-01 | 0.081 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 8.300213e-01 | 0.081 | 0 | 0 |
| Protein lipoylation | R-HSA-9857492 | 8.300213e-01 | 0.081 | 0 | 0 |
| Signaling by Activin | R-HSA-1502540 | 8.300213e-01 | 0.081 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 8.300213e-01 | 0.081 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 8.342868e-01 | 0.079 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 8.364846e-01 | 0.078 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 8.370773e-01 | 0.077 | 0 | 0 |
| Regulation of pyruvate dehydrogenase (PDH) complex | R-HSA-204174 | 8.370773e-01 | 0.077 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 8.370773e-01 | 0.077 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 8.422583e-01 | 0.075 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 8.432245e-01 | 0.074 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 8.451669e-01 | 0.073 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 8.451669e-01 | 0.073 | 0 | 0 |
| Atorvastatin ADME | R-HSA-9754706 | 8.451669e-01 | 0.073 | 0 | 0 |
| Activation of the phototransduction cascade | R-HSA-2485179 | 8.451669e-01 | 0.073 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 8.451669e-01 | 0.073 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 8.462353e-01 | 0.073 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 8.476155e-01 | 0.072 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 8.483540e-01 | 0.071 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 8.483540e-01 | 0.071 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 8.498157e-01 | 0.071 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 8.498157e-01 | 0.071 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 8.557810e-01 | 0.068 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 8.565567e-01 | 0.067 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 8.589156e-01 | 0.066 | 0 | 0 |
| Glycine degradation | R-HSA-6783984 | 8.589638e-01 | 0.066 | 0 | 0 |
| Phase 2 - plateau phase | R-HSA-5576893 | 8.589638e-01 | 0.066 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 8.589638e-01 | 0.066 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 8.589638e-01 | 0.066 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 8.589638e-01 | 0.066 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 8.589638e-01 | 0.066 | 0 | 0 |
| Biosynthesis of maresin-like SPMs | R-HSA-9027307 | 8.589638e-01 | 0.066 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 8.589638e-01 | 0.066 | 0 | 0 |
| Defects of contact activation system (CAS) and kallikrein/kinin system (KKS) | R-HSA-9651496 | 8.589638e-01 | 0.066 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 8.622847e-01 | 0.064 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 8.688000e-01 | 0.061 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 8.688000e-01 | 0.061 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 8.699070e-01 | 0.061 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 8.699070e-01 | 0.061 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 8.715321e-01 | 0.060 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 8.715321e-01 | 0.060 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 8.715321e-01 | 0.060 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 8.715321e-01 | 0.060 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 8.715321e-01 | 0.060 | 0 | 0 |
| Metabolism of ingested H2SeO4 and H2SeO3 into H2Se | R-HSA-2408550 | 8.715321e-01 | 0.060 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 8.721933e-01 | 0.059 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 8.780440e-01 | 0.056 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 8.806541e-01 | 0.055 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 8.829810e-01 | 0.054 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 8.829810e-01 | 0.054 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 8.829810e-01 | 0.054 | 0 | 0 |
| FGFR1 ligand binding and activation | R-HSA-190242 | 8.829810e-01 | 0.054 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 8.829810e-01 | 0.054 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 8.829810e-01 | 0.054 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 8.838856e-01 | 0.054 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 8.838856e-01 | 0.054 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 8.866831e-01 | 0.052 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 8.866831e-01 | 0.052 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 8.866831e-01 | 0.052 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 8.866831e-01 | 0.052 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 8.903711e-01 | 0.050 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 8.903711e-01 | 0.050 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 8.934102e-01 | 0.049 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 8.934102e-01 | 0.049 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 8.934102e-01 | 0.049 | 0 | 0 |
| Diseases of hemostasis | R-HSA-9671793 | 8.934102e-01 | 0.049 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 8.934102e-01 | 0.049 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 8.934102e-01 | 0.049 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 8.947518e-01 | 0.048 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 8.965372e-01 | 0.047 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 8.971468e-01 | 0.047 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 9.008521e-01 | 0.045 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 9.019050e-01 | 0.045 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.022830e-01 | 0.045 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 9.022830e-01 | 0.045 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 9.023960e-01 | 0.045 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 9.029105e-01 | 0.044 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 9.029105e-01 | 0.044 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 9.029105e-01 | 0.044 | 0 | 0 |
| Eicosanoid ligand-binding receptors | R-HSA-391903 | 9.029105e-01 | 0.044 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.058103e-01 | 0.043 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.058103e-01 | 0.043 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 9.060602e-01 | 0.043 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 9.060602e-01 | 0.043 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 9.079595e-01 | 0.042 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 9.093085e-01 | 0.041 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 9.093085e-01 | 0.041 | 0 | 0 |
| Matriglycan biosynthesis on DAG1 | R-HSA-9939291 | 9.115645e-01 | 0.040 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 9.115645e-01 | 0.040 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 9.115645e-01 | 0.040 | 0 | 0 |
| Acyl chain remodelling of PG | R-HSA-1482925 | 9.115645e-01 | 0.040 | 0 | 0 |
| Intrinsic Pathway of Fibrin Clot Formation | R-HSA-140837 | 9.115645e-01 | 0.040 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.125283e-01 | 0.040 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.132397e-01 | 0.039 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 9.166868e-01 | 0.038 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.178223e-01 | 0.037 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 9.194477e-01 | 0.036 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 9.194477e-01 | 0.036 | 0 | 0 |
| Ribavirin ADME | R-HSA-9755088 | 9.194477e-01 | 0.036 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 9.201571e-01 | 0.036 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.216132e-01 | 0.035 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 9.219620e-01 | 0.035 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 9.266285e-01 | 0.033 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 9.266285e-01 | 0.033 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 9.266285e-01 | 0.033 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 9.266285e-01 | 0.033 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 9.266285e-01 | 0.033 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 9.266285e-01 | 0.033 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 9.266285e-01 | 0.033 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 9.266285e-01 | 0.033 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 9.276465e-01 | 0.033 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 9.325474e-01 | 0.030 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 9.329381e-01 | 0.030 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 9.329381e-01 | 0.030 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 9.329381e-01 | 0.030 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 9.331696e-01 | 0.030 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 9.331696e-01 | 0.030 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 9.331696e-01 | 0.030 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 9.331696e-01 | 0.030 | 0 | 0 |
| Biosynthesis of maresins | R-HSA-9018682 | 9.331696e-01 | 0.030 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 9.364373e-01 | 0.029 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.386844e-01 | 0.027 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 9.391280e-01 | 0.027 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 9.391280e-01 | 0.027 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 9.391280e-01 | 0.027 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 9.391280e-01 | 0.027 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.404731e-01 | 0.027 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.409557e-01 | 0.026 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 9.409557e-01 | 0.026 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.409557e-01 | 0.026 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 9.424409e-01 | 0.026 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 9.424409e-01 | 0.026 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.427549e-01 | 0.026 | 0 | 0 |
| Defects in cobalamin (B12) metabolism | R-HSA-3296469 | 9.445554e-01 | 0.025 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 9.445554e-01 | 0.025 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 9.445554e-01 | 0.025 | 0 | 0 |
| Fertilization | R-HSA-1187000 | 9.445554e-01 | 0.025 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 9.445554e-01 | 0.025 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 9.448231e-01 | 0.025 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 9.466978e-01 | 0.024 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.484540e-01 | 0.023 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 9.494992e-01 | 0.023 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 9.494992e-01 | 0.023 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 9.494992e-01 | 0.023 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 9.494992e-01 | 0.023 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 9.494992e-01 | 0.023 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 9.494992e-01 | 0.023 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 9.494992e-01 | 0.023 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 9.494992e-01 | 0.023 | 0 | 0 |
| Defensins | R-HSA-1461973 | 9.506536e-01 | 0.022 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 9.506536e-01 | 0.022 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.516410e-01 | 0.022 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.518614e-01 | 0.021 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.518614e-01 | 0.021 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 9.540024e-01 | 0.020 | 0 | 0 |
| Cobalamin (Cbl) metabolism | R-HSA-9759218 | 9.540024e-01 | 0.020 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 9.540024e-01 | 0.020 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 9.543281e-01 | 0.020 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 9.577399e-01 | 0.019 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 9.580541e-01 | 0.019 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 9.581044e-01 | 0.019 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 9.581044e-01 | 0.019 | 0 | 0 |
| Prednisone ADME | R-HSA-9757110 | 9.581044e-01 | 0.019 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 9.610175e-01 | 0.017 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 9.618407e-01 | 0.017 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 9.618407e-01 | 0.017 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 9.618407e-01 | 0.017 | 0 | 0 |
| Activation of Matrix Metalloproteinases | R-HSA-1592389 | 9.618407e-01 | 0.017 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 9.634935e-01 | 0.016 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 9.638451e-01 | 0.016 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.648164e-01 | 0.016 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.652441e-01 | 0.015 | 0 | 0 |
| Glyoxylate metabolism and glycine degradation | R-HSA-389661 | 9.690976e-01 | 0.014 | 0 | 0 |
| DAG1 glycosylations | R-HSA-8931838 | 9.711677e-01 | 0.013 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 9.724404e-01 | 0.012 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 9.727968e-01 | 0.012 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.736626e-01 | 0.012 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 9.737396e-01 | 0.012 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 9.760823e-01 | 0.011 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.763738e-01 | 0.010 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.774837e-01 | 0.010 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.777409e-01 | 0.010 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.782161e-01 | 0.010 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 9.801596e-01 | 0.009 | 0 | 0 |
| Metabolism of ingested SeMet, Sec, MeSec into H2Se | R-HSA-2408508 | 9.801596e-01 | 0.009 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 9.819299e-01 | 0.008 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 9.819299e-01 | 0.008 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.820615e-01 | 0.008 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.834106e-01 | 0.007 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 9.835423e-01 | 0.007 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 9.835423e-01 | 0.007 | 0 | 0 |
| Lysine catabolism | R-HSA-71064 | 9.835423e-01 | 0.007 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 9.835423e-01 | 0.007 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 9.855732e-01 | 0.006 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.863485e-01 | 0.006 | 0 | 0 |
| Diseases associated with N-glycosylation of proteins | R-HSA-3781860 | 9.863485e-01 | 0.006 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.865896e-01 | 0.006 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.870078e-01 | 0.006 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.871586e-01 | 0.006 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.871586e-01 | 0.006 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.872858e-01 | 0.006 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 9.875669e-01 | 0.005 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 9.875669e-01 | 0.005 | 0 | 0 |
| Aflatoxin activation and detoxification | R-HSA-5423646 | 9.886765e-01 | 0.005 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.886765e-01 | 0.005 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.893402e-01 | 0.005 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 9.896872e-01 | 0.005 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 9.896872e-01 | 0.005 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 9.896872e-01 | 0.005 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.896872e-01 | 0.005 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.904502e-01 | 0.004 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.905367e-01 | 0.004 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.906078e-01 | 0.004 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.909734e-01 | 0.004 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.909998e-01 | 0.004 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 9.914462e-01 | 0.004 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.919679e-01 | 0.004 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.922098e-01 | 0.003 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.922098e-01 | 0.003 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 9.929053e-01 | 0.003 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.933081e-01 | 0.003 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.941157e-01 | 0.003 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.947717e-01 | 0.002 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.951196e-01 | 0.002 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.951858e-01 | 0.002 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 9.955555e-01 | 0.002 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 9.959416e-01 | 0.002 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.962393e-01 | 0.002 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.962393e-01 | 0.002 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.965679e-01 | 0.001 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.966297e-01 | 0.001 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.970735e-01 | 0.001 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.972071e-01 | 0.001 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.972161e-01 | 0.001 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.972314e-01 | 0.001 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.974725e-01 | 0.001 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.978133e-01 | 0.001 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.978976e-01 | 0.001 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.980854e-01 | 0.001 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.984123e-01 | 0.001 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.986834e-01 | 0.001 | 0 | 0 |
| Xenobiotics | R-HSA-211981 | 9.988011e-01 | 0.001 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 9.990391e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.990947e-01 | 0.000 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.993165e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid catabolism | R-HSA-9840310 | 9.993165e-01 | 0.000 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.993776e-01 | 0.000 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.993776e-01 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.994742e-01 | 0.000 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.994839e-01 | 0.000 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.995056e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.996479e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.996620e-01 | 0.000 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.996770e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.996770e-01 | 0.000 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.997059e-01 | 0.000 | 0 | 0 |
| Biosynthesis of DHA-derived SPMs | R-HSA-9018677 | 9.997561e-01 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.998416e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.998529e-01 | 0.000 | 0 | 0 |
| Class C/3 (Metabotropic glutamate/pheromone receptors) | R-HSA-420499 | 9.998848e-01 | 0.000 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.998930e-01 | 0.000 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.999045e-01 | 0.000 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.999142e-01 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.999208e-01 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.999213e-01 | 0.000 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.999370e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.999549e-01 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.999621e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.999626e-01 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.999645e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.999766e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.999784e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.999793e-01 | 0.000 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 9.999806e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.999879e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999898e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.999912e-01 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.999928e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.999969e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.999971e-01 | 0.000 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 9.999973e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid metabolism | R-HSA-1660662 | 9.999973e-01 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.999975e-01 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.999979e-01 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 9.999989e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.999991e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.999995e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.999995e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999997e-01 | 0.000 | 0 | 0 |
| Biosynthesis of specialized proresolving mediators (SPMs) | R-HSA-9018678 | 9.999997e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999998e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999998e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.999999e-01 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 9.999999e-01 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Expression and translocation of olfactory receptors | R-HSA-9752946 | 1.000000e+00 | -0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |